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Intensity Modulated Radiotherapy (IMRT) has been a major field of research over the last thirty 
years and is today the standard in radiotherapy treatment of cancer. The introduction of IMRT 
into the clinical environment has greatly improved the ability of the treatment team to conform 
the radiation dose to the tumour volume. Alongside improvements in image guidance, IMRT 
has led to a reduction in side effects for patients and opened up the possibilities of dose 
escalation and hypofractionation. IMRT is however by no means perfect. IMRT and derivatives 
such as Volumated Arc Therapy (VMAT) are limited by the exit dose from the X-ray beams 
and deliver a significant amount of radiation dose to normal tissues. The much publicised 
alternative to IMRT is proton therapy. Proton therapy beams deposit dose over a narrow range 
resulting in minimal exit dose. The future of radiotherapy certainly involves a significant 
contribution from proton therapy but the availability to patients is likely to remain limited for a 
long time to come. The research in this thesis considers the possibility of further improving 
IMRT by modulating radiotherapy beams along their direction of travel as well as across their 
intensity, i.e. the so called ‘Depth Modulation’ of the thesis title.  Although there are numerous 
possible ways to achieve depth modulation, this work proposes a combination of X-ray beams 
with electron beams of different energies with both modalities delivered with a conventional 
medical linear accelerator.  The research in this thesis is concerned with developing a proof of 
principle for this method. It is to some extent a theoretical study, however at each step the 
possibility of practical implementation has been considered with the view that the method is 
only a viable proposition if it can be effectively implemented into clinical practice.   
The technique proposed in this work is to use electron beams delivered through X-ray MLC 
with a standard patient set up. To reduce scatter and photon contamination it is proposed to 
remove the scattering foils from the beamline and to employ optimisation of the electron and 
photon components to compensate for any remaining penumbra broadening. The research has 
shown that improvements to dosimetry through removal of the scattering foil would allow 




delivery for both the electron and photon components practical.  Electron dose segments have 
been calculated using Monte Carlo radiation transport and a procedure to optimise dose for the 
combined photon and electron IMRT technique has been developed. Through development of 
the optimisation procedure the characteristics of the mixed modality technique have been 
examined. A number of findings are demonstrated such as the benefit of gaps between electron 
segments, the benefits of optimising for energy in three dimensions and the dependence of the 
cost function minimum on the electron to photon ratio.   Through clinical examples it has been 
shown that for tumours close to the surface the mixed modality technique has the potential to 
reduce the dose to normal tissues, particular in the low dose wash. Calculations of relative 
malignant induction probability demonstrate that this reduction in dose has the potential to 
reduce the incidence of secondary cancer induction. Possible treatment sites for application of 
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3D-CRT  Three-dimensional conformal radiotherapy 
CAX   Central axis  
CI  Conformity index 
CT  Computed tomography 
CTV  Clinical target volume 
DVH  Dose-volume histogram 
EUD  Equivalent uniform dose 
eMLC  Electron MLC 
exIMRT Combined electron and X-ray IMRT 
GTV  Gross tumour volume 
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IMRT  Intensity-modulated radiotherapy 
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LET  Linear energy transfer 
MC  Monte Carlo 
MIP  Malignant induction probability 
MLC  Multi-leaf collimator 
MU  Monitor units 
MV  Megavoltage 
NTCP  Normal tissue complication probability 
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PTV   Planning target volume 
RBE  Relative biological effectiveness 
R50   Half value depth 
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ssIMRT Step and shoot IMRT 
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TPS  Treatment planning system 
UHCW University Hospital Coventry and Warwickshire 
VMAT  Volumetric modulated arc therapy 
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Introduction and outline of approach 
1.1. Introduction 
This chapter introduces the background to the problem by describing current practice in the use of 
radiotherapy for the treatment of cancer. It introduces the concept of depth and energy modulation 
for external beam radiotherapy to help the reader understand the current issues in radiotherapy 
treatment planning and delivery addressed in this work. Following the description of the 
motivation, the research aims are identified before describing the contributions and resulting 
deliverables. The outline of approach is then given to provide the reader with a concise description 
of the organisation of this thesis as well as the logical connections between chapters. 
 
1.2. Background to the problem 
1.2.1. Radiotherapy 
Radiation therapy or radiotherapy is used as part of cancer treatment either as a curative treatment 
or as a palliative treatment to control symptoms and improve quality of life. Radiotherapy can be 
as a standalone treatment or used in conjunction with other forms of treatment such as 
chemotherapy and surgery. Controlled amounts of ionising radiation are used to destroy malignant 
cancer cells. The best way to deliver the dose of radiation will depend on the type and location of 
the cancer: 
a) External beam radiotherapy (teletherapy): delivers the required radiation dose from a 
source of ionising radiation outside of the patient. 
b) Brachytherapy: delivers the required radiation dose from radioactive sources implanted in 
the patient close to or inside the cancer location. 
c) Intraoperative: delivers the required radiation dose to the tumour bed during surgery. 
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d) Unsealed Source Therapy: delivers the required radiation dose from a radioactive substance 
swallowed or injected into the patient. 
 
The nature of methods b), c) and d) are such that they are only relevant for a small subset of 
tumours.  This work, will therefore consider external beam radiotherapy which constitutes the 
majority of radiotherapy treatments delivered in the UK/world. Henceforth, for conciseness, the 
term ‘radiotherapy’ will be used to refer to ‘external beam radiotherapy’. 
The history of radiotherapy starts with the discovery of X-rays in 1895. Just weeks after 
Wilhelm Roentgen’s discovery Emil Grubbé, a student doctor in Chicago, became the first person 
to use ionising radiation to treat cancer. Applying ionising radiation to a tumour can destroy the 
cancer cells making them unable to divide, reproduce and supplant the surrounding healthy cells. 
Today radiotherapy has developed into an integral part of cancer treatment.  It has been estimated 
that the addition of radiotherapy to cancer treatment improves 5 year survival by 16% (Barton et 
al., 1995). In comparison the 5 year survival contribution from chemotherapy drugs is estimated 
at 2% (Morgan et al., 2004), making radiotherapy second only to surgery in its effectiveness.   
 
1.2.2. Radiobiology 
Radiotherapy strives to destroy as many cancer cells as possible, while limiting damage to the 
healthy tissue. This is accomplished by directing, with great precision, high energy photons to the 
target volume defined by the clinician. The photons travel some distance in the patient before 
interacting with the tissue leading to a partial or total transfer of the photon energy to electron 
energy. Subsequent ionisations cause damage to the cell molecules either directly or through the 
creation of free radicals. A small fraction of the damages are non-repairable, which results in cells 
that eventually die.  DNA is thought to be the most important subcellular target molecule and it is 
DNA double strands breaks that most closely correlate with cell death. 
Unfortunately as with other forms of treatment radiotherapy is not without its side effects. 
Side effects result from damage to normal tissues as X-rays pass through the patient. In general 
the amount of damage and the severity of the side effects will increase with dose and the volume 
irradiated. The time from treatment to injury will depend on the rate of turnover of cells in the 
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organ.  Tissues that have a rapid turnover manifest acute effects with a timescale of days or weeks 
following treatment. Late effects with a timescale of months or years occur in tissues with a slow 
turnover.  Both early and late reactions can result in permanent effects ranging in severity from 
changes to the appearance of the skin to spinal cord injury resulting in paralysis. The severity of 
injury will also be influenced by the organisation of functional subunits within the organ. Damage 
to a small volume of an organ with serially arranged subunits, such as the bowel, will result in 
change to the whole organ. Organs where subunits are arranged in parallel, such as the kidney, can 
sustain damage to a larger volume as each subunit acts independently. In addition to the significant 
risk of side effects there is a potential small risk that irradiation of normal tissues will induce a 
secondary cancer at a later stage.  
In order to maintain a high ‘tumour control probability’ (TCP) it is necessary to deliver as 
much dose as possible to the target in order to kill all of the cancer cells. The radiation dose 
delivered in the path of the ionising radiation will also damage surrounding normal tissues and this 
dose must be minimised to give a low ‘normal tissue complication probability’ (NTCP).  Hence 
when designing a radiotherapy treatment technique, the aim is to increase TCP and reduce NTCP, 
or to maximise the ‘therapeutic ratio’ of TCP over NTCP.  
One way to improve the therapeutic ratio is through fractionation. In general early 
responding tissue cells damaged by ionising radiation can repopulate faster than the radiosensitive 
cancer cells. Most radiotherapy is therefore given in multiple small doses or ‘fractions’ with time 
in between treatments to allow for the repair of normal tissues.  
 
1.2.3. Hardware 
Protocols for dose and fractionation schemes are being continuously reviewed and updated based 
on evidence derived from clinical research. However for any given dose and fractionation scheme 
the technical challenge of how to deliver the dose to the tumour volume whilst minimising the 
dose to surrounding normal tissues remains. Attempting to meet these conflicting goals by 
improving the spatial distribution of dose in the patient has been a major motivation for the 
technological advances in radiotherapy.  In turn, as the conformity of dose distributions to the 
tumour volume improves, the next step is to review dose and fractionations schemes to permit 
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higher tumour dose to be achieved through a reduced number of fractions without increasing side 
effects.  
In the early days of radiotherapy some sparing of normal tissues was achieved by 
collimating the applied X-ray beam to the area to treat by using lead shielding on the surface of 
the patient. This conforms the dose distribution in the plane of the lead shielding but does not 
change the distribution of dose with depth in the patient. The distribution of dose with depth is 
characterised by an approximately exponential drop off as the X-ray photons are attenuated and as 
the X-ray intensity drops due to the inverse square law as the distance from the source of radiation 
increases (see Figure 1.1).  Due to this slow drop off in dose with depth, a tumour at some depth 
in the patient will receive less dose than the preceding tissues.  
Higher energy, more penetrating, X-ray beams can be used to reduce the dose towards the 
surface relative to the tumour dose for deep tumours. Hence, one of the early drivers for 
radiotherapy technology was to increase the energy from 100kV X-ray tubes to 1 MeV cobalt-60 
machines to up to 25MeV linear accelerators (Thwaites and Tuohy, 2006). 
The medical linear accelerator or linac is the current workhorse of radiotherapy 
departments. A linac produces ionising radiation by generating electrons and accelerating them in 
a pulsed RF field along a tuned waveguide.  In X-ray mode the electrons are directed towards a 
tungsten target where bremsstrahlung X-ray photons are produced.  
 Increasing the X-ray beam energy to ‘megavoltage’ levels has the additional benefit of 
reducing skin dose due to the so called build-up effect. The dose at the surface of the patient is 
actually less than the dose at depth due to the relatively long range of energetic secondary charged 
particles (electrons and positrons) that are first released in the patient by photon interactions and 
then deposit their kinetic energy in the patient downstream of the initial interaction. This region 
between the surface and depth of maximum dose in megavoltage X-ray beams is referred to as the 
dose build-up region (see Figure 1.1). 
However, this build-up region is a few centimetres deep at most. To deliver a cumulative 
dose higher at the tumour depth than at the surface it is necessary to combine several beams, from 
different angles of incidence, overlapping over the tumour location. This is achieved in a modern 
linac by mounting the linac head through which the X-rays are directed onto a gantry. The gantry 
is able to rotate around the patient permitting X-ray beams to be delivered from different directions 
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without moving the patient. The gantry rotation is centred at a point referred to as the isocentre 
and the machine calibrated such that the radiation isocentre is coincident with the mechanical 
isocentre. The gantry enables the direction of the beams to be in a direction coplanar with the 
gantry rotation and perpendicular to the patient that is typically lying on a patient support system. 
Non coplanar beam arrangement are possible by changing the orientation of the patient support 
systems. The approach developed in this work can be applied to either coplanar or non-coplanar 
beam delivery, however, it is demonstrated for the coplanar case only.      
It is also possible to run the linac in electron mode. In electron mode the X-ray target is 
retracted from the linac such that the accelerated electrons pass directly to the patient. Electrons 
are particles with a negative elementary charge and a mass that is 1/1836 that of a proton. When a 
charged particle enters a medium the energy it deposits is approximately inversely proportional to 
the square of its velocity, so as the particle slows the probability of causing ionisation events 
increases. The resultant rapid accumulation of ionisation events due to decreasing velocity at the 
end of the particles path causes a dose peak known as a Bragg peak. However, as electrons have 
extremely small mass they undergo multiple scattering events on their path into the patient. At 
each scattering event the electron will change direction and the energy deposition is spread in the 
transverse direction as it progresses forward in the initial direction. Hence no Bragg peak is seen 
for electrons. Megavoltage electron beams will deliver close to maximum dose at the patient’s 
surface rising to a plateau and steeply falling off with depth after a few centimetres. The dose 
gradient for lower electron energies is steeper than that for higher electron energies, because the 
lower energy electrons are scattered at a greater angle away from their initial directions. For 
electron energies less than 20MeV the steep dose gradient can be exploited to spare normal tissues 
beyond the range of the electrons. Such characteristics only allows treatment to superficial tumours 
up to 7cm deep (see Figure 1.1). 
Linac X-ray energy is defined by the maximum energy in the spectrum of the beam. For 
example, a linac with an energy distribution of up to 6 MeV would be described as ‘6 MV’. In 
electron mode there is less spread in the energy spectrum and an electron beam with approximately 
6MeV energy would be described as ‘6 MeV’ in electron mode.  For both X-ray and electron mode 
these are convenient approximate terms only. Accurate definition of the beams energy is achieved 
using parameters derived from the characteristics of its distribution of dose with depth or ‘depth 
dose’. 
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Shaping of the beam is necessary to further minimise dose to normal tissues. High energy 
X-rays need several cm of lead for shielding. Linac employ, within the head of the machine, 
moveable components made of heavy metal to block unwanted radiation and shape the radiation 
to conform to the target as seen from the beams eye view.  Two sets of movable jaws can form 
rectangles and multi leaf collimators (MLC), that are composed of 80 to 160 4 to 10mm wide 
interlocking motorised leafs (depending on design) can form complex shapes to conform the dose 
to the tumour volume. MLC can also be moved dynamically to modulate the amount of radiation 
passing through, (see Section 1.2.5). The head of the linac is typically about 40 to 50cm from the 
patient surface. In order to minimise scatter of electrons in the air between the linac head and the 
patient, electron beams are collimated using additional applicators or cones that bring the shaping 
of the beam close to the patient surface. This is made easier by the fact that a reduced thickness of 
shielding is required for electron beams compared to megavoltage X-ray beams. 
The amount of radiation absorbed by the tissue is called dose and has the unit Gray 
(abbreviated as Gy), with 1 Gy = 1 J/kg. If a linac runs at a constant dose rate then the amount of 
dose received in the patient will be proportional to the amount of time the X-ray beam remains on. 
Rather than using time, the output of the linac is monitored in real time using a monitoring 
ionisation chamber and the machine calibrated in terms of monitor units (MU). Typically the linac 
will be carefully calibrated to give 1Gy per 100 MU in specific reference conditions. If deviation 
from the reference conditions is known then the MU to give a required dose at the specified point 
can be calculated. 
 
Figure 1.1 The variation of dose with depth in the patient for X-rays and for electrons at energies 
commonly used in Radiotherapy. 
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1.2.4. Treatment Planning 
The process of using computer aided design to plan the delivery of the treatment is known as 
treatment planning.  To plan a treatment it is necessary to delineate the volume to be treated and 
the key anatomical structures to consider and if possible spare. Such information can be obtained 
by imaging the patient in 3D using CT as well as a number of other imaging modalities. In cases 
where organ motion is critical, it is also possible to create 3D movies of the relevant patient 
anatomy. 
Using such information, a clinician will define a volume corresponding to the tumour mass 
or gross tumour volume (GTV). This GTV may then be expanded to include subclinical 
microscopic disease to create the clinical target volume (CTV). To account for errors in setting up 
the patient, movement of the patient, internal movement of the CTV, or potential changes in size 
or shape of the CTV during treatment an additional margin for error is added to form the planning 
target volume (PTV). This PTV is a tool to shape the dose distribution and ensure with a clinically 
acceptable probability that an adequate dose will actually be delivered to all parts of the CTV. 
The aim of treatment planning is to determine the most appropriate setting for the linac 
parameters to create the spatial distribution of dose in the patient that delivers the required dose to 
the PTV whilst minimising dose to normal tissues, with specific care being taken of critical 
anatomical structures. Specific organs at risk (OAR) may be defined with associated planning 
constraints to ensure treatment is safe. A margin may be added to the OAR in a similar way to the 
PTV to create a planning risk volume (PRV) to ensure that adequate sparing of OAR will actually 
be achieved with a reasonable probability. 
Recommendations for the definition of GTV, CTV, PTV and PRV volumes along with 
methods for dose prescribing and reported are provided by the international committee on radiation 
units and measurement (ICRU) in (ICRU50, 1993, ICRU62, 1999, ICRU83, 2010). These 
guidelines help standardise the process of treatment planning allowing direct comparison of 
techniques internationally. 
Treatment planning is a complex process due to the large number of variables to consider, 
including beam energy, beam modulation, beam angle of incidence and rotation of the patient 
support system. In addition the optimisation of these variables by the treatment planner cannot be 
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achieved in isolation from the clinical context. For example uncertainties in the delivery of the 
radiotherapy need to be included in the treatment plan.  
For complex beam modulation an inverse planning approach is required. Rather than 
relying on the skill of the treatment planner to set the linac parameters a prescription is defined 
and an algorithm used to determine the beam intensity required to deliver that prescription. Inverse 
planned intensity modulated radiotherapy (IMRT) is now the current standard in radiotherapy. 
 
1.2.5. Treatment Technique 
There are a number of techniques available to deliver external beam radiotherapy treatment, all of 
which aim to conform the dose distribution to the PTV. 3D conformal radiotherapy (3DCRT) aims 
to conform to the shape of the PTV as seen from the beam’s eye view.  Prior to 3DCRT, treatments 
aimed to match the height and width of the tumour perhaps with a minimal amount of shielding. 
Advances in imaging technology have made it possible to locate and treat the tumour more 
precisely and advances in hardware allow shaping of the beams with MLC. 
An improvement to 3DCRT, referred to as intensity modulated radiation therapy (IMRT) 
can be made by modulating the intensity across each beam.  Individual beams are modulated using 
MLC to intentionally deliver a non-uniform dose to the target. When dose distributions from 
individual beams are superimposed the combined dose distribution is uniform and shaped to the 
target. The additional degrees of freedom are utilised to achieve a better target dose conformity 
and/or better sparing of normal tissues. 
The natural evolution of IMRT is to have one continuous gantry arc rather than multiple 
static beams and this technique is known as volume modulated arc therapy (VMAT). At the time 
of writing, VMAT is rapidly taking over from static field IMRT as, thanks to the high level of 
linac automation, it is much quicker to deliver and can potentially produce improved dose 
distributions (Teoh et al., 2011). 
 IMRT and VMAT are conventional linac based technologies, however there are others 
treatment machines available. For example TomoTherapy® employs a rotating compact linac and 
delivers the dose slice by slice like a CT scanner. CyberKnife® uses a compact linac attached to 
a robotic arm to allow freedom of movement in three dimensions. 
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 All these variations on the IMRT approach have their advantages and disadvantages but 
all use 4 to 25MV X-ray photons and work on a similar principle. They can produce highly 
conformal dose distributions sparing normal tissues but retain the limitations of the X-ray beam 
physics which dictates that a certain amount of dose will be deposited before and after the tumour 
as the beam passes through. 
The leading alternative to X-ray external beam radiotherapy is heavy charged particle 
therapy (CPT). Protons and other heavy charged particles have a definite range and the dose 
delivered is maximum over the last few millimetres of the particles range known as the Bragg 
peak. Proton therapy dose distributions can therefore achieve very low doses distal to the tumour 
and low integral dose (Jones, 2008). Unfortunately, the availability of accelerators capable of 
delivering high energy proton therapy is limited.  
There is a charged particle treatment option available with standard linacs and that is 
electron beam therapy. Historically a number of techniques have been described that use the 
properties of electron fields to conform the dose with depth and reduce normal tissue doses. For 
example abutting X-ray and electron fields have been used to treat head and neck cancers, where 
the sharp fall off in dose for the electron field is utilised to minimise the dose to the spinal cord 
(Sun et al., 1998).  In recent years, however, this type of treatment has largely been replaced by 
IMRT. There has been some interest in complex electron beam therapy around the use of scanning 
electron beam treatment machines but the popularity of these machines diminished following a 
series of fatal accidents due to the failure of the scanning system (Israelski and Muto, 2004).  
Today electron beam treatment is predominantly confined to simple treatment of small skin 
cancers and additional boost fields for breast treatments. The latter are also on the decline and are 
being replaced by integrated boost IMRT. Advanced electron beam therapy is confined to few 
small research groups (Mikael and Rockwell, 2013). 
 
1.3. Motivation for research 
Modern X-ray IMRT techniques can produce highly conformal dose distributions that spare organs 
at risk (OAR) and minimise side effects. What is less well understood is the effect of the low level 
‘dose wash’ received by OAR and other normal tissues. In particular, some studies estimate the 
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risk of developing a secondary cancer due to this dose wash at up to 2.5% (Verellen and 
Vanhavere, 1999, Hall and Wuu, 2003, Ardenfors et al., 2014).  
At the time of writing about 3% of the U.S. population are cancer survivors, corresponding 
to 11 million people, a figure projected to grow to 18 million by 2022 (de Moor et al., 2013). 
About half these people will have had Radiotherapy as part of their treatment. As the pool of 
people potentially effected is so large, even small increases in risk should be considered and 
reduced to levels as low as reasonably practical.  
It is currently not physically possible to deliverer the required dose to the tumour whilst 
delivering zero dose outside the tumour. To aid discussion of what is achievable a representation 
of the dose gradients for different modalities is presented in Figure 1.2. An ideal dose distribution 
of 100% dose in the PTV and an immediate drop to zero dose in normal tissues is shown in Figure 
1.2, curve a). Representative curves either in the direction of or perpendicular to the direction of 
the beam path are shown, offset to put the zero depth at the 95% dose level.  
X-ray IMRT techniques are represented in Figure 1.2, curve b) by the gradient of the dose 
at the junction between the PTV and an OAR (the parotid gland) taken from a typical VMAT head 
and neck plan. This dose gradient is sufficient to reduce the dose to the parotid gland below a 
threshold level (and consequently reduce the incidents of Xerostomia (Nutting et al., 2011)).  The 
gradient is however limited by the way X-ray dose varies with depth (see Figure 1.1) and by the 
penumbra at the edge of the field. The penumbra at the edge of the field, represented in Figure 1.2 
curve c), results from the finite source size but also scatter in the head of the machine and scatter 
in the patient. The combination of scattered dose and entrance and exit dose results in a significant 
level of ‘dose wash’ in the VMAT planed dose distribution. The dose does not immediately drop 
to zero but stays at the 20-30% level over several cm. 
By contrast the Proton depth dose curve, Figure 1.2 curve d), has a definite range and drops 
to less than 10% in just 1cm. It is the potential to exploit this physical characteristic of the proton 
beam to improve normal tissues sparing that drives the current interest in proton therapy 
(Newhauser and Zhang, 2015). 
The dose fall off for the electron beam depth dose curve, is not as steep as for the proton 
beam but does drop to less than 10% in 2cm, see Figure 1.2 curve e).  
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The curves in Figure 1.2 illustrate that the steepest dose gradients can be achieved with 
proton therapy. There is however some uncertainty in the long term role of proton therapy, largely 
due to scepticism about its cost-effectiveness (Newhauser and Zhang, 2015). At the time of writing 
there are no proton therapy facilities in the UK and just two NHS centres and a handful of small 
private centres planned for the in the next 2 to 3 years. Even when these centres are in operation 
radiotherapy patients with access to proton therapy has been estimated at roughly 1 % of the total 
number of patients currently receiving radiotherapy (DOH, 2012) 
 As proton therapy is not available for all patients, the work in this thesis will reconsider 
the role of the electron beam.  Although the fall off in dose for the electron beam is not as steep as 
the proton beam and although electron beams have other significant disadvantages (primarily 
limited range) electron beams have the significant advantage of being readily available. Perhaps 
by combining electron beams with X-ray photon beams to achieve ‘Depth Modulation’ as well as 
intensity modulation radiotherapy, IMRT dose distributions can be further improved.  
 
 
Figure 1.2 Examples of dose gradients in radiotherapy treatment. a) Ideal step function with an immediate 
drop to zero dose after PTV. b) Taken from a clinical bilateral Head and Neck VMAT plan showing the 
drop in dose from the target to the adjacent parotid gland. c) The penumbra at the edge of single direct 6MV 
X-ray 10cm square field at 10cm depth in the patient d) a 230MeV direct proton field depth dose taken 
from (Cai et al., 2015) e) 10MeV 10cm square field electron depth dose curve 
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1.4. Research aim and objectives 
The primary aim of this work is to answer the following question: 
 
 Can radiotherapy dose distributions be improved through a novel depth modulated X-
ray and electron therapy treatment technique? 
 
The literature review (Chapter 2) revealed a number of studies investigating complex 
combined X-ray and electron treatments but none which have been successful in making the 
transition to the clinical setting. The aim of this study was therefore refined to answer the following 
research question: 
  
 Is an isocentric combined X-ray and electron therapy treatment possible with no 
modifications to equipment and can it be used to improve radiotherapy dose 
distributions? 
 
Existing studies require add on electron MLC or a compromise in patient positioning to 
put the patient close to the X-ray MLC. It is suggested that to have a practical complex combined 
electron and X-ray treatment technique it would be desirable to have a single isocentre (point of 
rotation) and no add on components to reduce the need for intervention between the electron and 
X-ray dose delivery.  Hence the aim of this work is to produce a novel mixed X-ray and electron 
treatment technique with the electron component treated isocentrically through the X-ray MLC.  
The solution proposed in this work is to use electron beams delivered through MLC at 
standard SSD but reduce scatter and photon contamination by removing the scattering foils from 
the beamline and to employ optimisation of the electron and photon components to compensate 
for any remaining penumbra broadening. This mixed modality technique will be referred to as 
exIMRT (see Figure 1.3). To achieve this solution the following objectives were addressed: 
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 Create a radiotherapy treatment planning system (TPS) that is capable of implementing 
the proposed technique. The TPS development will require the following: 
o To select a programming environment for radiotherapy research. 
o To develop and validate an accurate electron beam model to model the specific 
features of this work. 
o To develop an optimisation scheme to optimise electron and photon 
concurrently.  
 Use the developed TPS for treatment planning studies, initially involving simple 
phantoms, to demonstrate the principle prior to applying to a range of clinical case 
studies.  
 Critically evaluate the performance of the proposed combined X-ray and electron plans 
to X-ray only treatment plans to determine whether the novel treatment technique 
developed has the potential for improving dose distributions in the patient. 
 
 
Figure 1.3 A comparison of 3D conformal radiotherapy (3DCRT), Intensity Modulated Radiotherapy 
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1.5. Thesis outline 
The thesis is organised as follows: 
 
Chapter 2 presents a short review of the depth modulation for the different modalities used in 
radiotherapy before focusing on modulated electron radiotherapy (MERT) and the combination of 
MERT with IMRT. This is followed by a review of published solutions to optimisation of the 
spatial dose distribution in radiotherapy. Finally a review of the methods for evaluating planned 
dose distributions is presented. The chapter concludes with a justification of the material and 
methods researched in this work. 
Chapter 3 introduces the concept of electron beam delivery collimated with X-ray MLC with 
scattering foils removed.  This scattering foil free mode of operation is examined for an Elekta 
Synergy MLCi linac at UHCW through a series of measurements. It is shown that a stable beam 
with a useful field size (FWHM) of 18cm can be produced with scattering foils removed. It is then 
demonstrated that by removing the scattering foils photon contamination and lateral scatter is 
reduced.  Such reduction makes delivery of small MLC collimated electron beams at isocentric 
SSD feasible. The ideal size of these segments is discussed and a 2x2cm square suggested. It is 
shown that acceptable dose rates are achievable over a useable treatment area and that the level of 
scatter/leakage dose in the patient plane outside the treatment field is similar to or less than X-ray 
therapy. Both the dose rate in field and unwanted dose outside the field are shown to improve with 
scattering foil removal. 
Chapter 4 presents the modelling of the scatting foil free electron beam using the Monte Carlo 
radiation transport software tool BEAMnrc. The model is adjusted to achieve good agreement with 
depth doses and profile measured in water. In addition the sensitivity to different modelling 
parameters is presented.  
Chapter 5 describes the development of an approach to optimising the combined electron and 
photon dose distribution. A novel two stage approach is used to make best use of the electron dose 
component. The development of this approach is presented including a comparison of different 
optimisation solvers. 
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Chapter 6 presents the application of the proposed technique to four different clinical cases. It is 
shown that in all cases the proposed technique is able to produce acceptable PTV coverage and 
uniformity whilst, at the same time reducing dose distal to the tumour volume. It is shown that 
reduced normal tissues dose with the proposed technique has the potential to reduce the risk of 
secondary cancer induction. 
 
1.6. Contributions of the thesis 
The contributions to the thesis are first described as a list of bullet points and then presented in 
Figure 1.4 to illustrate the relationship between the chapter organisation and the contributions 
arising from this work. 
 Performed a thorough survey of relevant literature. (Chapter 2) 
 Proposed a novel approach to reduce lateral scatter, reduce photon contamination and 
increase dose rate for MLC modulated electron beams by removing the electron 
scattering foils. (Chapter 3) 
 Showed that the proposed approach is feasible through a series of measurements. 
(Chapter 3) 
 Created a Monte Carlo beam model to calculate dose distributions generated by the 
proposed solution and shown that accurate dose calculation is possible. (Chapter 4) 
 Developed a novel method to optimise dose distributions using the Monte Carlo 
calculated electron dose and pencil beam calculated X-ray photon dose. (Chapter 5) 
 Shown through clinical examples that the proposed solution has the potential to reduce 
dose distal to the target for relatively superficial tumours. (Chapter 6) 
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Figure 1.4 flow chart illustration contributions of theses 
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1.7. Publications 
The work has led to the following publications: 
 
Baugh, G.M., Haas O.C.L (2013) ‘Optimisation of combined electron and photon IMRT using 
standard photon MLC’, poster presented at 2nd ESTRO Forum, Geneva, Switzerland, Rad. Onc. 
106(S2), S225-226 
 
Baugh, G.M., Haas O.C.L (2015) ‘Isocentric combined electron and photon IMRT using standard 
photon MLC’, paper presented at UKRO 2015, Coventry, UK









This chapter presents a short review of depth modulation for the different modalities used in 
radiotherapy before focusing on modulated electron radiotherapy (MERT) and the combination of 
MERT with IMRT. This is followed by a review of published solutions for the optimisation of the 
spatial dose distribution in radiotherapy. A review of the methods for evaluating planned dose 
distributions is then presented before offering conclusions that justify the approach undertaken. 
 
2.2. Depth Modulation in Radiotherapy 
The title of this thesis is ‘Depth Modulation in Radiotherapy’.  This title arose from the initial 
intention of investigating the modulation of dose in the direction of the beam as well as modulating 
the intensity of the beam perpendicular to the beam direction. To this end a review of depth 
modulation for different radiotherapy modalities was performed. 
 
2.2.1. X-ray energy modulation 
For X-ray photon beams the variation of dose with depth can be modified by the choice of energy 
or by using combinations of the different energies available. Standard clinical linacs are supplied 
to the user’s specifications with a choice of energies between 4 MV and 25 MV. The advantages 
of increased penetration and increased skin sparing with higher energy photons (10-25MV) to treat 
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deep seated tumours is well known. However, for IMRT an increase in the beam-on time relative 
to conventional radiotherapy has led to concerns about secondary malignancies arising from 
increased neutron dose. This risk becomes greater at higher energies where there is a greater 
neutron contribution. Hence, most centres use 6-10 MV for IMRT (de Boer et al., 2007). Even so, 
some studies have demonstrated that using higher energies can produce a reduction in normal 
tissue dose away from the target area outweighing the increased neutron dose (de Boer et al., 2007, 
Park et al., 2011, St-Hilaire et al., 2009). In addition, it has been shown in (Kry et al., 2007) that 
neutron production can be reduced by 69% for an IMRT plan by removing the flattening filter. It 
follows then that there may be benefits in modulating the photon energy (or rather finding the 
optimum mix of energies).  
A feasibility study for an energy modulated photon radiotherapy (EMXRT) technique was 
performed in (Zhang et al., 2016). The techniques used an energy selection algorithm that selected 
the energy from a look up table according to effective path length and tumour size. It would seem 
that this algorithm tended to select lower energies to minimise exit dose. The technique appeared 
to have some small benefits, for example in a lung tumour study the V5 for the whole lung, that is 
the percent volume of lung receiving  a dose of 5 Gy, was decreased from 18.8% to 16.9%. 
As well as increased penetration higher energy X-ray beams exhibit an increased skin 
sparing effect. When combining X-ray beams with electron beams this increased skin sparing 
could be used to offset the increase in dose over the first 1cm of tissue with electrons. However, it 
is suggested in (Butson et al., 1997) that the skin sparing of higher energy beams is compromised 
by electron contamination such that there is negligible reduction of the delivered dose to the basal 
cell layer (0.1 mm). Whilst a small increase in skin sparing at the dermal layer (1 mm) was found, 
the authors pointed out that this was negated by the increased exit dose from an opposing field of 
the same energy. 
 
2.2.2. Heavy charged particle energy modulation 
Depth modulation for proton therapy and other heavy charged particle therapies is achieved by 
combining multiple Bragg peaks to create a spread out Bragg peak (SOBP). By varying the number 
of peaks the extent of the uniform region can be can be varied.  Technically this is achieved with 
energy stacking (energy changed up stream of the beam exit nozzle) realised by passing the beam 
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through either a range modulator wheel or a ridge filter. There is some uncertainty in the final 
range of the SOBP which has to be built into the planning volume. However, both the absence of 
dose distal to the uniform region and the lower dose proximal to the uniform region result in a 
lower integral non-target dose when compared to X-ray therapy (Newhauser and Zhang, 2015).   
 
2.2.3. Very high energy electrons (VHEE) 
By contrast to the complex beam arrangement routinely used in X-ray therapy, electrons are 
generally used for single direct fields for superficial treatment (Hogstrom and Almond, 2006). Key 
to reaching deep seated tumour sites is being able to produce high energy electrons. Current 
clinical machines have the potential to produce up to 20 MeV electrons. Historically, some 
treatment machines were capable of up to 50 MeV (Karlsson and Zackrisson, 1997). However, it 
has been suggested that very high energy electron beams of 50-200 MeV (VHEE) would have 
advantages over X-ray photons. VHEE is a distinct category of treatment to electrons beams of 
energy less than 20MeV as the properties of the dose distributions produced differ greatly. High 
energy electron beams are highly penetrating (>40cm for 150MeV), but do not exhibit the steep 
drop off in dose at a definite range. By contrast to lower energy electrons, very high energy 
electrons exhibit a lack of lateral scatter that results in reduced penumbra widths, smaller than MV 
X-ray beams. VHEE also has the advantage that there is no electron disequilibrium at the interface 
between materials of different densities. This results in an improvement in the dose distribution at 
the lung tissue interface when compared to X-ray treatments. Similar or improved dose 
distributions, when compared to VMAT, for a theoretical 100-200 MeV scanning electron beam 
have been obtained in (Palma et al., 2016, Bazalova-Carter et al., 2015). However the studies do 
not consider depth modulation, only selection of the appropriate energy which is not as critical as 
it is for low energy electron treatments. The greatest improvements seen is for large centrally 
located tumours that take advantage of the penetration of the high energy electrons. For an 
oesophagus plan, improved conformity was shown resulting in a reduction in OAR dose below 
35Gy (76% of the prescribed dose). Mean dose to the heart was reduced by 20% and integral dose 
was reduced by 23%. Whether or not this level of improvement warrants the major investment that 
would be required to produce VHEE scanning electron machines remains to be seen. 
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2.2.4. Modulated electron radiotherapy (MERT) 
A number of studies have looked at the potential of modulated electron radiotherapy (MERT) for 
electrons beams of energy less than 20MeV. X-ray IMRT uses multileaf collimators to modulate 
the intensity of the beam.  Perhaps then the intensity of electron beams could be modulated in a 
similar way to produce MERT. Initial studies suggested that using the photon multileaf collimators 
(xMLC) for electron treatments was not practical (Klein et al., 1996). Electron scatter in the head 
of the machine and in the air between the head and the patient surface causes prohibitively high 
levels of penumbra broadening. To cut out this additional scatter the conventional method of 
shaping electron beams is to use collimation close to the patient surface. A fixed shape applicator 
or cone is attached to the linac head with a heavy metal cut-out added to conform to the tumour 
shape if required. As the shape is fixed there is no means to modulate the intensity of the beam 
using segmented fields in the manner of IMRT. 
 Modulating conventional electron beams is limited to varying the thickness of bolus on 
the patient’s surface. For example the depth of penetration into the patient can be reduced by 1cm 
by adding a 1cm slab of wax on the surface of the patient. More complex modulation across the 
field can be achieved using bolus contoured to create varying thickness (Low et al., 1992, 
Kudchadker et al., 2002). Paraffin wax can be shaped by hand or plastics can be milled into a 
shape that has been designed either by inverse planning or more usually through a process of trial 
and error. Recently there has been increased interest in this method driven by the availability of 
3D printers that can produce complex bolus shapes (Su et al., 2014, Zou et al., 2015). The use of 
3D printed bolus increases the precision of manufactured contoured bolus allowing for more 
complex shapes and resulting in increased conformity of dose distribution. It is still however a 
time consuming process and does not lend itself either to energy modulation or combing MERT 
with IMRT as each electron energy would require its own contoured bolus to be manufactured and 
the bolus would need to be removed in between electron field and X-ray photon field delivery. 
An alternative to contoured bolus is to use add-on electron multileaf collimators (eMLC) 
specifically designed to deliver MERT. These are positioned close to the patient surface to 
minimise the effects of scatter between the aperture and the patient. This approach has been 
investigated in a number of studies (Ma et al., 2000, Ma et al., 2003, Lee et al., 2001, Engel and 
Gauer, 2009). Hogstrom et al., (2004) proposed a retractable eMLC design but noted that eMLC 
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had the disadvantage of high cost and potential for patient collisions as located near to the patient 
surface.  There is also some concern about the induced photon contamination from add-on devices 
(Olofsson et al., 2004).  
To avoid the issues associated with eMLC a number of studies have looked into filling the 
linac head with inert gas and using a short source to surface distance (SSD) to minimise scatter 
when using standard X-ray MLC. Some scanning electron beam treatment machines use a Helium 
atmosphere to minimise scatter, as demonstrated by an increase in penumbra width when the 
Helium is replaced by air for a MM50 racetrack microtron (Karlsson et al. 1992).  Using a Helium 
atmosphere has also been shown to reduce penumbra width for conventional linacs in Monte Carlo 
simulations (Karlsson et al., 1999, Blomquist et al., 2002). However such a method would require 
significant modifications to conventional linacs. 
Through a series of measurements, it was shown in  (du Plessis et al., 2006) that a useful 
field could be produced with electron beams through a standard Siemens Primus photon MLC 
without filling the head with inert gas.  They demonstrated target dose conformity and tissue 
sparing with manual intensity and energy modulation using energies from 6 to 18MeV over an 
SSD range of 60-100cm. It was found that the most favourable SSD for MERT is 60cm.  
It has also been shown in (Henzen et al., 2014) that it is possible to create a Monte Carlo 
based beam model to accurately predict dose distributions from xMLC electron beams for a Varian 
Millennium photon multileaf collimator. Henzen et al. (2014) did however highlight that for small 
electron fields the X-ray contamination of up to 10% could be prohibitive. 
Klein et al. (Klein et al., 2008, Klein et al., 2009) have demonstrated that, by maintaining 
a short SSD and using Monte Carlo Calculations to correctly model the electron scatter, it is 
possible to implement MERT using standard X-ray MLC with no physical modifications. Klein et 
al., (2009) used a forward planning approach to successfully plan a chest wall case using: one 
gantry angle, 4 electron energies ranging from 6 to 15 MeV, and four segments at 70cm SSD.  
Comparison of calculations and measurements were presented with good agreement within 
±2%/2mm.  
In any electron therapy study, energy selection is important as it is the energy that will 
define the range and therefore the treatment depth. Some studies have taken this a step further by 
looking into the potential of modulating the electron energy by using a mixture of the available 
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electron energies over the treatment field. Theoretical advantages of electron energy modulation 
have been suggested in (Hyödynmaa et al., 1996, Mu et al., 2004, Olofsson et al., 2004). An inverse 
planning tool to select electron energy and modulate energy and intensity using bolus was devised 
in (Gentry et al., 2006). An inverse planning algorithm was used in (Ma et al., 2000, Ma et al., 
2003) to optimise energy and intensity using a custom eMLC for MERT breast cancer treatment. 
An edge feathering technique was presented in (Eley et al., 2011) to improve homogeneity for 
abutting eMLC fields of different energies. 
Jin et al. (2008) planned a MERT breast treatment on an anthropomorphic breast phantom 
at reduced (60cm) SSD for a Siemens Primus linac. They used Monte Carlo generated 1x1cm 
MLC beamlets with a ‘gradient based’ algorithm to adjust the beamlet weights. The plan produced, 
22 segments with a mixture of 6, 9, 12 and 15MeV. Comparisons between measurement and 
calculation agreed within 2% or 1mm.  
Surucu et al. (2010) demonstrated the advantages of energy modulated MERT with xMLC 
for chest wall treatments using a forward planning approach again with Monte Carlo dose 
calculation. Energy was selected across the field based on the calculated depth of the distal edge 
of the PTV and the electron energy range. MERT plans produced acceptable target coverage and 
lower doses to the heart in all 4 cases studied. 
Salguero et al. (Salguero et al., 2009, Salguero et al., 2010) have demonstrated that inverse 
planned energy modulated MERT can be delivered with an MLC using a multi objective 
minimisation through a simulated annealing optimisation algorithm (Kirkpatrick et al., 1983). Four 
cases of shallow head and neck tumours were considered, a recurring squamous cell carcinoma in 
the oronasal region, a parotid mucoepidermoid carcinoma, a basal cell carcinoma in the right ear 
and a large B cell lymphoma of the parotid gland.  For all cases DVH comparisons with 
conventional and IMRT plans demonstrated improvements in the dose delivered to the PTV and a 
reduction in the dose received by organs at risk. Comparisons of calculations and measurements 
for patient specific measurements analogous to the routine patient specific QC performed for 
IMRT were also presented. Gafchromic EBT radiochromic film was used for relative dose and a 
Roos PTW34001 plane parallel ion chamber for absolute dose. For the four cases studies absolute 
dose measurements were in agreement with calculations to ±2.0%. Good agreement between film 
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and measurement was found and a gamma analysis approach was suggested with 3%/3mm criteria, 
similar to that routinely used in patient specific quality control for IMRT. 
 
2.2.5. Mixed X-ray and Electron Therapy 
A few studies have looked at the potential advantages of mixing photon and conventional electron 
beams. Korevaar et al. (1999) demonstrated that photon fields could be used to sharpen the 
penumbra of a microtron electron beam.  Li et al. (2000) developed a technique using IMRT and 
conventional electron fields for breast-conserving radiotherapy demonstrating reduced dose to the 
ipsilateral lung and the heart when compared to IMRT alone. Similarly, Van der Laan et al. (2010) 
found that incorporating conventional electron fields into post-mastectomy IMRT enables a dose 
reduction which can only be achieved with IMRT alone when allowing large irradiated volumes 
in the contralateral breast. Rosca (2012) combined conventional electron beams with IMRT plans 
to minimise the integral dose to other sites including brain, lung and thyroid cases. 
These mixed electron and photon techniques have their advantages but there may be further 
improvements if IMRT is combined with MERT. Asell et al. (1999) demonstrated the possibility 
of improving dose conformity for electron beams by adding photon fields parallel or orthogonal 
to the electron beam by combining theoretical fluence profiles. Das et al. (2004) demonstrated that 
using an idealised electron beam fluence, mixed photon and electron IMRT could reduce the dose 
to critical structures.   
There have also been studies that have considered combing eMLC MERT with IMRT. In 
a theoretically planning study Korevaar et al. (2002) found that the addition of high energy (15-
50MeV) eMLC collimated electron beams could improve dose-volume histograms for the critical 
structures in an IMRT plan for deep seated tumours. This study by Korevaar et al. used the 
sequential quadratic optimisation of ORBIT (Löf, 2000) which was subsequently developed into 
a commercial X-ray IMRT optimisation solution.  Al-Yahya et al. (2005) performed a study using 
a custom made ‘few leaf’ eMLC comparing MERT, IMRT and IMRT+MERT for two head and 
neck cases. In this study electron fluence and energy were modulated using the deterministic steep 
DVH minimisation algorithm (Hristov et al., 2002). The conclusion of the study was that the 
addition of energy modulated MERT systematically leads to a reduction of whole body dose 
equivalent (WBDE) while still meeting dose constraints 
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Mu et al. (Mu et al., 2004) demonstrated that, using a commercial X-ray IMRT algorithm 
and non-modulated electron beams with the beam’s eye view shaped using xMLC, a lower integral 
dose outside the PTV could be achieved. They also commented: “It is reasonable to expect that if 
computerised optimisation tools were coupled with the mixed photon and electron beam technique, 
treatment goals would be more readily achieved”.  
 
 
The following three studies have been singled out as combing xMLC MERT with IMRT: 
 
 The PhD thesis of (Weinberg, 2007) used 2x2 cm xMLC electron beamlets beam weight 
optimised along with intensity modulation of the X-ray component using the X-ray 
optimisation algorithm of a commercial treatment planning system (Pinnacle®). The 
electron energy was selected manually. Although it did not appear that a reduced SSD was 
used, no consideration was given to the increased penumbra, increased X-ray 
contamination or reduced dose rate. There was also no particular attempt to exploit the 
benefits of electrons and plans tended towards a relatively low contribution from the 
electron component. The mean electron target dose for MERT was 17% of the mean target 
dose for the partial breast irradiation plans studied.  However, this study did show a small 
improvement in the dose distal to the target with the addition of the electron component for 
some plans. Mixed beam plans were selected as superior by a clinician for 6 of 9 partial 
breast plans. 
 As part of the reduced SSD xMLC MERT study in (Surucu et al., 2010), a Pinnacle® IMRT 
plan was combined with a MERT plan for a chest wall treatment. The combination plan 
was created by simply adding the two plans in proportion but demonstrated clinically 
acceptable target coverage with increased OAR sparing (heart, contralateral lung and 
contralateral breast D20 were decreased by 48%, 43% and 49% respectively although the 
ipsilateral lung D20 was increased by 10%, when compared to IMRT alone). It was noted 
however that further investigations were required to provide tools for combed modality 
planning.  
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 Palma et al. (Palma et al., 2012) performed a successful study looking at combining the 
reduced SSD xMLC MERT technique developed by Salguero et al. with IMRT for partial 
breast irradiation. They found a reduction by a factor of 3.2-3.6 in the volume of Heart and 
Lung, receiving 5% and 15% of the prescribed dose respectively.  
 
It is hypothesised that removing the scattering foil and carefully optimising the electron 
and photon component will produce a reduction in dose distal to the target without resorting to a 
reduced SSD. Removal of the scattering foils has previously been shown to reduce photon 
contamination for conventional electron beams (Eldib et al., 2014) and add on electron MLC 
(Connell et al., 2012) but may have additional benefits when utilising xMLC. 
 
2.2.6. Summary 
Depth modulation in one form or another is an important part of all radiotherapy treatment 
modalities.  A number of studies have shown that it is possible to achieve depth modulation by 
combining electron and X-ray fields.  Three of these studies have shown that Mixed X-ray and 
electron IMRT is credible without major modifications to existing standard treatment machines 
and these are summarised in Table 2.1 along with a summary of the proposed research.  
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Table 2.1 Summary of MERT+IMRT studies for <20MeV electrons 
 













































Iterative constrained optimisation 
 
2.3. Optimisation 
Optimisation aims to find the values of a set of variables that will result in the most appropriate 
solution to the problem considered, whilst at the same time meeting various constraints in terms 
of both the possible values of the variables and defined objectives. The objectives represent the 
specific goals of the optimisation problem. To solve the problem using numerical methods, it is 
necessary to express these objectives using appropriate mathematical expressions. Key to the 
success is the ability to ask the correct question to the optimisation algorithm. 
In the context of this work, namely radiotherapy treatment planning optimisation, the following 
features should be considered: 
 The aim of the optimisation is to meet clinical objectives. The optimisation is therefore 
traditionally expressed as a minimisation problem, which aims to reduce the error between 
the value of the objectives achieved by the current solution and the value of the objectives 
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representing the clinical prescription.  
 The variables optimised represent the energy delivered to the patient using various 
treatment modalities. It is not feasible to take away doses of radiation. This means that the 
variable representing the quantity of radiation delivered must be non-negative. 
 To deliver the prescribed high dose of radiation to the planning target volume, all the tissues 
in the beam path will also be irradiated and receive some dose. This means that some 
solutions, whilst desirable, may not be physically realisable. For example, it is not possible 
to meet an objective that will specify a dose of 0 to tissues in the beam path. This implies 
that the objectives considered are competing and not mutually achievable. The solution 
will therefore be a compromise. 
 Depending on the objectives considered, there can be several distinct sets of decision 
variables that can achieve apparently identical solutions due to the large number of 
variables that can be optimised.  
 Some objective formulations aim to represent closely the clinical objectives. Their 
drawback is that they can have complex nonlinear formulation that are difficult to solve.  
 Finally, depending on the approach adopted, the size of the optimisation problem could be 
very large with thousands of variables required to be determined.    
 
Historically 3DCRT plans were optimised by hand with experienced planners shaping the 
beams and selecting weights to create the optimum dose distribution. Today, due to the complexity 
of an IMRT plan this is not possible and generally some algorithm is required to adjust the intensity 
of the applied X-ray beams in such a way that the spatial distribution of the dose distribution in 
the patient is optimised. Bortfeld (Bortfeld, 2006) provides a useful review of the development of 
IMRT up 2006 which is around the time IMRT became a widely used clinical technique. MLC 
based X-Ray IMRT is established as a standard clinical technique and there have been many studies 
investigating the formulation of the problem and the application of novel optimisation algorithms.  
Most current commercial planning systems used in the clinic employ an ‘inverse planning’ 
approach  as suggested by Webb (Webb, 1989). The optimisation problem is formulated as: 
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min F(x)           (2.1) 
subject to x≥ 0 
subject to C(x) ≤ 0 
 
where F denotes the objective function, C the inequality constraints evaluated at x and  
x = x1, ...,xp is a vector of p>>1 decision variables describing the X-ray intensity. 
Optimisation of the IMRT plan can pose a challenge due to the size of the problem, the 
non-negativity bounds and potential inclusion of complex nonlinear objective functions. Various 
optimisation techniques have been employed to optimise dose distribution in IMRT planning 
(Bortfeld, 1999, Verhey, 2002, Webb, 2003). Current commercial solutions can generally be split 
into two distinct methodologies (Yu et al., 2006, Shepard et al., 2002) 
• sequential optimisation 
• direct aperture optimisation (DAO) 
 In the sequential method before an IMRT optimisation each beam is divided into a number 
of smaller ‘beamlets’, and the corresponding dose distributions computed as the sum of all 
weighted beamlets. The total dose to structure k can thus be written as: 
     dk= ∑ dk,i xi       (2.2) 
where dk,i is the dose to structure k from beamlet i given the beamlet weight xi. Beamlet weights 
are then optimised to produce the intensity map that minimises the objective function. The problem 
with this method is that a second stage is required to translate the ideal fluence map into apertures 
that are achievable under a given set of physical constraints. At this stage there is the risk of 
degrading the dose distribution to such an extent that the process has to be re-started. With DAO 
the physical constraints are included in the optimisation and aperture shapes and weights are 
optimised simultaneously. There is therefore no degradation of the plan due to a second 
segmentation stage. DAO also tends to produce fewer apertures, reducing treatment time (Shepard 
et al., 2002). However DAO is more difficult (non-convex) from a mathematical point of view and 
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is not guaranteed to find a global solution (Bortfeld, 2006).  For this study DAO was not considered 
for the following reasons: 
 Whilst physical constraints are considered, reducing treatment time and minimising plan 
complexity is not one of the aims of this project. 
 There is a greater risk of becoming trapped in local minima with DAO. 
 Sequential optimisation is computationally simpler to execute than direct aperture 
optimisation. 
 
In beamlet based optimisation a solver is required to find the beamlets weight to minimise 
an objective function within the given constraints. The objective function is typically a quadratic 
equation and one potential method is to find a direct solution of the inverse problem using 
conventional quadratic objective functions. Unfortunately as no constraints are possible this 
method would result in negative weights. A solution with negative beamlet intensities is not 
feasible as taking away dose from the patient is not possible.  
Goldman et al. did develop a fast inverse dose optimisation algorithm for IMRT via matrix 
inversion with non-negativity which showed positive results in two dimensions (Goldman et al., 
2005). The objective function is reformulated such that the optimisation problem is reduced to a 
linear set of equations. The optimal set of intensities is found through a matrix inversion. 
 Typically however beamlet weights are optimised using some form of numerical search 
algorithm. Webb, (1989) introduced simulated annealing as an IMRT optimisation method. 
Simulated annealing is a metaheuristic that models the physical process of heating a material and 
then slowly lowering the temperature to decrease defects, thus minimising the system energy. Slow 
cooling is interpreted as a slow decrease in the probability of accepting worse solutions as it 
explores the solution space. Accepting worse solutions is a fundamental property of metaheuristics 
because it allows for a more extensive search for the optimal solution. Following on from this work 
other heuristic algorithms have been suggested, such as genetic algorithms (Ezzell, 1996, Wu and 
Zhu, 2001) and tabu search (Gilio, 1998). However Bortfeld et al., suggested that typical quadratic 
objective functions do not have local minima and fast gradient related methods can be used 
(Bortfeld et al., 1990, Spirou and Chui, 1998, Cotrutz et al., 2001, Chang et al., 2002). Recent 
advances in improving the speed of optimisation in commercial treatment planning systems have 
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been achieved through the use of an algorithm that incorporates sequential quadratic programming 
(SQP) (Löf, 2000). At a given approximate solution SQP models the problem as a quadratic sub 
problem then uses the solution from this sub problem to form a better approximate solution. This 
process is iterated to create a sequence of approximations that converge to the solution. 
 
2.4. Practical IMRT planning 
In practical terms the typical computer aided IMRT treatment planning process can be described 
as follows (James et al., 2008): 
 
1. Set physical constraints. 
2. Set beam orientation.  
3. Define objective function (or cost function). 
4. Automatically optimise beam intensity maps to minimise objective function. 
5. Perform final dose calculation. 
6. If plan achieves the clinical goals go to step 7, if not return to step 3 and redefine the 
objective function 
7. Plan is approved for delivery by a clinician. 
Step 4 defines the optimisation variable as the beam intensity, or fluence, maps but could 
potentially include any number of variables such as beam angle or patient/couch motion. The 
work in this thesis will expand step 4 to read: 
4. Automatically optimise spatial variation of intensity, modality and energy to minimise the 
objective function. 
 
2.4.1. Physical Constraints 
The physical constraints are set to obtain a satisfactory dose distribution which can be practically 
delivered on the machine. First, limitations associated with the machine performance need to be 
considered. Geometrical constraints include the minimum distance between opposing leaves to 
avoid leaves crashing into each other. Dosimetric constraints include the minimum segment size 
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and the minimum segment MU. These are set to take into account limitations in the dosimetric 
performance of the machine. There are also a number of mechanical movements which need to be 
set. The collimator angle, couch angle, and in particular the number of beams must be chosen to 
obtain the optimum plan which can be practically treated. Increasing the complexity of the plan 
by increasing the number of mechanical movements can improve dose conformance but will 
reduce the efficiency of delivery. For IMRT the optimisation of these parameter is generally less 
critical than for conventional radiotherapy as the fluence can adapt to compensate for small 
changes (Bortfeld, 2006).  
The selection of beam angles can be significant and some studies have looked at 
automating this process (Haas et al., 1998, Nazareth et al., 2009). However, the use of beam angle 
optimisation (BAO) algorithm in routine clinical practice is not yet widespread. Most clinics still 
adopt the method of placing a sufficient number of equispaced beams, which has been found to 
produce clinically acceptable dose distribution in many anatomic sites (Ranganathan and Maria 
Das, 2016). 
 
2.4.2. Objective function 
The treatment prescription entered into the treatment planning system describes the goals of the 
treatment. These goals can be expressed in either an objective function or in constraints. 
Constraints are restrictions on the set of solutions that are considered feasible. They define what 
is an acceptable solution and not necessarily an optimal solution. The most basic constraint in 
IMRT is that all of the beam weights must be non-negative. Constraints can also be used to fix the 
dose in a particular structure.  However, each of these this constraints, which represents only a 
single threshold value, limits the freedom of the optimiser. If the constraints are conflicting there 
may not be any feasible solution. 
Alternatively a simple objective function would be the square of the differences between 
the prescribed dose and delivered doses summed for all points:   
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This has the advantage that all points are considered rather than optimising for a single 
point. The quadratic sum results in a higher penalty on outliers e.g. hot and cold dose regions in 
the target. The treatment plan will in reality include multiple structures (targets and organs at risk) 
such that there are multiple objectives. The objective function then becomes the sum over K 
structures. It is possible to increase the importance of certain structures using relative weights, thus 
the equation becomes a weighted sum objective function: 
 















where 𝑑 is the calculated dose,  𝐷𝑎𝑖𝑚 is the objective value and w is the relative weight for each 
of the K structures. An additional factor can be included if it is desirable to penalise only values 
less than or greater than the objective value (see equation 5.5). To produce an optimal treatment 
plan the values of  𝐷𝑎𝑖𝑚 and w need to be carefully chosen by the treatment planner. Alternatively 
these parameter can be included into an automation routine such as the fuzzy reasoning approach 
suggested by Dias et al. (Dias et al., 2016).  
 In this study objective values were chosen based on the goals of the treatment plan, set 
slightly low or high (as appropriate) to increase the penalty as the solution approaches the required 
value.  The relative weights of objectives were iteratively tuned in a trial and error approach until 
the resulting treatment plan was deemed acceptable. Priority was given to OAR dose tolerances 
and the plan was not deemed to be acceptable unless all OAR dose tolerances were met. The PTV 
dose objectives were of second highest priority with the proviso that a compromise should be made 
to meet the OAR dose tolerances (where a compromise may show a weakness in the treatment 
technique). Finally additional objectives were tuned to reduce normal tissue doses as much as 
possible without compromising the OAR dose tolerances or the PTV dose. In practice this 
approach resulted in relative weights in the range 1 - 5 for normal tissue objectives and 5 – 10 for 
OAR and PTV objectives. 
The clinical impact of dose to normal tissues will depend on a number of factors including 
the volume of tissue irradiated (discussed in 2.5.2). The objective function can therefore be 
improved to better represent the true goals of the treatment. Radiobiological objectives designed 
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to represent the actual biological response of tissues to a particular dose distribution can be 
constructed.  The use of biological objectives is an important area of research but, as the report of 
TG-166 states, due to their limitations reliance on biological objectives can be potentially 
dangerous (Allen Li et al., 2012). A more typical method is the use of dose-volume objectives. 
Rather than just using prescribed dose, objectives for a certain volume of the structure to receive 
a given dose can be defined. Biological objectives can then be used for evaluation of similar plans 
that both meet dose-volume objectives. 
 
2.5. Clinical Evaluation 
When comparing exIMRT with IMRT a method is required to determine whether or not the 
exIMRT plan is superior. The methods for comparing techniques therefore need to be defined.  
 
2.5.1. Isodose  
The first step is likely to be a qualitative analysis through visually assessing the three dimensional 
dose distribution.  The isodose are lines joining points of equivalent dose and these can be viewed 
and assessed on screen. It is also possible to set nominal isodose aims e.g. keeping the 95% isodose 
close to the edge of the target. This can be taken a step further by using the conformity number 
(CN) (van't Riet et al., 1997) or more simply the conformity index (CI) defined as the ratio between 
the target volume and the volume irradiated to a certain dose level  
 
2.5.2. Dose-volume data 
For further quantitative analysis, dose-volume data are required. That is information on the dose 
received by particular volumes in the patient. The simplest example being the minimum, maximum 
and mean dose in a particular structure. However this information is not always useful. The 
minimum and maximum dose may be in a non-representatively small volume e.g. a single voxel. 
In addition, the calculated values will be subject to errors from a number of sources. For example, 
the way the structure is drawn and the way voxels are included in the structure can give different 
maximum and minimum doses. It may then be more useful to look at dose-volume information for 
example the minimum dose in 1% of the volume (ICRU83, 2010). 
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The use of dose-volume data will depend on the structure that is being investigated. When 
looking at the target volume, the focus should be in ensuring that the correct dose is delivered to 
the target with no significant hot or cold spots. We may then wish to look at the volume of PTV 
receiving 95% of the dose or the volume receiving 107% of the dose (ICRU50, 1993). When 
looking at OAR we will have to consider the organ type and its response to radiation. For example 
it is known that some organs respond in a serial way and some respond in a parallel way. For serial 
organs the maximum dose must be kept below a fixed values whereas for parallel organs it is the 
dose to a particular volume, or volume receiving above a certain dose, that is of interest (ICRU83, 
2010). exIMRT plans will therefore be assessed using dose-volume objectives from UHCW 
clinical protocols as well as by simpler means. 
As opposed to specific dose statistics dose-volume histograms (DVH) summarise the dose 
distribution over the entire 3 dimensional dose matrix in a graphical form. A DVH in its simplest 
form is a frequency distribution of dose values within a specified structure. Rather than displaying 
the frequency DVH are usually displayed as percentage volume against dose. Two types of DVH 
are in use, differential DVH and cumulative DVH. The most commonly used is cumulative DVH.  
With cumulative DVH the volume receiving at least the specified dose is plotted against dose. 
This method is analogous to the qualitative technique of covering the target with a specific isodose 
(Cheng and Das, 1999).  
 
2.5.3. Equivalent uniform dose (EUD) 
Consider a structure within the patient. Depending on the dose delivered to that region, there will 
be different biological effects. Assuming that the biological effects can be quantified on some one-
dimensional scale, for example the grade of tumour control, there will be a number of dose 
distributions that give the same biological effect. The idea behind the EUD is to, for a given non-
uniform dose distribution, find the uniform dose that gives the same biological effect. For the 
target EUD is the absorbed dose that, when homogeneously given to a tumour, yields the same 
mean cell kill as the given non-homogeneous irradiation. The concept of EUD is presented by 
Niemierko (Niemierko, 1997) who suggested that EUD could be defined as (Niemierko, 1999):   
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where this is the same formulae as used in the LKB model for NTCP except that a corresponds to 
1/n in the LKB formulae (Appendix C). For a target volume, the logical choice would be an EUD 
objective with a < 1. The lower the value of a, the more effort will be given to avoiding cold spots. 
EUD could be of particular interest for exIMRT where it is expected that the target dose may not 
be homogeneous. For example, if an exIMRT plan reduces the OAR dose but exhibits a reduction 
in the target dose homogeneity this may still be preferred if the EUD for the target is unchanged.  
 
2.5.4. Normal tissue complication probability (NTCP) 
Either EUD or tumour control probability (TCP) and normal tissue control probability (NTCP) 
models can be used for biologically based plan evaluation. The report of TG-166 (Allen Li et al., 
2012) suggests that EUD has the advantage of being less dependent on the chosen parameters 
when it comes to ranking treatment plans. However it would be useful to be able to have a feeling 
for the change in NTCP when evaluating the exIMRT technique. 
NTCP is the probability that a given dose of radiation will cause an organ or structure to 
experience complications considering the specific biological cells of the organ or structure. The 
main NTCP models in common usage are the Lyman Kutcher Burman (LKB) model (Lyman, 
1985, Kutcher et al., 1991) and the relative seriality models (Källman et al., 1992). Parameters for 
these model need to be derived from published clinical outcome data. Burman derived parameters 
for the LKB model from the Emami data for normal tissue response (Emami et al., 1991) to 
produce what is referred to as the Emami-Burman parameters (Burman et al., 1991). However in 
some cases more accurate values are available based on more up to date data including that 
presented by QUANTEC (Bentzen et al., 2010). Details of the models and parameters used in this 
research are presented in Appendix C.  
 
2.5.5. Malignant induction probability (MIP) 
Plans than have similar dose-volume data EUD and even NTCP may carry with them different 
risks of inducing secondary cancers. By reducing the low dose wash through exIMRT it is hoped 
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that this risk can be minimised. A method of ranking methods by their relative risk would therefore 
be desirable. Radiation therapy gives rise to premalignant initiated cells when DNA damage is 
miss-repaired, leading to mutations in the genetic code. The study of (Timlin et al., 2011, Timlin 
et al., 2015) introduced the concept of malignant induction probability (MIP) by considering the 
expected number of transformed cells in each voxel of the treatment volume. Two models based 
on linear and linear quadratic models of the probability of a cells being transformed were presented 
both giving similar results when it comes to ranking plans. Although the absolute MIP value was 
found to be dependent on the parameters the value of relative MIP (relMIP) was found to be a 
useful metric to rank plans regardless of parameter and model based uncertainties. The relMIP was 
used compare proton therapy with X-ray IMRT in (Timlin et al., 2015) but could equally be used 
for combined electron and X-ray IMRT. Details of the models and parameters used in this research 
are presented in Appendix C. 
 
2.6. Discussion and conclusions 
Existing studies demonstrate that combing X-ray IMRT and electron beams to improve depth 
modulation can reduce the dose distal to the target. However none of these studies have progressed 
to routine clinical practice. It is suggested then that further research into combined electron and 
X-ray IMRT is valid. 
The study of (Das et al., 2004) demonstrates the theoretical benefits of combined electron 
and X-ray IMRT encouraging research into practical applications. The study of (Al-Yahya et al., 
2005) builds on this work by using an add on electron MLC (eMLC). The use of eMLC is a viable 
option but introduces problems with integrating the election and X-ray components. The eMLC 
would either have to be removed or retracted between modalities potentially causing issues with 
matching of the electron and X-ray components. The PhD thesis of (Weinberg, 2007) proposes 
using X-ray MLC (xMLC) to avoid the issues around eMLC but the study was only partially 
successful. Weinberg demonstrated only some small improvements in dose distributions with a 
small additional contribution from the electron beam. It is suggested that these results could be 
improved with reduction of penumbra broadening of the electron component. The studies of 
(Surucu et al., 2010, Palma et al., 2012) both employ a reduced SSD to minimise penumbra 
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broadening but this would make integration of the electron and X-ray component difficult 
(discussed further in Chapter 5).  
It is hypothesised that, rather than reduce SSD, scattering foils could be removed to reduce 
penumbra broadening of the electron field.  This would have the added benefit of reducing X-ray 
contamination which is stated by (Henzen et al., 2014) as being potentially prohibitive. Scattering 
foil free delivery of electron beams with xMLC is a novel contribution of this research. In parallel 
to the work undertaken by the author over the last 5 years, scattering foil removal has been shown 
to be feasible by others for conventional electron beams and add on electron MLC to reduce X-
ray contamination. 
Only Weinberg and Palma et al. optimise the combined electron and X-ray dose 
distribution. However neither optimise the electron energy. Palma et al. goes some way to 
optimising the electron energy with range selection but this does not consider variations in 
penumbra broadening with energy (discussed further in Chapter 5). It is hypothesised that an 
iterative constrained optimisation of the photon intensity, the electron intensity, and the electron 
energy could maximise the potential of combined electron and X-ray IMRT.  
BEAMnrc Monte Carlo modelling of radiation transport has been used for the electron 
component in a number of studies and shown to be accurate. However the scattering foil free 
electron beam line has not been modelled previously. This research will therefore use BEAMnrc 
to model the scattering foil free xMLC collimated beam. 
A number of treatments sites have been considered for combined electron and X-ray IMRT 
but the greatest number of successful studies have been for breast treatments and for cancers in 
the head and neck. The research will therefore consider breast and head treatments as well as other 
sites for clinical evaluations.  Clinical evaluation methods reviewed in this chapter will be used 
with the novel application of relMIP to combined electron and X-ray IMRT to quantify reduction 
of secondary cancer risk. 





Dosimetric characteristics of xMLC shaped 
scattering foil free electron beam 
 
3.1. Introduction 
This chapter presents an investigation into the feasibility of delivering electron beams shaped with 
X-ray photon MLC (xMLC) and jaws by way of measurement. It begins by addressing the 
fundamental problems associated with such a method. Following on from this the use of scattering 
foil free delivery as a novel way to minimise some of the problems is discussed and demonstrated. 
Finally questions raised about the practicality (dose rate) and safety (dose distal to the field) of 
xMLC delivery of electrons beams are addressed.  In all cases a 10MeV electron energy has been 




Existing studies investigating electron beam shaping with xMLC suggest short source to surface 
distance (SSD) of 60 to 70 cm (Chapter 2).  Although conceivable for MERT alone such short 
SSD would be very limiting if MERT were combined with X-ray IMRT. Short SSD dictates lateral 
or posterior beams only as anterior beams require the patient to be raised to an unsafe height. More 
importantly, matching with X-ray fields at an angle to the electron field would be limited by the 
X-ray field size. For an Elekta linac the half width of the maximum available X-ray field is 20cm. 
The distance from the source to the mechanical isocentre is 100cm. Hence the minimum SSD for 
an orthogonal electron beam would be 100-20 = 80 cm if the X-ray beam were to extend to the 
surface (see Figure 3.1).  In practice, combining short SSD MERT fields with X-ray IMRT would 
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require separate isocentres. Using separate isocentres would introduce inaccuracies into the 
matching of the electron and X-ray components. There may be errors due to the positioning of the 
patient between isocentres as well as increased internal or external patient movement due to the 
extra time required. In order to attempt to reduce these errors image guidance would need to be 
repeated for both isocentres resulting in additional dose to the patient. 
 
Figure 3.1 X-ray field orthogonal to MERT at 60cm SSD (left) and 80cm SSD (right), tumour not covered 
by maximum field size at 60cm SSD 
 
To overcome practical issues associated with combining electron and photon in the same 




Measurements with and without the scattering foil were made using an Elekta Synergy linear 
accelerator with MLCi head currently in clinical operation. The Elekta design uses a dual 
scattering foils design (Bjarngard et al., 1976). The primary thin tantalum (high-Z) foil scatters the 
initially narrow electron beam into an approximately Gaussian distribution. The secondary foil 
consists of a conical shaped copper or aluminium (low-Z) foil which is located downstream of the 
primary foil to flatten and broaden the beam.  Removal of the scattering foils from the beamline 
can be achieved with only minor modification to the treatment machine. The primary scattering 
foil can simply be rotated out of the path of the beam as is the case in photon mode. As the linac 
is digitally controlled this can be done in service mode simply be editing the corresponding 
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machine item part. The secondary scattering foils sit on a carousel along with the X-ray flattening 
filter. There are five spaces in the carousel but for the linac investigated here not all spaces are 
used clinically. Unused spaces are covered with an aluminium blanking plate but removal of the 
blanking plate to leave an empty space is a relatively simple matter (see Figure 3.2). The carousel 
can then be rotated into the correct position by changing the appropriate machine item part as with 
the primary scattering foil.  If this mode of operation were to be offered for clinical use by the 
manufacturers all that would be required is removal of the blanking plate and the addition of the 
scattering free foil mode to the software configuration of both the linac and the record and verify 
system. 
The linac co-ordinate system of A to B and G to T is referred in the text and figures of this 
chapter. The system is independent of linac movement where A to B indicates left to right and G 
to T indicates the gun to target direction perpendicular to A to B. In this chapter an A to B 
measurement refers to a measurement across the MLC travel direction and G to T refers to a 
measurement in the perpendicular ‘Y-jaw’ travel direction as all measurement were performed 
with zero degrees gantry and collimator rotation. 
A series of Measurements were made at 10MeV to characterise operation in scattering foil 
free mode, with additional measurements at 6MeV and 15MeV to provide a reference for Monte 
Carlo modelling at those energies (Chapter 5).  A Sun Nuclear IC Profiler 2D Diode array was 
used to check beam stability and ensure beam symmetry. Measurements of depth dose and off axis 
profiles were made with a PTW 60012 electron diode in a PTW MP3 water tank. A PTW 
Advanced Markus chamber in WTe solid water at the geometric centre of the field at 90cm SSD 
was used to determine the variation in output with field size on the central axis and towards the 
edge of the available treatment area for the un-scattered beam line.  Using xMLC to collimate the 
electron beams may result in an additional source of dose from electrons scattered in the linac head 
or in the air between the linac head and the patient. To determine whether this additional scatter 
dose is significant measurements were made in the patient plane at set distances from the field 
edge. A 10x10cm field was delivered and measurements were made using a 0.6cc farmer ionisation 
chamber with a 1.5cm thick Perspex build up cap. The chamber was positioned at distances up to 
1m from the patient and charge recorded normalised to the reading at the centre of the open field. 
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Figure 3.2  Elekta scattering foil carousel with empty space 
 
3.4. Electron beam delivery through xMLC 
Measurements were carried out to examine electron beam delivery through the Elekta MLCi head 
xMLC at 95cm and 90cm SSD.  The off axis profiles and depth doses were measured for a 10 
MeV electron beam with applicator and for the same beam collimated with jaws and the 1cm wide 
MLC to 10cm and 2cm square to show the effects of penumbra broadening and increased photon 
contamination. 
Off axis absorbed dose profiles measured at various depths in a water tank for a clinical 
(scattering foils in place) 10MeV 10x10cm electron beam with applicator are shown in Figure 3.3 
along with the same 10MeV beam collimated with xMLC. It can be seen that collimating the 
electron beam with xMLC results in penumbra broadening, widening of the field size and loss of 
in field flatness. 
 
Figure 3.3 Measured off axis profiles in water for a 10MeV electron beam (scattering foils in place) at 95cm 
SSD, field defined by a 10x10cm applicator and by 10x10cm (set field size) Jaws and MLC (measurement 
in the MLC direction, Elekta MLCi 1cm wide leaves). 
Some materials have been removed due to 3rd party 
copyright. The unabridged version can be viewed in 
Lancester Library - Coventry University.
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It may be possible to regain some in field flatness by intensity modulation with multiple 
small fields (Chapter 5). Moreover a flat field is not necessarily an advantage if intensity 
modulation to produce a non-uniform dose distribution is required. This is analogous to removal 
of the flattening filter for photon IMRT treatment which has now been generally accepted as best 
practice (Cashmore, 2008). Although it should be noted that as well as loss of flatness the lateral 
scatter of electrons results in an increase in dose outside the geometric field size for the electron 
field. 
To apply intensity modulation to the electron field with xMLC multiple small fields or 
‘segments’ will be required. This introduces another potential issue in that reducing the field size 
reduces the electron dose rate by reducing the contribution from electrons scattered onto the central 
axis. In order to give the correct dose the monitor units (MU) and therefore beam on time can be 
increased but this would increase treatment time, increase head leakage and importantly increase 
the relative contribution from contaminant X-ray photons.  
Photon contamination can be determined from the tail of the measured depth curves. For a 
10MeV 2cm square field at 90cm SSD the photon contamination is 7.3% of the maximum dose at 
7cm deep (see Figure 3.9). This level of X-ray contamination could be significant as one of the 
aims of incorporating electron beams into the plan is to reduce the low dose wash. 
In this work a new approach to reducing the two effects of increased penumbra broadening 
and increased X-ray contamination previously described above is proposed. The proposal is that 
the scattering foils are removed from the path of the electron beam. Removing the scattering foils 
will reduce the scattering angle of electrons leaving the linac head and remove a source of 
contaminant photons.  
 
3.5. Scattering foil free electron beam 
Scattering foils are designed to widen the electron beam that leaves the exit window to make it 
suitable for clinical use. By removing the scattering foils the width of the electron fluence and 
therefore the useful treatment area will be reduced. This electron fluence was measured as it leaves 
the linac head with EBT3 radiochromic film placed in air at 60 cm SSD (see Figure 3.4). This 
measurement shows that there is still significant scattering after removing the scattering foils.  This 
scattering is likely to be from the Nickel exit window but will be investigated further through 
Chapter 3 Dosimetric characteristics of xMLC shaped scattering foil free electron beam 
44 
Monte Carlo modelling (Chapter 4). The fluence distribution is approximately Gaussian with a 
FWHM of 12.8cm at 60cm SSD. This suggests a useful field diameter of around 12.8/60 * 90 ≈ 
19cm at 90cm SSD. 
 
Figure 3.4 Measured electron fluence across half the field at 60cm SSD for a 10MeV field, scattering foils 
removed jaws and MLC set at 40x40cm in orthogonal planes and across the diagonal.  
 
Although the linac is not designed to operate with the scattering foils removed, 
measurement with a Sun Nuclear IC Profiler 2D Diode array demonstrated that running in this 
mode is stable and that a homogenous electron beam can be produced. Symmetry in all directions 
to better than 1% was achieved with only minor adjustments to the beam steering currents set with 




Figure 3.5 Profiler measurements of field symmetry with scattering foils removed. Taken directly from Sun 
Nuclear Profiler software and showing measured profile (red), measured profile mirrored about the central 
axis (blue) and the % difference (purple), plotted against distance off axis (a) A-B and (b) G-T direction, 
25x25cm set field size. 
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The dose deposited in the patient is related to the incident electron fluence but will be 
modified by the additional scatter in the air and in the patient. This is considered by measuring the 
dose with an ionisation chamber at depth in a water tank with the surface of the water at 90cm 
SSD. Measurement of the 10MeV beam with jaws and MLC at 40x40cm at 2cm deep, 90cm SSD 
confirm an approximately Gaussian dose distribution at depth with scattering foils removed (see 
Figure 3.6).  
 
Figure 3.6 Measured off axis profiles in water for a 10MeV electron beam at 90cm SSD 2cm deep, 40x40cm 
Jaws and MLC (set field size). With and without the scattering foils across the A to B (similar profiles 
measured in the G to T and diagonal axis). 
 
With both foils removed the FWHM of the distribution is 18cm, agreeing with the fluence 
measurements within 1cm. Perhaps then the useful treatment area could be defined as an 18cm 
diameter circle or, if 18cm is the diagonal of square, a 12.7cm square. Although this is a significant 
reduction in area compared to the 40x40cm square (maximum field size available with scattering 
foils in place) it is still a potentially useful size and comparable to that available for add on electron 
collimators developed by others. A larger area is available if just the secondary foils are removed. 
Removal of just the secondary foil is an attractive proposition as the shaping by the secondary foil 
is not required if the beam is intensity modulated. Perhaps some gains can be made by keeping the 
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primary foil to widen the beam but removing the secondary filter. This possibility will be 
investigated further below. 
To investigate the potential advantages of delivery with scattering foils removed consider 
a 10x10cm field as a typical total treatment field size and a 2x2cm field as the component of a 
segmented field for MERT. 
The 10x10 field at 90 cm SSD shows that for a larger field the penumbra width is reduced 
when removing both scattering foils (see Figure 3.7). Penumbra width defined as the distance 
between the 80% and 20% dose points is reduced from 43mm to 34mm in the A to B direction and 
from 33 to 29mm in the G to T direction. 
Similarly widening of the field size is reduced with scattering foils removed. Field size 
defined as the 50% dose width has been compared to the ideal geometric width defined as the 
width of the light field on the water surface (for a 10cm wide field at 90cm SSD = 90/100x10 = 
9cm). With foils in place the field size is extended by 16mm in the A-B direction compared to the 
ideal geometric field width. This is reduced to 4mm with scattering foils removed. 
Removal of just the secondary foil appears to provide no advantage in terms of reducing 
the penumbra for 10x10cm field. 
  
Figure 3.7 Measured off axis profiles in water for a 10MeV electron beam at 90cm SSD 2cm deep, 10x10cm 
Jaws and MLC (set field size). With and without the scattering foils across the A to B axis (left) and across 
the G to T axis (right). 
 
For a 2x2 cm field penumbra broadening is relatively large and the field size is not 
maintained with or without scattering foils (see Figure 3.8). As discussed in Chapter 2 some studies 
suggest that one way to minimise penumbra broadening is to treat at reduced SSD. To investigate 
the SSD effect measurements were made at 90, 80, 70 and 60cm. For each SSD the set field size 
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was modified to give the same field size projected at the water surface as a 2x2cm set field size at 
90cm SSD. Results are presented in Table 3.1. These results demonstrate a clear benefit to 
reducing SSD by reducing in air scatter and therefore field spread. From 90cm SSD to 60cm SSD 
the penumbra width is reduced by 11.7mm with scattering foils in place. However there is also a 
significant reduction in scattering with removal of the foils. At 80cm SSD the penumbra width is 
reduced from 18.3 to 14.3mm with scattering foils removed. This brings it closer to the measured 
penumbra with of 14.7mm at 70cm SSD. There is also a reduction in the benefit of reducing SSD 
with scattering foils removed as from 90cm SSD to 60cm SSD the penumbra width is reduced by 
8.2mm. However the absolute penumbra is smaller at reduced SSD suggesting that SSD should be 
minimised where possible. 
 
Figure 3.8 Measured off axis profiles in water for a 10MeV electron beam 2cm deep, 2x2cm Jaws and MLC 
(set field size) across the A to B axis. With and without the scattering foils at 90cm SSD. 
 
 
Table 3.1 Reduction of penumbra width for a 2x2 field by reduction of SSD and by removal of scattering 
foils 





 80-20% Width (mm) Reduction (mm) 
90 23.2 18.6 4.6 
80 18.3 14.7 3.6 
70 14.5 12.6 1.9 
60 11.5 10.4 1.1 
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X-ray contamination can be investigated by considering the tail of the depth dose curve. 
Measuring dose along the central axis will give the characteristic electron depth dose curve with 
electron dose stopping at the practical range of the electrons and leaving just the contribution from 
the more penetrating contaminant X-rays.  For a 2x2 cm field removing the scattering foils reduces 
the dose at 10cm deep from 7.3% to 0.6% (see Figure 3.9). Removal of just the secondary foils 
has a reduced impact with the dose at 10cm deep remaining at 2.1%. Note that removal of both 
scattering foils does have the negative effect of a small reduction of the dose gradient between 
90% and 70% dose. 
 
Figure 3.9 Measured percentage depth dose for a 10MeV electron field delivered through the jaws and 
MLC at 90cm SSD for a 2x2 cm field with and without scattering foils to show reduction in X-ray 
contamination  
 
It has been suggested by (du Plessis et al., 2006) that the electron field should be defined 
by the MLC only, i.e. with backup jaws retracted, to avoid an additional source of scatter. However 
measurement of a 2x2cm profile with and without backup jaws demonstrated very little influence 
from the backup jaws for the Elekta linac investigated (see Figure 3.10). This is possibly due to 
the standard calibration procedure of setting the backup jaws 1mm behind the MLC. 
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Figure 3.10 Measured off axis profiles in water for a 10MeV electron beam 2cm deep, 2x2cm Jaws and 
MLC (set field size) across the A to B axis. With and without backup jaws. 
 
Unless otherwise stated all measurements above were made with a PTW 60012 electron 
diode detector and a PTW MP3 water tank. The electron diode is indicated for use with MeV 
electrons by the manufacturer and has been previously commissioned for use in the clinic. 
However to increase the confidence in results for dose delivery without scattering foils and small 
electron fields it has been compared to measurements using a PTW microDiamond detector. The 
microDiamond detector is a single crystal diamond detector utilising a diamond synthetically 
manufactured for reproducibility. Diamond detectors have been shown to demonstrate an 
improved response compared to silicon diodes including field size dependence, directional 
dependence and a response shift in very small fields (Laub and Crilly, 2014). If differences existed 
between microDiamond measurements and electron diode measurement this could indicate an 
inaccuracy that requires further investigation. In fact for the conditions used here there difference 
between the microDiamond and the electron diode data is <0.5% confirming the validity of the 
electron diode measurements. 
 
3.6. Dose rate 
A potential issue with the use of small electron fields collimated by the xMLC is the 
reduction in the effective dose rate, or ‘output’, seen as a reduction in the dose delivered per MU. 
The electron fluence at the surface of the patient on the central axis is a combination of electrons 
originating on the central axis and electrons scattered onto the central axis. Collimating the field 
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at the head rather than at the patient stops electrons high up that might otherwise scatter onto the 
central axis. This effect can be seen in Table 3.2. Measurements of dose rate have been made using 
an Advanced Markus Chamber at 2cm depth in solid water. For each field 100 MU was given and 
the recorded charge normalised to the recorded charge for a clinical 10MeV beam under reference 
conditions (1cGy/MU). With the scattering foils in place, it can be seen that collimating down to 
a 2x2cm field reduces the dose rate to 8%. However, with the scattering foils removed the dose 
remains at 40% of the clinical beam, a factor of 5 higher than the same beam delivered with 
scattering foils. This is partly because fewer electrons are absorbed by the scattering foils which 
results in an increase in the dose rate for a 10x10 applicator field when scattering foils are removed. 
It is also likely that fewer electrons originating on the central axis in the forward direction have 
been scattered away, reducing the effect of collimating down to the small field size. 
 
Table 3.2 Dose rate relative to Clinical 10x10 10MeV beam, all at 2cm depth in WTe Solid Water measured 
with an Advanced Markus ionisation chamber 
Relative Dose Rate 
 
With Scattering foils No Scattering foils 
10x10 Applicator 95cm SSD 1.00 2.29 
10x10 xMLC 90cm SSD 0.87 2.44 
2x2 xMLC 90cm SSD 0.08 0.40 
 
The same method of measurement was used to determine how dose rate varied if small 
fields were delivered off the central axis. In section 3.5 it was determined that a useful treatment 
area would be around 180mm diameter or 127mm square. This suggests that individual small 
segments could be delivered with a field offset of 180/2 = 90mm, neglecting field width. To 
investigate the change in dose rate in this region, measurement were made for a 2x2cm field offset 
by 60 to 120mm in the B direction (see Figure 3.11). Over the full 120mm offset the dose rate 
remains at >10% of the clinical beam under reference conditions. This drop in dose rate does apply 
radially so that with an offset in both B and G of 80 mm the offset from the CAX along the diagonal 
equates to 113mm and the dose rate drops to 11% (not shown in Figure).      
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Figure 3.11 Variation of dose rate with field offset in the B direction for a 10MeV 2x2 xMLC scattering 
foil free electron beam at 90cm SSD relative to a clinical 10MeV 10x10 field delivered with an applicator 
at 95cm SSD 
 
3.7. Peripheral doses 
So far only the dose to the patient from the direct electron field has been considered. In general 
with any external beam radiotherapy technique there will also be photons and electrons that leak 
through the linac shielding or scatter in the head of the linac that reach the patient plane distal to 
the treatment field. This results in a low level of dose to the patient in areas other than the area 
being treated. This dose contribution should be minimal and is regulated to be <0.1% of the useful 
beam exposure at 1m. Using xMLC to collimate the electron beams may result in an additional 
source of dose from electrons scattered in the linac head or in the air between the linac head and 
the patients.  
To determine whether this additional scatter dose is significant, measurements were made 
in the patient plane at set distances from the field edge. A 10x10cm field was delivered and 
measurements were made using a 0.6cc farmer ionisation chamber with a 1.5cm thick Perspex 
build up cap. The chamber was positioned at distances up to 1m from the patient and charge 
recorded normalised to the reading at the centre of the open field.  Spot check measurements were 
also made with the build-up cap removed to account for dose from low energy scatter. For 
comparison, similar measurements were made for a 6MV 10x10cm field with and without a 
motorised heavy metal wedge (used for 3DCRT treatments) inserted.  
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It can be seen in Figure 3.12 dose drops of quickly for electrons delivered with xMLC. The 
relative dose is less than 0.1% at 1m and is actually lower than a for a 6MV wedged field (where 







Figure 3.12 Dose distal to the field edge measured using a 0.6cc Farmer chamber and 6MV build up cap. 
Distance from the field edge towards G (a), towards T (b) and towards B(c).  Detail with and without build 
up cap (d). 
 
There is some reduction in dose away from the field edge when removing the scattering 
foils. At 5cm from the field edge in the A-B direction it is reduced from 3% to 1% (see subfigure 
(c)). At distance greater than 10cm from the field edge there is a small reduction in dose when 
removing the scattering foils (see subfigure (d)) but in all cases it is less than 0.01% at 50cm. This 
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includes dose measured with the build-up cap removed suggesting no high levels of low energy 
electrons are present. 
 
3.8. Segment size 
Previously, a 2cm electron segment size was assumed. This is the minimum field size suggested 
by Klein et al. in the context of MERT using xMLC at reduced SSD (Klein et al., 2008). Small 
fields are necessary to achieve the required resolution for intensity modulation. However, as the 
field size is reduced the extent of lateral scatter in the air and the patient does not reduce 
correspondingly such that the minimum effective field size is limited.  The typical beamlet size of 
a few mm used for X-ray photon IMRT is therefore not practical. To investigate this effect small 
fields were measured with EBT3 radiochromic film at depth in WTe solid water (see Figure 3.13). 
The dose profiles for the scattering foil free 10MeV beam at 90cm SSD 2cm deep have been 
plotted for a 1x1cm, a 2x2cm and a 5x1cm field. Reducing the field size from 2cm to 1cm does 
not produce a smaller effective field size as expected (but has the negative effective of reducing 
effective dose rate). Increasing the length of the field to 5cm only increases scatter contribution, 
further increasing the width of the field. 
 
Figure 3.13 EDR2 radiochromic film measurements of 10MeV profiles at 90cm SSD and 2cm deep 1x1cm  
and 2x2cm profiles overly each other and 5x1cm (across the 1cm direction) is wider. 
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3.9. Discussion and conclusions 
Shaping of the electron field with the xMLC is generally seen as an impractical proposition due to 
scatter in the linac head and in the air between the exit window and the patient. It has been shown 
in this chapter that some of the issues can be minimised by removing the scattering foils which is 
the primary source of scatter in the linac head. This in itself may at first seem impractical but it 
has been demonstrated that a stable symmetrical beam can be maintained with a reasonably sized 
effective treatment area of 18cm diameter. By removing the scattering foils penumbra broadening 
is significantly less. For a 10MeV field the 80-20% width is reduced by up to 9.6mm for a 10x10cm 
field and 4.6mm for a 2x2cm field. This reduction in penumbra broadening is not seen when only 
the secondary scattering foil is removed so for the technique to be effective both foils must be 
rotated out of the beam. 
It has also been demonstrated that the issues of low dose rate and increased X-ray 
contamination associated with small fields can be avoided by removal of the scattering foils. 
Measured X-ray contamination is negligible with the scattering foils removed and the dose rate is 
over 20% of a standard clinical electron beam as long as segments are not offset beyond the 18cm 
diameter circular effective treatment area. 
These results suggest that shaping the electron beam with xMLC is feasible but that the 
dose distributions produced are not ‘flat’ and significant lateral spread remains with scattering 
foils removed. What is required is to determine whether intensity modulation and combination 
with IMRT can produce useful dose distributions within these limitations.  It is not practical to do 
this with direct measurement so first the electron beam will be modelled to allow calculated 
intensity modulated electron dose distributions to be produced.





Monte Carlo modelling of an xMLC 
scattering foil free electron beam  
 
4.1. Introduction 
Historically one reason for a reluctance to implement complex electron treatments in the clinic has 
been the difficulty of calculating dose in the patient. Deterministic pencil beam models assume 
that the beam incident on the patient is actually a conglomeration of many smaller narrow pencil 
beams. This does not fully take into account the effects of inhomogeneities and lateral scatter. 
Consequently, in inhomogeneous media, pencil beam dose calculations have large errors for 
complex geometries. This issue is largely solved by using Monte Carlo based dose calculations 
(Lee et al., 2001).  
Monte Carlo dose calculations use simulations of particle transport to build a true picture 
of the physical reality. The geometry of the system is defined along with a source of particles. 
Particles are created then travel a distance before interacting with matter based on random 
sampling from a probability distribution defined by the total interaction cross section. At this point, 
the particle may scatter into another energy or direction which is defined by the differential cross 
section. The same principle applies for if a new particle is produced. The process is continued until 
all particles are absorbed or leave the geometry. The dose delivered can be determined by making 
a tally of the energy absorbed in the area of interest. This value is the dose averaged over the 
number of initial source particles or ‘histories’, N. Mathematically, this averaging procedure is a 
Monte Carlo integration where the random points in the problem space are the random particle 
trajectories in the given geometry. According to the central limit theorem the dose calculated will 
approach the true value for large values of N. Calculated values will be subject to a statistical 
uncertainty that decreases as N-1/2. If a high statistical precision is required calculation time may 
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be therefore be prohibitively long. Techniques that speed up Monte Carlo simulations without 
introducing a systematic error in the result are known as variance reduction techniques. With the 
application of variance reduction techniques and with improvements in high speed computing, 
Monte Carlo calculations have recently become a viable option for use in the clinic and are 
available as part of a number of commercial treatment planning systems.  
As long as the model is specified correctly and with enough detail in the geometry Monte 
Carlo dose calculations of electron radiotherapy can be highly accurate (Lee et al 2001). Monte 
Carlo has been used in this study as the most accurate method of predicting not only dose in patient 
but also the interplay of scatter from the linac head when collimating with xMLC. Thus, any 
conclusions about the potential of modulated electron beams from this work will be based on data 
that reflects the clinical reality.  
  
4.2. BEAMnrc scattering foil free model 
BEAMnrc has been used to create a Monte Carlo model of the linac. BEAMnrc is a medical linac 
modelling tool which acts as a front end for creating the geometry to feed into radiation transport 
calculations by EGSnrc. There are a number of Monte Carlo codes available but, as well as having 
existing tools for the modelling of  the medical linac, EGSnc is one of the most widely used Monte 
Carlo codes for simulating electron transport in medical applications and has been extensively 
validated against measurement (Rogers et al., 1995). 
A three stage BEAMnrc model was used. Stage 1 models the passage of the electron beam 
through an Elekta linac head up to the collimators. The particles from the Stage 1 phase space file 
are then transported through Stage 2 which consists of an accurate model of the Elekta MLCi head 
collimating jaws and MLC. Stage 3 takes the particles from Stage 2 and transports them through 
the air gap between the bottom face of the MLC and patient, as well as in the patient phantom 
itself. 
If modelling an unmodified linac Stage 1 could either include the scattering foil geometry 
explicitly or employ a virtual source model. Rather than simulate the passage of electrons through 
scattering foils directly a virtual source model considers the electrons as being created after the 
scattering foils with an energy and scattering angle as if they had passed through the scattering 
foils. In this work, however, the scattering foils are removed completely so there is no requirement 
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for the foils to be modelled. Therefore, the electron source simply becomes the direct parallel beam 
of electrons that exit the accelerating waveguide.  The remaining components of scatter in the linac 
head do, however, have to be modelled, namely the ionisation chamber, the mirror and most 
importantly the exit widow. The exit window is designed to act as a barrier between the near 
vacuum of the accelerating waveguide and the open atmosphere of the linac head whilst providing 
minimum absorption of exiting electrons. On the Elekta linac the exit window consists of 0.125mm 
thick Nickel. In the absence of scattering foils the Nickel exit windows becomes the primary source 
of scatter and as such the density and thickness are critical. 
Figure 4.1 shows the difference in scatter conditions with the nickel exit window only and 
with the primary scattering foil (a 0.07mm Tantalum disk) in place. There is still a significant 
amount of scatter just from the exit window. Removal of the primary scattering foils does reduce 




Figure 4.1 Monte Carlo Simulation of a 10MeV parallel electron beam incident on the nickel exit widow  
and a 0.07mm Tantalum primary scattering foil (left) and the exit window alone (right).  Electrons tracks 
are shown in blue, contaminant X-ray photons in yellow as they enter the opening of the primary collimator. 
Disks represent the planes of the foils.  
 
For each component of the Monte Carlo model every effort has been made to correctly 
reflect the geometry, materials and density of materials used in the linac design. Reference has 
been made to measurement of individual components and to the manufacturer’s supplied technical 
drawings. The EGSnrc distributed ICRU521 materials (lower threshold energy for secondary 
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electron production than ICRU700) based on data from ICRU 44 (ICRU44, 1989) have been used 
except where new materials have been constructed to match Elekta specifications. 
 
4.3. Monte Carlo transport parameters 
In the process of slowing down within a system a typical fast electron path will involve 105 
collisions most of which will involve only a slight change in direction and energy (Larsen, 1992). 
In the context of Monte Carlo modelling of radiation transport following each electron path 
directly from creation to absorption would require the tracking of a prohibitively large number of 
tracks. For this reason many track segments of the real electron path are grouped into a single step, 
a so called Condensed History (Berger, 1964). The cumulative effect of elastic and inelastic 
collisions during the step are taken into account by sampling energy and direction changes from 
the appropriate multiple scattering distributions at the end of the step. This approach is justified 
because the change in electron state in a single collision is usually small at high energies. The 
approach breaks down at lower energies and individual electron paths have to be followed. At high 
energies, the creation of secondary particles along the electron path is also required to be 
considered. EGSnrc uses the Class II Condensed history scheme where above set threshold 
energies bremsstrahlung processes that result in the creation of photons and inelastic collisions 
that set in motion atomic electrons are simulated explicitly and the secondary particles transported 
(Kawrakow, 2000).  
There are some subtle variations to the condensed history approach available within 
EGSnrc which are controlled through user input parameters. Setting of the parameters that control 
the model incorrectly could potentially have a negative influence on accuracy of the simulation 
and therefore the calculated dose distribution. Each of these parameters along with the chosen 
value is described in the following subsections, followed by an associated sensitivity study. 
 
4.3.1. Electron-step algorithm= PRESTA-II 
The simplest possible approach one could take is to ignore deflections due to multiple elastic 
scattering during the condensed history step and to transport the electron on a straight line along 
the initial direction of motion. In order for this approach to be accurate the Condensed History 
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steps must be sufficiently short so that the straight line approach does not represent too severe an 
approximation. However, making the step lengths very short may cause the simulation to become 
extremely inefficient. EGSnrc employs electron-step algorithms that attempt to make corrections 
for deflections from the straight-line approach. The modified PRESTA-II algorithm is less efficient 
than PRESTA-I but better accounts for lateral deflections (deflections perpendicular to the initial 
direction of motion), and longitudinal straggling. 
 
4.3.2. Spin effects= On 
EGSnrc employs the screened Rutherford elastic scattering cross section. With spin effects turned 
on the correction for relativistic electron spin proposed by Mott is applied to the cross section. The 
effect of spin is significant below 1MeV for high-Z materials and below 100keV for low-Z 
materials. The physical effect of including spin is to make the effective range of electrons longer 
for low-Z materials and shorter for high-Z. 
 
4.3.3. XIMAX = 0.5.  
This value defines the maximum path length size before a new path is generated. It is equal to the 
first Goudsmit-Saunderson (GS) moment per step and is roughly half the multiple scattering angle 
squared. 
 
4.3.4. ESTEPE = 0.25 
Fractional energy loss per step is restricted to 25%. This is the Default value in EGSnrc. Smaller 
values can be used for high precision work but increase computation time. 
 
4.3.5. Boundary crossing algorithm= PRESTA-I 
One problem with the condensed history approach is that part of the electron path may be between 
two materials. The true electron trajectory would then be different to that simulated leading to 
interface artefacts. The PRESTA boundary crossing algorithm reduces the step size close to the 
interface between materials. No electron can take a path that is greater than the perpendicular 
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distance to the next boundary, unless that distance becomes less than a set value. The alternative 
is to use EXACT. EXACT reverts to single elastic scattering mode at the boundary between 
structures making the simulation less efficient. 
 
4.3.6. Skin depth for BCA= default 
This value sets the maximum perpendicular distance required by the PRESTA boundary crossing 
algorithm or the distance at which the simulation goes into single elastic scattering mode for the 
EXACT algorithm. The default is to allow the algorithm to calculate a value based on the scattering 
power at the electron cut of energy ECUT. 
 
4.3.7. Global ECUT= 0.7, Global PCUT= 0.01, Global SMAX= 5  
These are Global limits on the electron and photon cut off energy and step size for all calculations. 
Photon cut off energy has been set relatively low at 0.01 MeV (10keV) due to the need to model 
the effect of any low energy head scatter component on the surface dose. The electron cut off has 
been set at a kinetic energy of 0.7 – 0.511 = 0.189 MeV.   
 
4.3.8. Sensitivity study 
Confidence that the above parameters are appropriate was achieved through a sensitivity study.  
The depth dose for a 10MeV 2x2 cm field at 90cm SSD was calculated in water with different 
Monte Carlo transport parameters to determine the sensitivity of the accuracy and speed of the 
calculation to these values.  The effect on simulation time and the change in the dose at a depth of 
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Table 4.1 Sensitivity of calculated dose and calculation time to Monte Carlo transport parameters  
Change in dose at 
4cm deep 
CPU time for 
1E7 histories 
effect on  CPU 
time 
All parameters as 4.3.1 to 4.3.7 - 418.9 - 
Spin = off -6.5% 392.3 -6.3% 
XIMAX = 0.1 0.0% 487.8 16.5% 
XIMAX = 1.0 0.0% 435.0 3.9% 
ESTEPE = 0.05 -2.0% 520.9 24.4% 
ESTEPE = 1.0 0.0% 456.3 8.9% 
ECUT = 0.511 0.0% 449.0 7.2% 
ECUT = 3.0 15.3% 126.9 -69.7% 
PCUT =1.0 -2.7% 390.0 -6.9% 
PRESTA-I 
 electron step algorithm 
-0.6% 356.7 -14.8% 
 
With spin turned off as expected the effective range of the electrons is reduced resulting in 
a shift in the depth dose curve and a reduction in D4cm of 6%. Variations in XIMAX or ESTEPE 
do not have enough of a macroscopic effect to alter the calculated dose distribution and do not 
have a large effect on calculation time. Reduction of ECUT down to the rest mass energy makes 
no change to the dose distribution with a small increase in CPU time. Conversely increasing ECUT 
to 3 MeV discounts enough electrons to increase the average beam energy and significantly affect 
the calculated depth dose. The D4cm is increased by 15% compared to the reference value.  
Although calculation time is reduced this is clearly not acceptable. Increasing PCUT makes a small 
reduction in calculation time but with a small associated change in depth dose. Using the old 
PRESTA-I electron step algorithm reduces calculation time slightly and in this situation there is 
only a small change in calculated dose. However, it is known to be less accurate in some situations 
so it is not recommended for use. 
Boundary crossing parameters only affect the dose at the junction between materials. To 
test them the dose was re-calculated in a phantom consisting of 1.6cm layers of 
water/air/water/bone/water.  Results are summarised in Table 4.2 and Figure 4.2. Changing from 
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the PRESTA boundary crossing algorithm to the potentially more accurate EXACT algorithm had 
no effect on the calculated depth dose within 1SD but increased calculation time by 200%. 
Similarly setting the skin depth to a fixed small value (0.01mm) had no discernible effect on the 
depth dose but increased calculation time by 500%. 
 
Table 4.2 Sensitivity of calculation time to Boundary Crossing algorithm 
Boundary Crossing 
Algorithm 
CPU time for 
1E7 histories 
effect on  CPU 
time 
PRESTA 416.6 - 
EXACT 1279.3 207.1% 
PRESTA 





Figure 4.2 10MeV 2x2cm Monte Carlo calculated depth dose in a water/air/water/bone/water phantom with 
different boundary crossing algorithms 
 
4.4. Parallel processing 
The nature of the Monte Carlo dose calculation lends itself to the use of parallel processing as a 
method of reducing calculation time. Multiple sets of histories can be run separately as batches 
(with different random number seeds) and then combined at the end of the run. This is not a true 
parallel approach where processors communicate with each other but allows any single calculation 
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to spread over as many processors as are available (as long as each batch has 100+ histories, not 
an issue when ~106 histories are used). Batches have been run on either an Intel® Core™ i5-
2450M CPU @2.5 GHz with two cores and hyper-threading allowing 4 batches to be run 
simultaneously with only minimal reduction in the speed of each batch or on the Coventry 
University high performance computing cluster Zeus with up to 144 nodes of Intel® Xeon® E5-
4620CPU processors 8 cores per node allowing >100 batches to be run simultaneously in single 
submission depending on availability.  
 
4.5. Tuning the beam model 
The beam model was tuned in order to agree with measurements for the 10MeV beam investigated 
in Chapter 3. The primary electron source was modelled as a 1mm diameter disk of parallel 
electrons incident on the nickel window. The energy spectrum of the incident electrons was 
approximated to a Gaussian function. This creates the following four parameters that need to be 
iteratively adjusted until dose predictions agree with measurement. 
 
1. Thickness of exit window 
2. Mean energy of incident electron beam 
3. Energy spread of incident electron beam (FWHM of Gaussian) 
 
The simulations were run to a variance of better than 1% and the parameters varied in order 
to improve agreement with measurement for a 10x10cm field at 90cm SSD (see Figure 4.3 and 
Table 4.3). 
  




(a) 10MeV (b) Increase energy 
  
(c) broad spread of energies (d) monoenergetic 
  
(e) correct material 0.15mm thick (f) final model (0.11mm thick) 
 
Figure 4.3 10MeV Energy tuning using 10x10cm field depth dose curve at 90cm SSD. See Table 4.3 for 
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Table 4.3 Modelling parameters for energy tuning as displayed in Figure 4.3 
  Mean Energy 
(MeV) 
FWHM (MeV) Window Material Window 
Thickness (mm) 
(a) Initial guess 10 1.5 Aluminium 0.1 
(b) Increase energy 12 1.5 Aluminium 0.1 
(c) Increase energy spread 12 3.5 Aluminium 0.1 
(d) Decrease energy spread 12 monoenergetic Aluminium 0.1 
(e) Correct window material and 
optimised energy 
11.7 1.2 Nickel 0.15 
(f) Optimised window thickness 
and energy 
11.7 1.2 Nickel 0.11 
 
With an initial guess of 10MeV mean energy and 1.5MeV FWHM and a 0.1mm aluminium 
exit window the penetration of the calculated depth dose falls short of the measured data (see 
subfigure (a)). Increasing the mean energy to 12 MeV improves the comparison but there is an 
overestimate of dose in the first 2cm (see subfigure (b)). Increasing the spread of energies 
correspondingly broadens the depth dose (see subfigure (c)) whereas a monoenergetic beam is 
closer to measurement (see subfigure (d)). 
 The Elekta technical specification for the SL series linac exit window is 99.9% purity 
Nickel 8.9g/cm3 0.125mm thick. Using the correct specification for the exit window the energy 
was tuned to provide the beast fit to measurement. Small changes in the thickness of the window 
were then made to find the best fit to measurement (see subfigure (e) and (f)). Optimum agreement 
was found with a 0.11mm thick 8.9g/cm3 Nickel window with Gaussian distribution with 11.7MeV 
mean energy and 1.2MeV FWHM. The window thickness is 0.015mm off the manufactures 
specification which could be due to manufacturing tolerances and impurities in the physical 
window but is more likely to be compensating for small inaccuracies in the electron source model. 
 
4.6. Small fields 
In Chapter 2, an electron segment size of 2x2cm was chosen. The Monte Carlo model was 
therefore validated for a 2x2cm field. The model was used to calculate the dose distribution for a 
2x2cm field on the central axis, collimated with Jaws and MLC and this was compared to 
measurement.  As the dose profiles exhibit a high dose gradient the gamma index analysis (Low 
et al., 1998) was used to compare data. A gamma analysis criteria of 1% global dose difference 
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(relative to maximum dose) and 1mm distance to agreement were used. Good agreement was seen 
between predicted and measured dose without further modification of the beam model tuned to 
the 10x10cm data (see Figure 4.4). Gamma index was less than 1 for most points and less than 1.2 







Figure 4.4 Comparison of measured and Monte Carlo calculated dose for a 2x2cm field at 90cm SSD, (a) 
profiles at 4 depths, (b) detail of depth dose and (c) detail of profile at 3cm deep both with error bars from 
Monte Carlo variance and gamma index overlaid in green. 
 
Although not all potential segments position were validated a single offset segment was 
investigated by calculating the dose for a field offset from the central axis by 6cm and comparing 
to measurement. Similarly good agreement was seen for the offset field. 




Figure 4.5 Comparison of measured and Monte Carlo calculated dose for a 2x2cm field at 90cm SSD 3cm 
deep offset from the central axis by 6cm in the A-B direction (offset defined at 100cm SSD). Error bars 
from Monte Carlo variance and gamma index overlaid in green. 
 
4.7. SSD 
Variations in SSD will result in dosimetric effects due to changes in the volume of air between the 
linac and the patient as well the divergence of the electron beam. Air is correctly accounted for in 
the Monte Carlo model as ICRU air with a density of 1.20E-3 g/cm3. By changing the distance 
between the phase space file and the phantom surface, the SSD and the volume of air the electron 
beam passes through should change correspondingly. This was tested by recalculating the 90cm 
SSD 10MeV data with the phase space source moved to simulate 80cm SSD.  
Good agreement was seen between Monte Carlo and the measured data at 80cm SSD 
suggesting that the corresponding variation in scatter of the beam are correctly modelled (see 
Figure 4.6) 
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Additional energy modes for use with treatment planning studies have been created by modifying 
the validated 10MeV beam model. A total of three energies have been chosen from the clinical 
energies available at UHCW.  Energies between 4MeV and 15MeV are available but 4MeV is 
likely to be too low to be of use.  A 6MeV and 15MeV model have been created alongside 10MeV 
providing a range in half value depth (R50) of between 2.8 and 6.6cm. Energies have been modelled 
by shifting the mean energy of the source energy spectrum and altering the FWHM to match 
measured 10x10cm percentage depth dose at 90cm SSD with scattering foils removed collimated 
by MLC and jaws (see Figure 4.7).  
 
Figure 4.7 comparison of measured and Monte Carlo calculated dose for a 10x10cm field at 90cm SSD 
6MeV, 10MeV and 15MeV. 
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4.9. CT calibration 
In Chapter 5, dose will be calculated in geometries of unity density but for the clinical evaluation 
of Chapter 6 dose will be calculated using geometries generated from patient CT (X-ray computed 
tomography) data. When a CT scan is taken X-ray images from multiple angles are back projected 
to build a cross sectional picture of the inside of the patient in that position. Cross sections at 
multiple positions are taken to form the CT data set which can then be reconstructed into a three 
dimension image of the patient. For each voxel of the image a grey scale value equal to the 
Hounsfield unit (HU) is calculated describing the attenuation of X-rays relative to water at that 
point in the patient. For deterministic dose calculations all that is required is to convert this HU to 
the electron density of the material. For water like materials there is a linear relationship between 
electron density and HU. When bone like materials are included there is an increase in attenuation 
due to the photoelectric effect and the relationship becomes two hinged straight lines. This 
relationship can be defined by scanning materials of known electron density and building an 
electron density calibration curve. 
For the Monte Carlo dose calculation material composition as well as the physical density 
are required to determine the correct interaction cross sections. The Monte Carlo dose calculation 
therefore requires a calibration between HU unit material and density. This calibration has been 
achieved using the DOSXYZnrc CTcreate utility with a ramp function as described by (Kawrakow 
et al., 1996). The ramp function has been modified for the CT scanner used for patient scans via 
the electron density calibration phantom dataset (see Figure 4.8).  
The HU for air is by definition -1000.  However, many CT image voxels in air will have a 
HU value that is higher or lower than -1000 due to image noise and non-uniformity.  For the 
purposes of this study it is important that voxels are recognised as air and not defaulted to vacuum 
or assigned to lung material in error. To encompass all voxels with a value of -1000 ±10% the HU 
range for ICRUair was set at -1100 to -900. The density of ICRUair was set to 1.19E-3 g/cm3 at   
-1100 HU and 1.21E-3 g/cm3 at -900 HU to result in an interpolated density of 1.20E-3 g/cm3 at   
-1000 HU.  The small (less than 1%) variation in air density with HU was included as the CTcreate 
utility cannot perform the interpolation when identical HU values are used. 
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Figure 4.8 CT calibration curve for Monte Carlo dose calculations 
 
4.10. Conclusions 
This chapter has described the development of the electron Monte Carlo beam model for use in 
the studies in Chapter 5 and Chapter 6. In doing so, it has been shown that small scattering foil 
free electron segments collimated with jaws and MLC at 90cm SSD can be accurately calculated 
with Monte Carlo dose calculation. Note, however, that creating a clinical beam model would 
require additional work to validated dose calculations in inhomogeneous media and with variations 
in obliquity as well as calibration of output (IAEA, 2004, Hu et al., 2008, Smilowitz et al., 2015).







5.1.  Introduction 
Having determined that the delivery of xMLC shaped scattering foil free electron segments is 
feasible (Chapter 3), this chapter exploits the accurate dose calculation algorithm developed in 
Chapter 4 to optimise the combined electron and X-ray photon (exIMRT) spatial dose distribution.  
The chapter starts with a description of the problem formulation including the optimisation 
methods investigated. This is followed by simulation studies to investigate the interaction of 
electron segments. These studies include investigation of the most appropriate dimension and 
separation of segments to deduce the number of free variables in the optimisation problem.  This 
is followed by a comparison between both deterministic and heuristic search strategies. The overall 
optimisation approach developed in this work is then presented and its performance evaluated on 
appropriate test cases. 
In a real situation such as the optimisation of radiotherapy dose distributions, the solution 
will be only as good as the formulation of the optimisation problem. Although the development of 
the optimisation approach is presented as a linear narrative in this chapter, some iteration was 
required due to the interdependence between defining an effective objective function and 
identifying a suitable solver. 
 
5.2. Problem formulation 
To be in a position to solve the problem of optimising the exIMRT dose distribution it is necessary 
to first ensure that the problem is well defined and understood before formulating it in such a way 
as to be able to use computational techniques to solve it.  
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5.2.1. Limitations and assumptions 
As detailed in Chapter 2 current solutions to the optimisation of IMRT dose distributions can 
generally be split into two distinct methodologies, sequential optimisation and direct aperture 
optimisation (DAO). For this study beamlet based optimisation equivalent to the first stage of 
sequential optimisation is used. It is noted that the required conversion of the idealised X-ray 
intensity map resulting from the beamlet weight optimisation into a deliverable segmented field is 
not implemented. This approximation will however be considered when comparing calculated 
dose distributions with ‘segmented’ plans from commercial treatment planning systems (Chapter 
6). Such limitation does not however apply fully to the electron components. Indeed, whilst the 
overall electron segmentation has not been implemented, each 2x2cm segment, that, when 
combined together, form the overall electron component, is practically deliverable.  
Automated selection of beam angles is feasible (Chapter 2) but is not in the scope of this 
work. Similar to standard current clinical practice, beam angles have been optimised through 
trial and error guided by the experience of the investigator.  
The only constraint imposed is that the beamlet weights must be positive. The 
requirements in terms of goals are expressed within the objectives such that the cost resulting 
from an objective met would be minimum.  
 
5.2.2. Constrained minimisation problem  




 𝑠𝑢𝑏𝑗𝑒𝑐𝑡 𝑡𝑜: 𝑥 ≥ 0  
where 𝑥 is a vector of the electron segment weights and the X-ray beamlet weights that form the 
problem variables for the cost function 𝐹(𝑥).  
To complete the problem formulation a set of dose objectives need to be defined and the 
cost function must be formulated in such a way to enable the dose objectives to be met. In this 
work, consideration is given to the so called weighted sum approach using quadratic cost function 
of the form given in equation 5.2: 
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where, k =1 to K represents the set of structures defined by the user; o=1 to 𝑂𝑘 represents the 
number of objectives per structure k and 𝑑𝑘(𝑥)=Ak x is the calculated dose where Ak is the 
influence matrix for each structure and x is a vector containing the electron segment weights and 
X-ray photon beamlet weights. For each structure k, one or more objectives  𝑓𝑘,𝑜(𝑑𝑘(𝑥))
 are 
defined to contribute to the total objective function. A user input weighting, wk,o, is defined for 
each objective. The weighting is adjusted, based on clinical requirements, to tune the overall cost 
function. Such formulation is applicable to the MERT, IMRT and exIMRT problems detailed in 
the following sections.  
Although methods for solving IMRT optimisation problems are well documented (see 
Chapter 2) the addition of electrons to the IMRT plan introduces an additional level of complexity. 
The dependence of the dose distribution on the modality and energy of the beam as well as the 
intensity may lead to a non-convex problem with local minima. Different approaches to 
optimisation of the exIMRT problem have therefore been considered. 
 
5.3. Methods 
5.3.1. Radiotherapy treatment planning environment 
The CERR environment (Deasy et al., 2003) was used as a framework for this study. CERR 
(Computational Environment for Radiotherapy Research) is a software platform created by 
Washington University St-Louis for developing and sharing research in radiotherapy treatment 
planning. CERR is able to display medical images, display and manipulate calculated dose, 
calculate dose metrics and calculate X-ray dose for IMRT research.  Using a platform such as 
CERR removes the need to reproduce these tools as part of this study. CERR is written in 
MATLAB allowing efficient integration with MATLAB's optimisation toolboxes as well as 
allowing additional functionality to be added simply by creating a new function in MATLAB.  
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The photon dose component of the exIMRT beam has been calculated using the QIB pencil 
beam algorithm using the method of Ahnesjö (Ahnesjö et al., 1992). This dose calculations forms 
part of CERR and has been validated and used in a number of studies including (Sayre and Ruan, 
2013, Craft et al., 2014, Salari and Unkelbach, 2013, Rocha et al., 2012, Unkelbach et al., 2014). 
There are limitation to the accuracy of the QIB dose calculation and these are discussed in Chapter 
6. A nominal 6MV energy X-ray dose calculation has been used with 4mm square beamlets. CERR 
was run on an Intel Core i5-2450M CPU. 
 
5.3.2. Optimisation solvers 
A simple approach to optimising the dose distribution is to select segment weights to minimise the 
difference between the calculated and desired dose. This approach has been taken from the CERR 
optimisation example (Deasy, 2005) and used initially as a way to investigate the combining of 
multiple electron segments. It was later incorporated into the final two stage algorithm (see Section 
5.5.4). A description of this approach follows. 
The desired dose 𝐷𝑘
𝑎𝑖𝑚 and a weighting wk is defined for each structure. The difference 
between the desired dose and the calculated dose 𝑑𝑘,𝑛(𝑥) is determined for each voxel n of each 
structure k. The square of this value is summed over all 𝑁𝑘voxels of each structure to use as the 
objective 𝑓(𝑥) in equation 5.2. The problem becomes one of finding a solution for x to minimise 
this function:  
 








As this is a quadratic objective with linear constraints (𝑥 ≥ 0),  𝑓(𝑥) can be expressed in 
matrix notation and the problem re-written as: 
  






𝑥𝑇𝐻𝑥 + 𝑓𝑇 
(5.4) 
 𝐻 = 𝑤𝐴𝑇𝐴  
 𝑓 = −𝑤𝐷𝑎𝑖𝑚𝐴  
where 𝑥 is a vector containing the electron segment weights, 𝑤 is the weighting factor, 𝐷𝑎𝑖𝑚 is 
the desired dose and 𝐴   is the influence matrix. Such equation can be solved by quadratic 
programming using the MATLAB quadprog trust-region-reflective solver (Coleman and Li, 
2006).  
Alternative solutions to minimising the more complex weighted sum cost functions have 
been investigated as part of this study. Methods that use the gradient of the function to define the 
search direction are more efficient at finding the optimal solution than line search or trust region 
methods. As a bounded non-linear multivariable problem the natural choice from the MATLAB 
optimisation toolbox is the fmincon gradient-based optimisation with either the interior-point or 
sequential-quadratic programming (SQP) solvers. The interior point algorithm (Karmarkar, 1984) 
uses a barrier function  to define a feasible region and reaches a solution by traversing the interior 
of a this feasible region. The SQP solver expands the problem to a sequence of optimisation sub 
problems, each of which optimises a quadratic model of the objective subject to a linearisation of 
the constraints. 
A set of solvers that do not rely on the quadratic formulation of the objectives was also 
investigated. Whilst any type of objective formulation could be adopted, for the purpose of 
comparison the same quadratic cost function was used with all the solvers investigated.  
The simplex search algorithm (Nelder and Mead, 1965) implemented in the ‘fminsearch’ 
function is a direct search method that does not use numerical or analytic gradients.  
Three algorithms inspired by nature were also investigated, namely genetic algorithm, 
particle swarm optimisation (PSO) and firefly optimisation.  
Genetic algorithms are metaheuristic algorithms inspired by the process of natural 
selection. Populations of candidate solutions undergo random mutations and crossover between 
populations. During each successive generation, a proportion of the existing population is selected 
to breed a new generation.  
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PSO attempts to solve the problem by moving populations of candidate solution, dubbed 
particles, around the search space. Each particle movement is governed by its local best known 
position but also the best know position found by other particles.  
The Firefly algorithm is a modification of the PSO algorithm where the attractiveness of 
two particles is now proportional to the distance between them. Details of the metaheuristic 
algorithms investigated and the parameter used are given in Appendix A. 
 
5.3.3. Common set up for optimisation solvers 
The common algorithms parameters defined to help the comparison between algorithms were: 
normalisation of problem, starting value of x, normalisation of the cost function value, termination 
tolerance on change in function value, termination tolerance on step size and maximum number 
of iterations or maximum number of function evaluation. Given incorrect parameters the function 
might either give an inaccurate result or fail to recognise when it has converged. The problem was 
normalised by dividing the prescribed dose by the median dose of a single segment/beamlet and 
the total number of segments/beamlets. Given this normalisation an appropriate starting value for 
x is: x=1.  Using this starting value the optimisation function was evaluated and normalised to give 
a value of F(x)=10 for x=1. The termination tolerance on the change in function F(x) (TolFun) and 
the termination tolerance on step size (TolX) were set at 1.0e-08 and 1.0e-10 respectively. For 
functions that fail to converge within these criteria a maximum number of function evaluation of 
80000 was set. A value of 80000 was chosen based on the number of function evaluations the 
simplex search method required to begin to approach a minimum and terminate on TolFun. If 
solvers did not approach a minimum value in the same time as the simplex search method then it 
was decided to discount them as being too inefficient.  The actual time taken for optimisation 
depends slightly on the algorithm but 80000 iterations for this problem corresponds to 
approximately 6 hrs running time. 
 
5.3.4. Phantoms used to evaluate the approach 
Two different software phantoms with unit density were created to evaluate the principle prior to 
validating the approach using clinical case studies.  
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The first software phantom was a 20cm cube developed to evaluate the electron only 
(MERT) optimisation, (see section 5.4). It included the following target shapes: 
 A slab placed close to the depth of maximum dose at 2cm deep to evaluate the impact of 
the electron segment location and size as well as gaps between segments on field penumbra 
and flatness. 
 A stepped target to assess the capability of the algorithms to realise depth modulation for 
a simple plan geometry. Three steps were selected to correspond to the 90% dose level for 
6, 10 and 15MeV respectively. 
 A slab at depth modified to create shapes similar to those described in TR430 (IAEA, 
2004).  An asymmetric oval, a ‘C’ shape and a triangle, all approximately 7.5 by 7.5cm, 
were designed to evaluate the ability to modulate the intensity in two dimensions. 
 
The second phantom was a 20 cm diameter cylinder created to develop and test the 
combined electron and photon exIMRT method, (see section 5.5). The target and OAR geometry 
aimed to approximate to a clinical situation (see Figure 5.1). The phantom includes a concave PTV 
which follows the cylinder outline with 5mm between the PTV and the surface. The PTV wraps 
around a 2 cm diameter OAR, denoted OARhigh. Two additional OARs, denoted OARmed and 
OARlow are located at increasing depth in the patient, each separated by 2cm. The PTV and OARs 
were designed to evaluate the ability of the procedure to produce conformal treatments. A large 
volume structure, labelled ‘distal’, was realised to monitor the low dose wash away from the PTV. 
The PTV has been edited back from the surface of the phantom to leave a 5mm gap between 
the surface and the PTV. As explained in Chapter 1 both the X-ray dose distribution, and to a much 
lesser extent the electron dose distribution, exhibit a region of build-up at the surface of the patient. 
If the PTV were to extend to the surface this could cause problems. First, because it is difficult to 
achieve the required dose in the region close to the surface the optimiser might fail to converge. 
Second, in attempting to optimise the dose distribution in the region close to the surface the 
algorithm might create peaks in the X-ray dose fluence to push the dose up in this region (ICRU83, 
2010). The PTV exists to ensure dose coverage of the CTV in the presence of set up errors and 
patient movement. A high skin dose may therefore not actually be required. Peaks in the fluence 
distribution may also result in hot spots in the dose distribution when movement is taken into 
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account. One option is to simply edit the PTV away from the surface of the patient by a few mm 
(James et al., 2008) and this is the approach simulated here. 
It should be noted that editing the PTV in a clinical situation does reduce the robustness of 
the plan to set up errors and patient movement. In a clinical situation if the PTV extends close to 
or beyond the surface, but a high skin dose is undesirable, then virtual bolus can be used to provide 
a so called ‘flash margin’. The virtual bolus is added in the planning system for the process of 
optimisation but then removed for the final dose calculation. Alternatively if the CTV itself 
extends close to the surface of the patient then a layer of real bolus can be used to provide build-
up. It is possible that the higher surface dose of the exIMRT electron component could be used to 
negate the need for bolus in some situations. However comparisons of surface dose have not been 
included in this study as the accuracy of the X-ray dose calculation in the build-up region has not 
been verified and it is recognised that most dose calculation algorithms cannot accurately calculate 
dose in the build-up region (ICRU83, 2010). 
 A prescribed dose of 60 Gy and a maximum OARhigh dose of 45 Gy were chosen to mimic 
a typical PTV/OAR relationship. Specific dose objectives were defined as shown in Figure 5.1. A 
PTV target of at least 95% of the volume to 95% of the prescribed dose and less than 5% of the 
volume to 105% of the prescribed dose was used as simplistic analogy to clinical dose volume 
objectives. Clinically these target dose objectives are occasionally used exclusively (for example 
breast radiotherapy) but are typically used in combination with the ICRU83 (ICRU83, 2010) 
recommended values for reporting near-minimum, D98%, and near-maximum, D2%, or similar. For 
example dose objectives of 98% of the volume to >90% dose and <2% of the volume to >107% 
dose as well as 95% volume to >95% dose and <5% volume to >105%.  Although it is convenient 
to use a single minimum and maximum dose constraint in order to develop the technique, it should 
be noted that as a result there may me small areas of the target with clinically unacceptable dose 
coverage or small unacceptable hot spots. Clinically approved dose objectives, in use at UHCW, 
have been used for the treatment plan comparisons of Chapter 6. 





>95% volume to 57Gy 
50% volume to 60Gy 




as low as possible 
 
Figure 5.1 Cylindrical software phantom to test exIMRT optimisation 
 
5.4. MERT 
5.4.1. MERT Introduction 
Although optimisation of photon IMRT is well established the optimisation of electron beams is 
not and the optimisation of the combined exIMRT dose distribution even less so. This section will 
address optimisation of the electron (MERT) dose component and examine what is achievable 
using the xMLC collimated scattering foil free electron segments before moving onto exIMRT in 
the next section.  
 
5.4.2. Electron matrix resolution 
This study adopts the 2x2cm electron segment size that was chosen based on measurement in 
Chapter 2 and calculated using Monte Carlo in Chapter 3.  Ideally, the location of each 2x2 cm 
field on the position matrix would not be constrained such that the spacing and overlap of segments 
formed part of the optimisation. However, this is computationally difficult and it would be much 
simpler to have the segments arranged on a predefined position matrix. For this study a fixed 
position matrix has been used but the resolution of this matrix has been considered. With a regular 
2cm square matrix each segment is abutting to the next. Increasing the matrix resolution would 
allow more control over the overlap of segments and the gaps between segments to create a 
‘feathering’ effect.  This is analogous to Gaussian edge feathering for abutting open electron fields 
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of dissimilar energy which has been shown to improve uniformity of dose in the PTV by up to 
33% (Eley et al., 2011). Increasing the matrix resolution would however have the negative effect 
of increasing the number of variables and therefore computation time. For each energy, a 10x10cm 
field with 2cm spacing would consist of 25 electron segments but reducing the spacing to 0.5cm 
would increase the number of electron segments to 400. 
Determining the optimum resolution of this position matrix is perhaps not trivial. For X-
ray photon IMRT it is assumed that the dose contribution outside the edge of the beamlet is small 
and beamlets are arranged abutting each other on a regular matrix. However, for electron segments 
the geometric field size is not maintained and the dose contribution from beyond the shadow of 
the jaw opening is just as important as that inside.  This is demonstrated with two 10MeV 2x2cm 
segments in Figure 5.2. Two segments side by side create a single larger Gaussian dose distribution 
with a match plane that happens to fall at the 85% isodose at 2cm deep (see sub-figure (a)). In fact 
in this situation a more uniform distribution could be obtained with a 1cm or even 2cm gap 
between segments (see sub-figures (b) and (c)). An alternative could be to separate the segments 
and attempt to match each segment according to the fifty percent isodose (see sub-figure (d)).  
However, this does not appear to hold any intrinsic advantage. 
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Figure 5.2 Matching of two 90cm SSD 10MeV 2cm segments at 2cm deep a) no gap, b) 1cm gap, c) 2cm 
gap and d) matched to 50% isodose (gap size defined at isocentre). 
 
There are advantages to reducing the size of the position matrix to allow a finer resolution.  
A smaller position matrix would allow for more precise positioning of the effective field edges. In 
the example of two 10MeV 2x2cm fields there is a difference in the 50% widths between having 
no gap between segments and a 2cm gap between segments of 14 mm (see Figure 5.3). This could 
lead to an error of up to ±7mm if the PTV edge lies between these two points. With a 1 cm 
resolution a 1cm gap is possible which would reduce the potential error to ±3.5mm in this case at 
this particular depth.  
This demonstration with just two electron segments suggests that there are potential 
advantages to increasing the resolution of the 2x2cm electron segment position matrix by reducing 
the spacing of segments. Intensity and energy modulation of the electron field will therefore be 
tested with 0.5mm and 1cm spacing alongside 2cm spacing to allow greater control over gaps and 
positioning of the field edge. 
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Figure 5.3 Matching of two 90cm SSD 10MeV 2cm beamlets at 2cm deep. Field edge position with gap 
(gap size defined at isocentre). 
 
5.4.3. Electron intensity modulation 
Intensity modulation of the electron field will be achieved through optimisation of the electron 
segment weights. One of the greatest challenges of combining multiple electron fields is to do so 
without creating hot and cold spots. This section will start by attempting to create a uniform field 
through modulation. 
The achievable uniformity of a 10x10cm 10MeV field was determined by optimising dose 
to a slab placed close to the depth of maximum dose at 2cm deep.  The profiles for the composite 
optimised fields have been evaluated for flatness, defined as the ratio of the maximum and 
minimum dose in the central 8cm of the 10cm wide field (IEC, 1989). Maximum and minimum 
dose have been used rather than reference to the central axis as this may not be relevant for the 
modulated field. 
By modulating the weights of a 5x5 matrix of 2x2cm segments for 10MeV at 2 cm deep a 
uniform field in the high dose region can be achieved (see Figure 5.4 and Table 5.1). Within the 
central 8cm of the field, the flatness of the optimised profile is similar to a clinical electron field 
delivered with a 10x10cm applicator at the surface. Compared to the non-optimised field (all 
weights =1) the flatness is improved from a value of 1.46 to 1.11. As expected there is an increase 
in dose outside the field edge with penumbra width increasing by 1.7cm. 
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Due to the dependence of lateral scatter on energy there is a reduced penumbra width at 
15MeV and an increase at 6MeV when compared to 10MeV. However, the achievable flatness 
within the 8 cm area is similar for all energies (1.09, 1.11 and 1.11 for 6MeV, 10MeV and 15MeV 
respectively).  
There is an improvement in both flatness and penumbra width moving from 90cm SSD to 
80cm SSD demonstrating that minimising SSD where possible is advantageous.  
Using an increased resolution position matrix creates only a small improvement in field 




Figure 5.4 Intensity modulation to create a flat dose distribution. Calculated profile for a 5x5 matrix of 2cm 
electron segments optimised for uniformity at 2cm depth 90cm SSD 10MeV electron beam compared to 
measured 10MeV 10x10 field collimated with jaws and MLC and a measured clinical 10MeV field 
collimated with a 10x10cm applicator at the water surface also at 2cm deep 
 
The profile for individual segments as well as the combined dose profile is given in Figure 
5.5 for 6, 10 and 15MeV. Examining the optimised segments weights for 10MeV reveals that at 
some points the optimiser will choose to leave a gap between segments. This can be seen in 
subfigure (b) where only three out of the 5 segments across the midline contribute to the composite 
dose. As penumbra width will depend on energy so will the matching of segments. In subfigure 
(a) the central segment weight is reduced for 6 MeV compared to 10 MeV and in subfigure (c) 
there is a small contribution from all 5 segments for 15 MeV. 
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Table 5.1 Calculated field penumbra width and flatness for a modulated and un-modulated electron beam 
at 2cm deep (2cm segment spacing unless stated) 




10x10 Applicator 10MeV 95 1.18 1.08 
10x10 MLC  90 3.38 1.55 
Composite 2x2cm (all weights=1)  90 3.30 1.46 
Composite 2x2cm Optimised  90 2.83 1.11 
Composite 2x2cm Optimised – 1cm spacing  90 2.79 1.09 
Composite 2x2cm Optimised – 0.5cm spacing  90 2.79 1.08 
Composite 2x2cm Optimised   80 2.48 1.06 
Composite 2x2cm Optimised  6MeV 90 3.47 1.09 
Composite 2x2cm Optimised 15MeV 90 2.26 1.11 
 
 
Figure 5.5 The effect of energy on the segment weighting required to produce a flat field. Composite 
profiles and the constituent segments for a) 6MeV, b) 10MeV, and c) 15MeV at 90cm SSD 1.5cm, 2cm 
and 3.0cm deep respectively. The optimisation leads to segment 2 and 4 having zero weighting for 6MeV 
and 10MeV. Composite profile is for a 2d matrix so also includes a contribution from segments not in this 
plane.  
 
Intensity modulation to conform dose in two dimensions was tested by optimising dose to 
the structures defined in section 5.3.4.  10MeV electron segments were optimised to conform dose 
to the three distinct shapes, namely the asymmetric oval, the ‘C’ shape and the triangle. Conformity 
of the dose distributions is limited by the penumbra width of the electron segments but target 
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coverage to 95% of the volume with the 95% isodose was achievable with some shaping of the 
surrounding isodose distributions with the highest dose limited to 110% (see Figure 5.6). 
 
   
 a) asymmetric oval 
 
b) C shape 
 
c) triangle  
 
Figure 5.6 Intensity modulation of segments to conform dose to 2D shapes as seen from the beams eye 
view. 90cm SSD 10MeV 2cm deep. 
 
5.4.4. Electron energy modulation 
The use of multiple energies is potentially advantageous as this will allow true depth modulation. 
However combining multiple energies is problematic due to the matching of dissimilar penumbra 
widths (see Chapter 2).  
 Some improvement to dose distributions with multiple energies can be made with the use 
of gaps as described in 5.4.2 and by weighting of energies relative to each other. In Figure 5.7 it 
is shown how by abutting a 6 MeV field to a 15 MeV field increases the maximum dose to 140% 
of the 15 MeV only value due to the overlap of the larger penumbra width. Removing one 6 MeV 
segment to create a 2cm gap reduces the maximum dose back to 100% but reduces dose on the 6 
MeV side of the distribution. The situation can be improved by manually increasing the weight of 
the remaining 6 MeV segment by a factor of 1.08 to improve the uniformity of dose distribution 
whilst limiting the maximum dose to 110%.  
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a) 3 15MeV + 2 6MeV 
140% max dose 
b) 3 15MeV + 1 gap +1 6MeV 
100% max dose 
c) 3 15MeV + 1 gap +1 6MeV 
increased 6MeV weight  
110% max dose 
Figure 5.7 Isodose lines for abutting segments of dissimilar energy without optimisation. Without a gap, 
with a 2cm gap and with a 2cm gap and manual increase of the 6MeV segment weight. 
 
There are two options, defined in this work as ‘range selection’ and ‘free optimisation’ to 
automatically optimise the electron energy. Range selection determines the energy at each position 
based on the depth of the target and the electron energy range. Free optimisation enables the 
optimiser to choose the energy based on the cost function to be minimised. 
To test the electron energy optimisation methods, segments were optimised to conform 
dose to a stepped PTV while minimising dose to a similarly stepped OAR.  For range selection the 
energy at each step was limited to the energy corresponding to 90% dose at the PTV depth (where 
the step depths are set such that this is the case for three energies used). For free optimisation 6, 
10 and 15MeV segments were allowed at all positions and no preference was built into the 
optimisation. The results for both range selection and free optimisation are shown in Figure 5.8 
and Table 5.2.  
The resulting electron weights are shown as a relative intensity map in Figure 5.9. As 
expected the optimum solution for both range selection and free optimisation contains gaps 
between the segments. In particular the column of 6 MeV segments abutting to 10 MeV segments 
has zero weight with both methods. Free optimisation produces a much more uniform dose 
distribution within the PTV. This is achieved partly by mixing of enegies (energy modulation) and 
partly by choosing 15 MeV over 10 MeV in much of central part of the PTV.  This does have the 
negative effect of increasing OAR dose for free optimisation compared to range selection. In a 
clinical situation the improved target dose uniformity would be adventageouse as long as the 
clinical OAR dose objectives were met. Free optimisation will therefore be used for the exIMRT 
study. 
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As in 5.5.3 there is little or no improvement in either uniformity or  OAR dose by increasing 
the resolution of the position matrix. Compared to a 2cm spacing, with a 0.5mm spacing maximum 
dose is reduced from 111.7 to 110.2 % of the mean dose and minimum dose is increased from 
72.0% to 72.6% of the mean dose. This suggests that the benfits of increased resolution for 
segmented electron fields is small compared to the application of feathering to the edge of open 
electron fields.  Increased resolution therefore unnecessarily increases calculation time for the 
optimisation procedure so will not be used for the exIMRT study. 
 
 
Figure 5.8 Dose distribution for a stepped PTV used to demonstrate energy modulation of the MERT beam. 
Energy fixed at 6, 10 then 15 MeV across the PTV (range selection) or left to the optimiser to choose 
between the three energies (free optimisation). 
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Figure 5.9 Fluence maps for a stepped PTV used to demonstrate energy modulation of the MERT beam. 
Energy fixed at 6, 10 then 15 MeV across the PTV (range selection) or left to the optimiser to choose 
between the three energies (free optimisation). 
 
Table 5.2  Dose data for a stepped PTV used to demonstrate energy modulation of the MERT beam. 5x7 
matrices of 2cm square segments with 0.5, 1cm or 2cm segment spacing. Dose normalised to mean dose to 
PTV. 





PTV mean (%) max (%) Dmin (%) max (%) mean (%) 
range selection 2 35 100.0 121.2 59.0 53.2 19.2 
free optimisation 2 105 100.0 111.7 72.0 66.6 33.6 
free optimisation 1 105 100.0 110.5 72.6 66.5 33.9 
free optimisation 0.5 105 100.0 110.2 72.8 66.5 33.9 
 
5.5. exIMRT 
5.5.1. exIMRT Introduction 
Having investigated the optimisation of the MERT field, this section is concerned with 
incorporating this work into the optimisation of the combined electron and photon dose 
distribution. The approach used in this study is intended to test the hypothesis that MERT can be 
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improved by combining it with photon IMRT to produce exIMRT. That is that the photon IMRT 
component is used to ‘fill in the gaps’ in the desired dose distribution not covered by the electron 
dose distribution. This is illustrated in Figure 5.10 where the IMRT X-ray beam has been used to 
sharpen the penumbra of the electron field producing a combined dose distribution that is similar 
to a 6MV X-ray only field at 1.5cm deep but with a reduced dose to the central axis at 10 cm depth. 
 
 
Figure 5.10 Illustrative dose distributions calculated with XiO treatment planning system pencil beam 
model for overlaid 6MV X-rays and 15MeV electrons. 6MV X-ray beam intensity modulated to offset the 
wide penumbra of the electron beam and produce a uniform dose distribution at 1.5cm deep. At 10cm 
combined electron and X-ray dose has dropped to less than 5% on the central axis but the X-ray only dose 
is 68%. 
 
To this end a two stage optimisation process has been developed. In the first stage the 
electron dose distribution is optimised and the photon dose distribution used to fill in the gaps. 
Some overlap of the exit dose from the photon beams with the electron beams is inevitable so the 
electron dose is reduced by a user input weighting and a 2nd stage used where the electron and 
photon weights are optimised as one. The development of this two stage approach is described in 
the following sections. 
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5.5.2. Treatment plan set up for the cylindrical phantom 
An X-ray IMRT only treatment plan was set up with 5 fields equally spaced starting from gantry 
zero.  The isocentre was placed in the centre of the PTV and X-ray beamlets calculated with 4mm 
width to an 8mm margin around the PTV. This resulted in a total of 388 beamlets each weighted 
independently to produce an optimisation problem with 388 variables.  
A separate exIMRT plan was created with an anterior MERT field added to the IMRT plan 
with overlapping 6, 10 and 15 MeV segments. The isocentre was moved to the centre of the 
phantom to provide some reduction in SSD for the electron beam. As there is a significant dose 
contribution from the anterior electron component it is possible to use more oblique photon fields 
to avoid OAR with the exIMRT plan. Hence, for the exIMRT plan, gantry angles were altered 
from the equispaced 5 field arrangement to oblique fields (62, 104, 256 and 298 degrees) retaining 
the anterior (0 degree) X-ray beam coincident with the electron beam. For each electron energy a 
7x5 matrix of electron segments was used (chosen to cover the PTV).  There is a slight reduction 
in X-ray beamlets due to the change in beams eye view compared to the IMRT problem giving a 
total of 507 variables for the exIMRT problem. 
 
5.5.3. Optimisation solvers 
For this study to be successful the exIMRT inverse planning process should be sufficiently 
efficient to allow the creation and modification of treatment plans in real time. The optimisation 
algorithm should therefore take minutes/hours rather than days. However, it is also important that 
the best possible, and ideally the globally optimal, exIMRT solution be found. If the algorithm 
becomes trapped in a local minimum then the solution might give a false representation of the 
benefits of exIMRT as compared to IMRT. 
 For simplicity the selection of an optimisation solver was first evaluated using an X-ray 
only IMRT problem and a simple cost function using minimum and maximum dose objectives, 
(equation 5.5).  
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𝑚𝑖𝑛 − 𝑑𝑘,𝑛(𝑥)) 
(5.5) 
 
where 𝑑𝑘,𝑛(𝑥) is the calculated dose determined for each of the n to 𝑁𝑘 voxels contained by each 
structure k, C(y) =1 for y>0 and C(y) = 0 for y ≤0 and suitable values of maximum, 𝐷𝑘
𝑚𝑎𝑥, and 
minimum, 𝐷𝑘
𝑚𝑖𝑛, objective values based on the dose objectives were used. Using this optimisation 
function different optimisation solvers were tested against each other for accuracy and efficiency. 
First, the MATLAB fminsearch solver was used as a baseline for comparison with other methods 
before investigating the solvers described in 5.3.2. 
Results of optimisations with each of these solvers are presented in Figure 5.11.  As might 
be expected fminsearch iterates towards a solution but does so over the maximum set of function 
counts. The most efficient fmincon option for the IMRT problem was the interior-point algorithm 
with the ‘l-bfgs’ (limited memory Broyden–Fletcher–Goldfarb–Shanno) large scale quasi-Newton 
Hessian approximation. This produced an acceptable (within dose objectives) solution in less than 
8000 iterations. A factor of 10 improvement over the fminsearch simplex search method. The 
performance of the SQP algorithm was disappointing. Some commercial treatment planning 
systems use solvers based on the SQP method (Chapter 2) but the MATLAB implementation of 
the algorithm was not suitable for this problem. 
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Figure 5.11 Plot of cost function value F(x) against function counts for an IMRT problem with the 
MATLAB fminsearch simplex search and fmincon interior-point and SQP algorithms  
 
For the exIMRT problem the dependence of the dose distribution on the modality and 
energy of the beam as well as the intensity may lead to a non-convex problem with local minima. 
There may then be advantages to using a heuristic or metaheuristic algorithm designed to find an 
approximate global solution avoiding getting stuck in local minima.  
Before application of the metaheuristic algorithms to the IMRT problem they were first 
tuned and tested with known optimisation problems. First the optimisation algorithms were used 
to calculate effective gains for a proportional–integral–derivative (PID) controller. Application to 
such a simple systems serves as a proof of concept exercise and provides an opportunity to 
effectively program and structure the algorithm for later use.  The algorithms were then applied to 
three mathematical functions that exhibit multiple local optima, the Griewank function, the Ackley 
function and the Rosenbrock function. These are well known structure optimisation function 
problems taken from published comparisons of optimisation methods (Karaboga and Basturk, 
2007).  The Griewank and the Ackely functions create a series of spaced out local optima that 
some optimisation programs could become trapped inside. For the Ackely function each local 
optima has a steeper gradient than the global optima such that an algorithm that uses the gradient 
to calculate its variables will become trapped in a local optima. The Rosenbrock function is 
perhaps most similar to the IMRT problem with a global minimum inside a long, narrow, parabolic 
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spaced flat valley. All three functions have a global minimum of zero. The ability of each 
metaheuristic algorithm to approach a solution of zero provides an effective benchmark for the 
algorithms to assess their performance. Each of the algorithms was tuned until the best results with 
each of the test functions was achieved. A description of these tests in presented in Appendix A 
and a summary of the results is presented in Table 5.3. 
 
Table 5.3 Results of errors for three optimisation algorithms and three test functions with 30 variables 
Function GA PSO Firefly 
Griewank function 1.23 1.11 E-02 2.87E-09  
Ackley function 1.09 1.49 E-06 3.01 E-12 
Rosenbrock function 166.28 402.54 2.20 E-01 
 
For all three test functions the GA iterates to an approximate solution but does not begin 
to approach the global minimum. The GA solution is significantly higher than the PSO and the 
Firefly algorithm solutions for both the Griewank and Ackley functions.  For the Rosenbrock 
function the GA algorithm gives an improved result compared to PSO, however neither algorithms 
are approaching the global minimum of zero. The Firefly modification to the PSO algorithm gives 
improved results for all three test functions and a lower value than the GA for the Rosenbrock 
function. This suggest that modifying the attractiveness of particles according to the distance 
between them allows the Firefly algorithm to search multiple local minimum and better find a 
global solution than either the fixed attractiveness of the PSO algorithm or the  unguided mutation 
of the GA. 
The tuned metaheuristic algorithms were then applied to the five-field X-ray only IMRT 
problem. As with the test functions, the best performing metaheuristic algorithms tested was the 
Firefly algorithm, (see Figure 5.12).  The metaheuristic algorithms require an increased number of 
function evaluations compared to gradient based optimisation due to the random element of their 
search. However the Firefly algorithm drops to 0.3 after just 40000 function evaluations whereas 
the GA and PSO algorithms remain a factor of 10 higher after 80000 function evaluations. These 
results were used to justify the adoption of the Firefly algorithm for the exIMRT optimisation 
problem. 
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Figure 5.12 Plot of cost function value F(x) against function counts for an IMRT problem with genetic 
algorithm, particle swarm optimisation (PSO), Firefly and MATLAB fmincon interior-point algorithms. 
 
5.5.4. exIMRT optimisation 
The two best performing algorithms tested on the IMRT problem, namely Firefly and fmincon 
interior point algorithm were subsequently selected for the exIMRT problem.  The original cost 
function described in equation 5.5 was modified to include dose objectives in terms of PTV 
coverage and dose homogeneity as well as OAR specific dose limits. To force the algorithm to 
conform the target dose to the PTV an artificial OAR, referred to as a ‘Helper’ structure, was 
wrapped around the PTV. The objectives definitions together with the importance factors allocated 
to each objective are given in Table 5.4.  Note that the sum of the square of dose differences has 
been divided by the total number of voxels in that structure and by the square of the aim value. 
Normalising in this way removes any dependence of the objective function on either the size of 
the structure or the magnitude of the aim value. 
To provide a comparison with the exIMRT problem the X-ray IMRT optimisation problem 
was re-optimised using the objectives described in Table 5.4. These objectives include a target for 
𝐷𝑂𝐴𝑅𝑚𝑒𝑑
𝑚𝑎𝑥  that was set at a relatively low value based on preliminary work with exIMRT. For the 
IMRT problem a value of F(x)= 1.54E-4 was achieved, 65% of which was from the 𝐷𝑂𝐴𝑅𝑚𝑒𝑑
𝑚𝑎𝑥  
component. 
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With the exIMRT problem the fmincon interior-point algorithm iterates to a solution in a 
similar number of function evaluation to the IMRT problem (see Figure 5.13). The Firefly 
algorithm reduces the optimisation function with each step but does not reach a solution close to 
the fmincon interior-point algorithm after 80000 iterations. 
Although reduced from 10 to 7.09E-03, the final solution of the fmincon optimisation is 
higher than the IMRT solution and dose objectives are not met.  
One option to attempt to improve the solution is to perform a ‘warm start’ by seeding the 
optimisation algorithm with known good solutions. Attempting multiple warm starts from the last 
position with the fmincon interior-point algorithm did not yield any significant improvement. If 
we hypothesise that the Firefly algorithm is tending towards a global solution then perhaps it is 
this solution that should be used for the warm start. Using the Firefly final position as a warm start 
for the fmincon interior point algorithm provides a large improvement over the Firefly algorithm 
alone and a slightly improved result over fmincon interior point algorithm alone. However it is 
still not an acceptable solution. 
 
Table 5.4 Objectives contributing to the cost function. Where C(y) =1 for y>0 and C(y) = 0 for y ≤0, 𝑵<𝐃𝑷𝑻𝑽
𝒎𝒊𝒏  
is the number of voxels with value less than 𝑫𝑷𝑻𝑽
𝒎𝒊𝒏 , 𝑵>𝐃𝑷𝑻𝑽
𝒎𝒂𝒙 is the number of voxels with value greater than 
𝑫𝑷𝑻𝑽
𝒎𝒂𝒙 and all other variables are defined in the text or assigned a target value in the table. 
Structure dose 
objective 
objective function objective value wk 
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Figure 5.13 Plot of cost function value F(x) against function counts for an exIMRT problem with Firefly 
and MATLAB fmincon interior-point algorithms. 
 
Results of the fmincon and Firefly+fmincon optimisations are presented in Table 5.5. Note 
that the two methods give similar values for the optimisation function but very different solutions. 
The difference in the solutions is illustrated by the mean dose to the PTV from the electron 
contribution as a ratio of the mean dose to PTV from the combined electron and X-ray photon 
dose. The Firefly+fmincon method produce a solution with 31% electron dose whereas the 
electron contribution is just 14% with fmincon alone.  
Given enough time for the Firefly optimisation to converge, it is possible that a two stage 
‘metaheuristic+gradient’ method would iterate towards the global solution with an optimal 
combination of photon and electron dose. This is a possible area for future research, however for 
this study an alternative approach was developed. The approach developed in this work was to 
allow the user to control the fraction of dose from the electron component in the first stage. As 
with the metaheuristic+gradient method, the solution from the first stage is then used to warm start 
the fmincon interior-point algorithm minimisation of the cost function. This method is described 
as follows and summarised as a flow chart in Figure 5.15.   
First the electron dose distribution is optimised according to equation 5.3. Only the electron 
component of the weight vector, xe, is optimised and no dose is recognised from the X-ray photon 
component. The photon IMRT component is then optimised to fill in the gaps in the desired dose 
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distribution not covered by the electron dose. The total desired dose 𝐷𝑘
𝑎𝑖𝑚 is defined for each 
structure such that the desired photon dose at each voxel becomes.                    
𝐷𝑝,𝑘
𝑎𝑖𝑚   = (𝐷𝑘
𝑎𝑖𝑚 – 𝑚𝑑𝑘(𝑥𝑒))                                       (5.6) 
where 𝑑𝑘(𝑥𝑒) is the calculated dose from the electron component and m is the user input electron 
weighting. This weighting is required to allow the electron component to be reduced to allow for 
exit dose from the photon component. The photon beam weight vector xp is then found to minimise 
the cost function given the objective 𝑓𝑝,𝑘(𝑑). 
 







As with the electron component, minimisation is achieved with quadratic programming 
using the MATLAB quadprog trust-region-reflective solver. 
By default the desired electron dose and photon dose are the same but they do not have to 
be. The electron dose can be set to a different value in order to use the electron component as an 
additional boost dose (see Chapter 6 for example of integrated breast boost). 
This first stage very quickly produces an approximate solution to the problem. A second 
stage then uses the standard IMRT optimisation approach using fmincon and the cost function 
defined in Table 5.4 to further refine the combined electron and photon dose distribution.  
The second stage refinement follows a first stage that is biased towards a solution that 
includes electron dose. If the global solution to the problem does not include electron beams then 
such a solution may not be found. This is not necessarily problematic for this study as it is the 
relative benefits of the combined electron and photon dose that is investigated. However, the 
amount of electron bias used is critical. To investigate the importance of the weighting factor 
associated with the electron component, the exIMRT problem was run with values of m between 
0 (no electrons) and 1 (electrons only).  The results of this investigation are shown in Figure 5.14.   
For this particular exIMRT problem F(x) is reduced as m is increased up to a value of 0.85.  
There is a small increase of F(x) from m=0.85 to m=0.95 before a sharp increase at m=1. This 
suggests that the inclusion of the electron dose is beneficial but that some X-ray photon dose is 
required, with the optimum value being 85% electron dose. This is not unexpected as the problem 
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has been set as an exIMRT treatment plan. X-ray beam Gantry angles were set to maximise the 
benefit of the exIMRT plan (0, 62, 104, 256 and 298 degrees). These oblique beams do not pass 
through the posterior section of the phantom (minimising dose in this region) and are only effective 
due to the shape of the electron depth dose curve. Hence it is expected that the optimal plan 
includes a large electron dose contribution and this does not necessarily imply that the exIMRT 
plan is superior to an X-ray only IMRT plan (m=0) with an alternative gantry arrangement. 
 
 
Figure 5.14 Plot of cost function value F(x) against the electron weighting factor m.  X-ray beam Gantry 
angles have been set to maximise the benefit of the exIMRT plan (0, 62, 104, 256 and 298 degrees).  
 
For all values of m the relative contribution of the electron dose is approximately 
maintained following the 2nd stage optimisation. The difference between m and the ratio of the 
electron contribution to the mean PTV dose and the total mean PTV dose is less than 5%. This 
suggests that only a slight modification of the electron contribution from the solution at the 1st 
stage is made by the 2nd stage. 
For a value of m= 0.85, F(x) is reduced from 1.30E-05 to 5.55E-06 with the 2nd stage 
optimisation. Although this is a relatively small reduction it is sufficient to refine the dose 
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Table 5.5 Solutions to the IMRT and exIMRT problem. The final value of the cost function for objectives 
detailed in Table 5.4 is given along with the fraction of the PTV dose from the electron component. 
Method 𝐹(𝑥) 𝑃𝑇𝑉𝑚𝑒𝑎𝑛
𝑒 𝑃𝑇𝑉𝑚𝑒𝑎𝑛
𝑡𝑜𝑡𝑎𝑙⁄  Dose objectives 
met 
5fld X-ray IMRT gradient (fmincon) 1.54E-04 - Y 
exIMRT gradient (fmincon) 7.09E-03 0.14 N 
 metaheuristic (Firefly) 7.78E-01 0.30 N 
 metaheuristic+gradient 
(Firefly+fmincon) 5.38E-03 0.31 
N 
 After 1st stage 1 (m=0.85) 1.30E-05 0.84 N 
 After 2nd stage (m=0.85) 5.55E-06 0.84 Y 
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Figure 5.15 Flow chart depicting two stage exIMRT optimisation processes 
X-ray Optimisation 
Set the importance weighting and desired 
dose for each structure (potentially 
different to that for electrons). Optimise 
the photon beamlet weight vector to 
minimise the weighted square of the dose 
difference with trust region reflective 
solver accounting for existing electron 
dose weighted by m set by user. 
Electron Calculation 
6, 10, 15, 18MeV 
2x2cm BEAMnrc calculated 
segments, isocentric, 
collimated with Jaws & MLC 
Stage 2 Output 
  




0.4x0.4cm QIB calculated 
Beamlets from CERR 
Electron +X-ray Optimisation 
Set dose-volume based objectives and 
further optimise combined electron and 
X-ray beamlet weight vector to minimise 




Set importance weighting and desired 
dose for each structure.  Optimise the 
electron beamlet weight vector to 
minimise the weighted square of the 
dose difference with trust region 
reflective solver. 
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5.6. Results of exIMRT comparison with IMRT 
The optimal exIMRT plan created with the above two stage method has been compared to the 
optimal five field X-ray only IMRT plan. Dose-volume data are given in Table 5.6. Figure 5.16 
shows the dose distribution for the IMRT plan and the exIMRT mixed modality plan (c) along 
with its electron (a) and 6 MV photon (b) components.   
 
Figure 5.16 Dose distribution on the central slice for the phantom study for the 6MV X-ray photon IMRT 
plan and a) the MERT component, b) the 6MV X-ray photon IMRT component and c)  the total dose for 
exIMRT (a+b=c). 
 
The final exIMRT plan is able to meet all dose objectives with a reduced OAR dose 
compared to the IMRT plan. Doses to all OARs are reduced with the relative reduction increasing 
with distance from the PTV and largest improvement in the low dose demonstrated by a 79.0% 




Chapter 5 Optimisation 
102 
Table 5.6 Dose-volume data for phantom study showing the benefits of using exIMRT 
  achieved 
 target IMRT exIMRT 
Dose to PTV (Gy)  Volume (%) 
57Gy >95% 95.4 95.0 
60Gy 50% 50 50 
63Gy <5% 4.7 2.7 
Structure  Max Dose (Gy) 
OARhigh <45Gy 44.2 38.9 
OARmed - 5.2 3.3 
OARlow - 1.7 0.5 
  Mean Dose (Gy) 
distal - 6.2 1.3 
 
5.7. Discussion and conclusions 
A two stage iterative optimisation procedure has been developed in this Chapter to optimise dose 
for combined photon and electron IMRT with fields of different modality and energy overlapping 
to produce depth modulation (exIMRT). The two stage iterative optimisation allows the user 
control over the electron contribution through a modifying factor and separate dose constraints at 
the first stage. The electron component is optimised for energy as well as intensity by allowing 
overlapping beamlets of three energies. It has been shown for a simple example that the optimal 
proportion of electron dose is 85% of the total dose, or m=0.85. Compared to a 6MV X-ray IMRT 
plan, the exIMRT technique has the potential to reduce the dose in the low dose wash whilst 
retaining target coverage.  
Having demonstrated the benefits of the proposed optimisation scheme, this chapter 
provides the required evidence to extend the study from a phantom with artificially generated plans 
to clinical situations. The application of the proposed mix-beam mix-modality optimisation to re-
plan previously delivered IMRT treatment plans is presented in the following chapter.





Clinical treatment plan comparison 
6.1. Introduction 
This chapter presents four clinical cases to demonstrate the proposed technique and evaluate its 
potential. Treatment sites have been chosen that are appropriate to the physical properties of the 
electron beams as described in previous chapters.  Specifically each plan includes a CTV that 
extends to within 5 to 10 mm of the skin surface and a PTV that is less than 7cm deep and less 
than 18cm in diameter.  
Existing historical clinical treatment plans have been re-planned using the exIMRT method 
to a prescribed dose and dose objectives defined by clinical protocols for the given treatment site. 
Each exIMRT plan has been compared to the original clinical 6MV VMAT or ssIMRT plan 
created using the Elekta Monaco® treatment planning system at UHCW. Plans have been 
compared in terms of dose-volume data and the reduction in mean dose to organs at risk (OAR). 
The radiobiological impact of exIMRT has been considered by comparing equivalent uniform dose 
(EUD) for the PTV and normal tissue complication probability (NTCP) for selected OAR in each 
case. Secondary cancer induction has been considered by comparing the dose conformity and by 
calculating relative malignant induction probability (relMIP).  
 In reviewing the treatment plan comparisons there are a number of assumptions and 
approximations inherent to the exIMRT plan that we need to be aware of. These assumptions and 
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6.2. Assumptions and approximations 
6.2.1. RBE 
The first assumption made is that the radiobiological effectiveness (RBE) of the X-ray photon and 
electron components are equivalent. RBE is related to the linear energy transfer (LET) of the 
ionising radiation so there may be small differences for MeV electrons and MV X-rays. RBE may 
also vary with electron energy or even as a function of depth due to an increase in LET (Schwarz 
et al., 1966). However, the assumption that RBE for MeV electrons and MV X-rays is equivalent 
is supported by in-vitro studies (Zackrisson et al., 1991). There is also a long history in the effective 
use of electrons without RBE correction (Hogstrom and Almond, 2006). RBE variation is an issue 
that also affects proton therapy but in that field a generic RBE of 1.1 tends to be used (Giovannini 
et al., 2016).  It is suggested that using a generic RBE of 1.0 for electrons in this study is not 
unreasonable.  
 
6.2.2. X-ray photon dose calculation and segmentation 
Some care has been taken to ensure that the dose calculation for the electron component of the 
exIMRT plans are representative of deliverable electron doses (Chapter 3 and 4). For the photon 
component the 6MV QIB Pencil beam algorithm as implemented in CERR has been used without 
modification (Deasy et al., 2003). The Monaco treatment planning system uses a clinically 
validated Monte Carlo dose calculation. In certain situation, these two algorithms will give 
different results. In particular the QIB pencil beam algorithm does not correctly predict the effects 
of lateral scatter (Knöös et al., 2006). The Monte Carlo dose calculation will therefore be more 
accurate in high or low density tissue and at the junction between dissimilar materials.  Pencil 
beam dose calculations are particularly inaccurate in lung tissue which can lead to errors for a 
beam passing through the lung of up to 6% (Morgan et al., 2008).  
As well as dose calculation, differences due to segmentation should be considered. The 
exIMRT treatment plans are constructed from idealised X-ray intensity maps whereas the Monaco 
plans represented deliverable plans with intensity maps segmented into MLC shapes or VMAT 
control points. Segmentation of the plan according to the physical constraints will limit the 
complexity of the final X-ray photon intensity maps. In addition, the accurate modelling of the 
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MLC and Jaws may result in increased penumbra widths, leakage etc. that further reduces plan 
quality. 
The effect of X-ray dose calculation and segmentation errors should be reduced with the 
exIMRT calculation as the contribution of the photon component is relatively low. Of the four 
cases considered the biggest differences could be expected in the breast plan case where the photon 
dose contribution is largest and the incorrect calculation of lateral scatter from lung tissue with the 
QIB algorithm will lead to overestimate of the dose at the lung/chest interface. 
To address the issue of comparing dissimilar treatment planning systems all cases have 
also been planned with the exIMRT system but with X-ray IMRT only. Hereafter the X-ray only 
IMRT plan will be referred to as the xIMRT plan. The xIMRT plan allows comparison of the 
exIMRT plan with an idealised X-ray IMRT plan. As this xIMRT plan is not limited by physical 
constraints it may be superior to the segmented IMRT plan. However the segmented IMRT plan, 
from the commercial treatment planning system, has the advantage of being independent of the 
exIMRT planning system. It will therefore be determined whether there is an improvement in 
mean OAR dose with the exIMRT plan as compared to the xIMRT plan as well as the segmented 
IMRT plan.  
 
6.3. Case descriptions 
6.3.1. Case descriptions: Introduction 
The following sub-sections present a brief description of four clinical cases considered for the 
exIMRT technique. With the exception of Case 3 all cases use an initial electron photon weight of 
m=0.85, as described in Chapter 5. Case 3 uses a weighting of m=1.00 but separate electron and 
X-ray dose objectives in the first stage to create an electron ‘boost’ field. The contribution of the 
electron component to the total dose for each case is presented in Table 6.1 as the ratio of the mean 
dose to the PTV from the electron field to the mean dose to the PTV from combined electron and 
X-ray dose distribution. All cases exhibit a significant contribution from the electron component 
with > 72% of the dose from the electron field for Case 1, 2 and 4 and 34% of the dose from the 
electron field for Case 3. 
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6.3.2. Description: Case 1 - Paraspinal sarcoma 
Sarcomas are malignant tumours that invade the soft tissues such as muscles nerves and fat. 
Sarcomas in the paraspinal muscles pose a technical challenge due to their proximity to the spinal 
cord. The treatment plan must irradiate the tumour to the prescribed dose whilst observing the dose 
constraint of maximum dose to the spinal cord and at the same time minimise dose to underlying 
organs at risk. For this reason paraspinal sarcomas are a potential area of expansion for adult proton 
therapy treatment (Weber et al., 2004, Weber et al., 2007)  
This particular example includes a CTV approximately 13cm wide by 13cm long with a 
depth of up to 5.5cm. The CTV extends close to the skin surface and is overlying the spinal cord 
but not wrapped around the cord. The clinical plan is a 6MV VMAT 200o partial arc to 60Gy in 
30 fractions. The dose objectives of the plan are to cover the PTV defined as the CTV plus a 5mm 
isotropic margin maintaining a maximum of 50Gy to 1cc of the spinal cord planning risk volume 
(PRV) and minimising dose to normal tissue, in particular the underlying liver and kidneys. For 
optimisation the PTV was edited back 5mm from the skin surface. No bolus was added and the 
reduced surface dose was accepted by the Clinician. Clinically the dose to the actual PTV as well 
as the modified PTV was reported. Only dose to the modified PTV is reported here due to 
uncertainty in the dose calculation at the surface. The VMAT plan was created by an experienced 
member of staff using the Monaco treatment planning system with two arcs both arcing between 
260o and 100o. The treatment was re-planned for this study using the exIMRT technique with a 
single anterior MERT field and an anterior and four oblique 6MV photon IMRT fields (gantry 
angles of 300o, 270 o, 0 o, 60o and 90o). All fields share a single isocentre in the patient midplane. 
The field arrangement and dose objectives are similar to the non-clinical example in Chapter 5 and 
the same approach to optimisation has been used.  
For comparison, an xIMRT plan was created with 6 fields equally spaced between 260o 
and 100o (mimicking the Monaco VMAT plan) with the isocentre in the centre of the PTV. This 
xIMRT plan has been optimised using the same objectives as the exIMRT plan. 
 
6.3.3. Description: Case 2 – Brain 
Brain tumours are amongst the most devastating of all malignant diseases. Glioblastoma multiform 
(GBM) is the most common primary brain tumour in adults. The standard therapy for GBM is 
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maximal surgical resection followed by radiotherapy and concurrent chemotherapy. In spite of 
extensive treatment the diseases is associated with poor clinical outcome (von Neubeck et al., 
2015). The maximum radiation dose is limited by neurological toxicities so perhaps if the dose to 
normal brain tissue could be reduced with exIMRT there would be an opportunity to attempt dose 
escalation or at least make re-treatment following local recurrence more acceptable.  
For low grade brain tumours where radiotherapy is potentially more successful, irradiation 
of normal brain tissue has been related to radiation induced cognitive impairment (Greene-
Schloesser et al., 2012). In a similar manner to Case 1 there is some suggestion that reducing 
normal tissue dose with proton therapy could reduce side effects and the risk of secondary cancers 
(Arvold et al., 2012, Dennis et al., 2013, Brown et al., 2013). Although brain tumours can occur 
anywhere in the brain, they may be suitable for exIMRT if they are close to the surface. 
In this example a right sided high grade glioblastoma multiform tumour with PTV 8 cm by 
6 cm up to 6.6 cm deep extending 5mm to 9mm from the surface (no bolus or editing of PTV 
required) was treated with 6MV VMAT to 60 Gy in 30 fractions.  The clinical treatment plan was 
created using the Monaco treatment planning system by an experienced planner with a start angle 
of 190 o and a finish angle of 340 o. The treatment was re-planned for this study using the exIMRT 
technique with a single MERT field and 5 X-ray fields at gantry angles of 190o, 230o, 270o, 310o 
and 340o. All fields shared a single isocentre, level with the centre of the PTV in the superior 
inferior direction but in the centre of the brain to provide some reduction in SSD for the electron 
field. For comparison an xIMRT plan was created with 5 fields at the same gantry angles as the 
exIMRT plan, which cover the same arc as the Monaco VMAT plan. This xIMRT plan has been 
optimised using the same objectives as the exIMRT plan. 
  
6.3.4. Description: Case 3 – Concomitant breast boost 
Test Case 3 is slightly different to the first two in that the electron field is used as a boost dose 
within a larger X-ray photon dose distribution. Electron boosts have historically been used for 
breast treatments in order to take advantage of the dose drop off distal to the target to spare heart 
and lung tissue. Tangential X-ray field are used to treat the whole breast, angled to avoiding lung 
and heart tissue with additional electron fields added as boost to the tumour bed. This technique 
does have its drawback such as the limited control over dose conformity and the difficulties in 
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accurate set up (Davidson et al., 2015, De Santis et al., 2016). exIMRT could perhaps be used to 
create a more complex and stable integrated dose distribution still taking advantage of the dose 
drop off in the electron component.  
The example is taken from the IMPORT-HIGH trial for dose escalated intensity modulated 
radiotherapy (Bliss, 2015). The trial protocol includes a concomitant boost to the tumour bed 
normally achieved with additional small X-ray boost fields on top of tangential whole breast fields. 
The more difficult planning test case from the trial QA process was selected. This case is the higher 
dose arm and is on the left side overlying the heart. The total desired dose was set to 53 Gy to the 
tumour bed (PTVtb) 40Gy to the partial breast (PTVpb) and 36Gy to the whole breast (PTVwb). 
Both the PTVwb and PTVpb were edited back 5mm from the patient surface. For the clinical 
Monaco step and shoot IMRT (ssIMRT) treatment plan virtual bolus was used in order to achieve 
a flash margin. For the IMRT and exIMRT treatment plan virtual bolus was not used, as robustness 
to set up was not considered as part of this study.  
For the exIMRT plan tangential X-ray fields at the same gantry angles as the Monaco 
ssIMRT plan (307 o and 132o) were used but no boost X-ray fields were added. In place of the 
boost X-ray fields a single MERT field was added to the tangential photon fields. To create the 
boost effect the initial desired electron dose was set to just 17Gy to the tumour bed and 4Gy to the 
partial breast. Dose objectives were taken from the IMPORT-HIGH protocol. All fields were 
placed with a single isocentre level with the centre of the PTV in the superior inferior direction 
but at the lung/chest interface to provide some reduction in SSD.  
The exIMRT plan created was compared to the Monaco ssIMRT plan which used boost X-
ray fields confined to the PTVpb volume as well as tangential fields to cover the whole breast 
volume.  Boost X-ray fields were positioned at gantry angles 0o, 45o and 90o. The Monaco ssIMRT 
treatment plan had previously been accepted by the trial validation team. The ssIMRT arrangement 
was replicated for an xIMRT plan which was optimised using the exIMRT objectives modified to 
create the boost with the X-ray fields.   
 
6.3.5. Description: Case 4 – Head and Neck re-treatment 
In this example a patient who has had previous radiotherapy treatment to a volume on the right 
side of their oropharynx has returned for treatment to new tumour that has developed on the left 
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side. This situation presents a technical challenge as it is difficult to assess the amount of repair to 
normal tissue between treatments and therefore determine what new dose can be safely given. If 
we assume no repair in-between treatment then the total dose received by OAR from the two 
treatments combined must be considered (McDonald et al., 2011).  
For this example the maximum dose to the spinal cord was limited by the clinician to just 
5 Gy in order to ensure a combined maximum dose for the original plan and retreatment plan of 
<50 Gy. The clinician also requested that the dose to the mandible be reduced as much as possible 
in order to reduce what is a significant risk of osteoradionecrosis (Nadella et al., 2015). 10mm 
thick wax bolus was added for the planning CT scan (and retained for treatment) to ensure adequate 
dose to the CTV in regions where it extends close to the patient surface. The bolus was added to 
an area indicated by the clinician using clinical judgment prior to the CTV being defined.  
Consequently the bolus covers a wider area than it would if it were determined by the proximity 
of the drawn CTV to the patient surface.  
The clinical treatment plan was created using the Monaco treatment planning system by an 
experienced planner with 6 fields angled away from the spinal cord at gantry angles 300o, 330o, 
0o, 60o, 90o and 120o. This plan was achieved after exploring multiple options including VMAT 
and a single direct electron field. The treatment was re-planned for this study using the exIMRT 
technique with a direct MERT field and X-ray fields at the same gantry angles as the Monaco 
ssIMRT plan. All fields shared a single isocentre level with the centre of the PTV in the superior 
inferior direction but on the patient midline to provide some reduction in SSD for the electron 
field. The ssIMRT arrangement was replicated for an xIMRT plan which was optimised using the 
exIMRT objectives. 
Table 6.1 Contribution of the electron component to the mean PTV dose for exIMRT treatment plans 





Case 3 Case 4 
PTV PTVtb PTVpb-tb PTVwb-pb 
Electron  49.53 44.56 18.03 10.36 2.25 44.10 
Total  60.04 59.83 52.69 43.05 35.50 60.80 
%electron  82.5% 74.5% 34.2% 24.1% 6.3% 72.5% 




6.4.1. Results: Introduction 
A summary of results for the four clinical cases is presented in the following sub-sections. 
Although it is not always clinically relevant, the mean dose to the OAR is presented as an indicator 
of the reduction in OAR dose with exIMRT. Similarly, the average reduction in the mean dose 
with exIMRT has been calculated to summarise this reduction in a single quantitative value. A 
table of the full dose-volume data together with clinical dose objectives has been provided for each 
case in Appendix B.  
 
6.4.2. Results: Case 1 - Paraspinal sarcoma 
The Monaco VMAT, xIMRT and exIMRT plans meet all clinical dose objectives (Appendix B). 
The exIMRT technique is able to produce adequate target coverage with improved conformity. A 
representative dose distribution and DVHs are shown in Figure 6.1 and  
Figure 6.2 respectively. There is a reduction in the low dose wash with a corresponding 
improvement in dose for all OAR with the exIMRT plan. The reduction in the mean dose to OAR 
with exIMRT is 76.3% on average (see Figure 6.3). The X-ray only xIMRT plan is slightly more 
conformal than the clinical VMAT plan. In particular the xIMRT has an improved dose gradient 
between the spinal cord and the PTV than either the VMAT plan or the exIMRT plan.  The dose 
to 1cc of the spinal cord PRV is therefore lower for the xIMRT plan than the exIMRT plan, 25.2 
Gy compared to 33.0Gy. The exIMRT plan spinal cord dose is however within tolerance (1cc ≤ 
50Gy) and there is reduction in the low dose wash and a corresponding reduction in the dose to 
the kidneys, spleen and liver when compared to the xIMRT plan. Compared to the xIMRT plan 
exIMRT achieves a reduction in mean dose to OAR of 66.1% on average (not including the spinal 
cord).  
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Figure 6.1 Case 1: Dose distribution on the isocentre slice for paraspinal sarcoma plan in the axial (top) and 
sagittal plane (bottom) for Monaco 6MV VMAT, xIMRT and exIMRT treatment plans. 





Figure 6.2 Case 1: DVH for paraspinal sarcoma plan Monaco 6MV VMAT (top), xIMRT (bottom) and 
exIMRT treatment plans. 
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6.4.3. Results: Case 2 – Brain 
The Monaco VMAT, xIMRT and exIMRT plans meet all clinical dose objectives (Appendix B). 
Dose distribution and DVHs are shown in Figure 6.4 and Figure 6.5 respectively. The exIMRT 
technique is able to produce adequate target coverage whilst avoiding the ocular apparatus with a 
reduction in dose to normal brain tissue. This reduction in normal brain dose can be seen in Figure 
6.4 as a reduction in the exit dose beyond the tumour depth. In order to achieve this reduction the 
dose fall of the electron field is boosted by a posterior X-ray field resulting in a posterior hot streak. 
This streak is however thin and less than 70% of the prescribed dose.  There is a 68.3% average 
reduction in the mean dose to all OAR with exIMRT (see Figure 6.6).  
As with Case 1 the xIMRT plan is slightly more conformal than the clinical VMAT plan 
and the reduction with exIMRT is reduced to 61.2% on average. In particular the dose for normal 
brain tissue, defined as Brain-PTV, is lower for xIMRT than Monaco VMAT such that reduction 
in Brain dose with exIMRT is 55.5% when compared to Monaco VMAT but only 34.1% when 
compared to xIMRT. 
 
 
Figure 6.4 Case 2: Dose distribution on the isocentre slice for brain plan in the axial plane for Monaco 
6MV VMAT (left) and exIMRT (right) treatment plans. 
 





Figure 6.5 Case 2: DVH for Brain plan Monaco 6MV VMAT and exIMRT treatment plans. 
 
 
Figure 6.6 Case 2: OAR mean doses for Monaco 6MV VMAT, xIMRT and exIMRT treatment plans.  
 
6.4.4. Results: Case 3 - Concomitant breast boost 
The Monaco ssIMRT, xIMRT and exIMRT plans meet all clinical dose objectives (Appendix B). 
A representative dose distribution and DVHs are shown in Figure 6.7 and Figure 6.8 respectively. 
The Monaco plan and the X-ray only xIMRT plan compare well considering the numerous 
differences in the systems. The exIMRT plan is able to produce adequate target coverage but with 
only small improvements in the higher dose OAR values. The volume of ipsilateral heart or lung 
receiving 10 Gy or more is not significantly improved with exIMRT. However, as the exIMRT 
plan has no exit dose from X-ray boost fields there is a reduction in the low dose wash resulting 
in a reduction in the average dose to OAR.  There is a 45.6% average reduction in the mean dose 
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to all OAR with exIMRT (see Figure 6.9). There is a reduction in the dose to the contralateral side 
with the mean dose for the Contralateral Lung and Contralateral Breast reduced from 1.0 Gy and 
0.5Gy respectively to a negligible 0.1 Gy with exIMRT. These values should be viewed with 
caution due to the inaccuracies of dose calculations at these low levels (Huang et al., 2013) but 
demonstrate the fact that there is no exit dose to the contralateral side with exIMRT.  As with 
Cases 1 and 2 the xIMRT plan is slightly more conformal than the clinical IMRT plan and the 
reduction with exIMRT is reduced to 59.3% on average. 
 
 
Figure 6.7 Case 3: Dose distribution on the isocentre slice for concomitant breast boost plan in the axial 
plane for Monaco 6MV ssIMRT (left) and exIMRT (right) treatment plans. 
 
  







Figure 6.8 Case 3: DVH for concomitant breast boost plan Monaco 6MV ssIMRT and exIMRT treatment 
plans (with detail at under 10Gy). 
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6.4.5. Results: Case 4 – Head and Neck re-treatment 
This was a difficult case and not all clinical dose objectives were met by any of the three plans 
(Appendix B). The Monaco ssIMRT plans meets all objectives apart from the optimal objective of 
1cc of the spinal cord PRV to ≤5Gy, where 5.9Gy was achieve and clinically accepted. The xIMRT 
plan meets all objectives apart from the dose to 99% of PTV which is just under the 54Gy tolerance 
at 53.5 Gy. The exIMRT plan meets all objectives apart from the objective of 1cc of the spinal 
cord PRV to ≤5Gy, which is just over at 5.1Gy, and the dose to 5% of the PTV which is just over 
the 63Gy tolerance at 63.5Gy. Representative dose distributions and DVHs are shown in Figure 
6.10 and Figure 6.11 respectively. The exIMRT plan is able to match the Monaco ssIMRT plan 
for target coverage and low dose to the spinal cord but not without some dose from the X-ray 
photon component passing through the mandible. Having a very low objective on the spinal cord 
limits the amount of coverage achievable with the electron component and some X-ray dose is 
required to boost dose in the electron dose fall off region. As this X-ray dose is only required at 
the distal edge of the PTV some sparing of the mandible is achieved and the mean dose is reduced 
by 20.8% from 19.7Gy to 15.6Gy. The maximum dose to the mandible is not reduced as this is 
limited by the overlap between the mandible and the PTV. As with Case 1, 2 and 3 the xIMRT 
plan is slightly more conformal than the clinical IMRT plan and mean dose to the mandible is only 
reduced by 12.3% to 17.8Gy (see Figure 6.12). In addition the dose to the spinal cord is actually 
lower for the xIMRT plan than for the exIMRT plan, with 1cc of the spinal cord PRV receiving 
3.3Gy compared to 5.1Gy. 
 
Figure 6.10 Case 4: Dose distribution on the isocentre slice for head and neck re-treatment plan in the axial 
plane for Monaco 6MV ssIMRT (left) and exIMRT (right) treatment plans. 











Figure 6.12 Case 4: OAR mean doses for Monaco 6MV ssIMRT, xIMRT and exIMRT treatment plans. 
 
The dose to the mandible could be reduced further but only with some compromise in PTV 
coverage. A second plan was produced with a single direct mixed X-ray and MERT field. With no 
fields passing through the mandible this single field plan has a mean mandible dose of 8.2Gy. The 
PTV coverage is however reduced to 95% of the PTV volume receiving 50.1Gy (not 57Gy as 
required). The CTV is covered by the 90% isodose dose. This compromise could conceivably be 
clinically acceptable in a situation where mandible dose is a priority. 
 
6.5. Radiobiology 
The EUD for the PTV and the NTCP for relevant OAR have been calculated for all four 
cases above. For the PTV EUD a nominal value of a =-10 has been used as described in the report 
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of TG-66 for the comparison of planning systems (Allen Li et al., 2012). For NTCP an attempt has 
been made to find the most relevant data for each organ with the default being the LKB model 
with Emami-Burman parameters if no other values were found (Burman et al., 1991).  Details of 
the models and parameters used have been provided in Appendix C. 
 
6.5.1. Radiobiology: Case 1 
For Case 1 the target coverage and uniformity of dose within the PTV with exIMRT is 
much the same as for the Monaco ssIMRT plan leading to similar values of EUD for the PTV.  
There is a reduction in the low dose wash leading to a reduction in EUD for the OAR with exIMRT. 
However, the dose received by these organs is already low and the predicted NTCP using the LKB 
model and Emami-Burman parameters is < 0.001 for all OAR with both ssIMRT and exIMRT 
(see Table 6.2). 




 EUD  
PTV 59.02 59.51 1.01 
Rt Kidney 8.36 2.12 0.25 
Liver 4.03 0.29 0.07 
 NTCP  
all OAR <0.001 <0.001 - 
 
6.5.2. Radiobiology: Case 2 
In Case 2, as with Case,  the target coverage and uniformity of dose with the PTV achieved 
with exIMRT is similar to that of the Monaco VMAT plan leading to similar values of EUD for 
the PTV.  The EUD for the brain as a whole is reduced with exIMRT due to a reduction in low 
dose outside the PTV.  Similar to the previous case the NTCP using the LKB model and Emami-
Burman parameters is < 0.001 for both the VMAT and exIMRT plans (see Table 6.3).  
 
 
Chapter 6 Clinical treatment plan comparison 
120 
  




 EUD  
PTV 59.75 59.43 0.99 
Brain 20.47 4.62 0.23 
 NTCP  
Brain <0.001 <0.001 - 
 
6.5.3. Radiobiology: Case 3 
For Case 3 there are some differences in the distribution of dose within the PTV with the exIMRT 
plan leading to differences in EUD. In the tumour bed PTV there is an increase in cold spots but 
also an increase in hot spots resulting in higher EUD for exIMRT. In the whole breast volume 
there is a small reduction in EUD due to a reduction in coverage with the exIMRT plan. 
A common side effect of breast radiotherapy is fibrosis. Modern radiotherapy attempts to 
reduce hot spots within the treated volume to try to minimise the risk of fibrosis. The impact of 
exIMRT on fibrosis risk should therefore be considered. The probability of fibrosis has been 
studied in detail in (Mukesh et al., 2013) by fitting NTCP curves to data from two trials and testing 
the models against data from a third trial. The best fit parameters from these curves have been used 
in this work to calculate a NTCP for the whole breast volume. Although there is an increase in 
hotspots with the tumour bed volume with exIMRT the EUD for the breast volume as a whole is 
lower for the exIMRT plan resulting in a reduction in NTCP.   
One of the aims of breast radiotherapy is to minimise the dose to lung tissue in order to 
minimise the risk of radiation induced pneumonitis. There are a number of published models 
describing the risk of pneumonitis associated with breast cancer as outlined in a review by Svolos 
et al. (Svolos et al., 2011).  In this work the model described in  (Rancati et al., 2007) is used as it 
predicts the highest probability of complications. Using the parameters from (Rancati et al., 2007) 
the risk of Grade >=1 pneumonitis for the ipsilateral breast have been calculated. The exIMRT 
plan demonstrates a risk relative to the ssIMRT plan of 0.36, or 36% of the risk with the IMRT 
plan. Using the model in (Seppenwoolde et al., 2003) for the lung as a paired organ gives a much 
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lower absolute risk of Grade >=2 pneumonitis but with a similar reduction for exIMRT with a 
relative risk value of 0.36 (see Table 6.4).  
The risk of cardiac mortality has been predicted using the relative seriality model suggested 
by Gagliardi (Gagliardi et al., 2000). Although the EUD for the Heart is reduced with exIMRT the 
calculated NTCP with both ssIMRT and exIMRT for this plan is already very low,  <0.001, so a 
relative reduction is not relevant. 




 EUD  
PTVtb 41.94 52.26 1.25 
PTVpb-tb 40.69 40.72 1.00 
PTVwb-pb 37.12 33.13 0.89 
Ipsilateral lung 5.40 3.37 0.62 
Lung paired organ 3.07 2.66 0.87 
Heart 1.76 0.20 0.11 
 NTCP  
PTVwb 0.105 0.086 0.82 
Ipsilateral lung 0.031 0.014 0.36 
Lung paired organ 0.007 0.004 0.37 
Heart <0.001 <0.001 - 
 
6.5.4. Radiobiology: Case 4 
For Case 4 the target coverage and uniformity of dose within the PTV with exIMRT is similar to 
that observed for the Monaco ssIMRT plan, leading to similar EUD for the PTV. The most 
clinically relevant issue associated with this treatment is the risk of osteoradionecrosis to the 
mandible. As this is a retreatment this will be the cumulative effect of this treatment and the 
original treatment. The cumulative effect has been estimated by assuming a uniform 30Gy dose 
wash to the mandible from the original 60Gy treatment. The total dose has therefore been 
calculated as the retreatment plan dose plus 30Gy.  Using the LKB model and Emami-Burman 
values this leads to high complication probability with both methods but with exIMRT it is reduced 
by a factor of 0.72 (see Table 6.5). 
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 EUD  
PTV 59.68 60.84 1.02 
 NTCP  
(Inc. 60Gy previous treatment) 
Mandible 0.813 0.584 0.72 
 
 
6.5.5. Conformity and Malignant induction probability (MIP) 
One of the aims of exIMRT is to minimise the exit dose from IMRT to reduce dose wash and 
improve conformity. This effect has been examined by calculating the conformity index (CI) 
defined as the ratio between the target volume and the volume irradiated to a certain dose level 
(Knöös et al., 1998). The CI is typically greater than 1, with values closest to 1 being the most 
conformal. CI is often used to describe the conformity of the 95% dose isodose to the PTV. The 
interest of this study is to determine where the improvement in conformity lies. Therefore, CI has 
been calculated for the 95% and 50% of the prescribed dose and at fixed dose levels of 20, 10, 5 
and 2 Gy (see Table 6.6).  
For Cases 1, 2 and 3 the conformity of the 95% isodose for the Monaco plan and the 
exIMRT plan is similar with less than 0.1 difference in CI. For Cases 1 and 2 the conformity of 
the 50% isodose is improved with exIMRT as is the conformity of the 20, 10, 5 and 2Gy dose 
levels with the relative improvement increasing at the lower dose levels. There is a relatively high 
low dose wash for the VMAT plan of Case 1 leading to the biggest improvement with exIMRT 
with CI2 reduced from 24.75 to 8.14.  
Case 3 is different to Case 1 and 2 in that the limitations of using the electron as a boost 
with fixed tangential fields leads to less of an improvement in conformity. There is some 
improvement in CI for the lowest dose levels for Case 2 with CI2 reduced from 4.23 to 2.32. 
Case 4 has not been included in this analysis as the improvement of conformity was not 
one of the aims of that planning study. 
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Table 6.6 Conformity index for clinical Case 1, 2 and 3 










95% 1.19 (57Gy) 1.10 (57Gy) 1.00 (57Gy) 1.02 (57Gy) 1.24 (32.4) 1.22 (32.4 ) 
50% 2.88 (30Gy) 2.04 (30Gy) 1.53 (30Gy) 1.22 (30Gy) - - 
20 4.47 2.57 4.38 2.13 1.61 1.53 
10 8.53 4.82 6.26 2.81 1.94 1.67 
5 15.28 5.40 6.78 3.58 2.47 1.81 
2 24.75 8.14 7.41 5.28 4.23 2.21 
 
It hypothesised that this improvement in conformity with exIMRT could result in a 
corresponding reduction in the probability of secondary cancer induction. In order to assess this 
effect the malignant induction probability (MIP) has been calculated according to the method of 
Timlin et al. (Timlin et al., 2011, Timlin et al., 2015).  With reference to the work of Timlin et al. 
values of alpha = 0.09 and beta = 0.03 have been used in Cases 1 and 2 to give an alpha/beta = 3 
whereas in Case 2 values of alpha = 0.06 and beta = 0.04 have been used. Details of the MIP 
calculation are given in Appendix C. The absolute value of MIP depends on parameters that must 
be tuned to clinical data for secondary cancer induction and should therefore be used with caution.  
Of most interest is the relative MIP value (relMIP). The relMIP is only weekly dependent on the 
model and parameters used (Timlin et al., 2011) so it is more useful for comparing similar plans. 
With exIMRT the relMIP is less than 1 in all cases and between 0.20 and 0.67 (see Table 6.7). 
Table 6.7 Relative Malignant Induction Probability (relMIP) for exIMRT compared to the Monaco 
IMRT/VMAT plan 
 relMIP 
Case 1  
Liver 0.24 
Kidney 0.49 
Case 2  
Brain 0.67 
Case 3  
Ipsilateral lung 0.64 
Contralateral lung 0.20 
Contralateral breast 0.35 
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6.5.6. Discussion and conclusion 
In each of the four cases studied here the exIMRT technique was able to produce good quality 
plans that met the dose constraints. In all cases these exIMRT plans were able to reduce the dose 
to OAR when compared to the clinical Monaco 6MV IMRT or VMAT plan. In particular, on 
average, a mean dose reduction between 59.3% and 76.3% was observed. This comparison is 
perhaps optimistic resulting from the use of idealised X-ray photon intensity in the exIMRT plan, 
however, comparison with an idealised X-ray only still revealed OAR mean dose reduction of 
45.6% to 66.1%. This suggest that a reduction in OAR dose distal to the target of around 50% is 
achievable with exIMRT. 
As dose to these OAR is already low the actual clinical impact of exIMRT may also be 
low. The calculated NTCP is in most cases already small therefore the relative improvement is not 
clinically significant. However, calculations with the latest models for pneumonitis in breast 
cancer reveal a NTCP that is 36% of that for the standard plan. With future improvements to the 
sensitivity of NTCP models it might be possible to realise similar improvements in other cases. 
As the dose gradient for the electron field is limited some X-ray photon dose may be 
required to boost dose at the distal edge of the PTV. This effect leads to streaking in Case 2 and to 
the requirement of X-ray beams through the mandible in Case 4. This however assumes no change 
to the PTV for exIMRT. True robust planning, rather than the use of planning target volumes, may 
yield further improvements due to the insensitivity of changes to the electron dose to movement 
along the field direction. 
The greatest improvement with exIMRT in this study is the reduction of the low dose, seen 
as improvement in the conformity index at the 20Gy to 2Gy level.  This is potentially associated 
with a relative reduction in secondary cancer induction as demonstrated by a relMIP of 20% to 
67% for the exIMRT plans. 
This study shows just four examples of possible applications of the exIMRT technique to 
carefully selected clinical cases. Although results are encouraging a full planning study would be 
required   in order to determine conclusively whether or not the improvements with exIMRT over 
standard IMRT and VMAT are statistically significant.





General conclusions and further research 
perspectives 
 
This final chapter presents the overall conclusions that can be drawn from this research and 
suggests some of the future work that may follow-on from it. 
 
7.1. General conclusions 
 
The research described in this thesis aimed to answer the following question posed in Chapter 1: 
 
 Is an isocentric combined X-ray and electron therapy treatment possible with no 
modifications to equipment and can it be used to improve radiotherapy dose 
distributions? 
 
The first contribution of this work towards answering this question is the proposition that 
the linac is run in scattering foil free mode. Through measurement it has been demonstrated that 
improvements to dosimetry by removal of the scattering foils would allow delivery with xMLC 
without reducing SSD making a single isocentre and synergistic delivery of the electron and 
photon components a practical proposition. 
The second contribution of this work is the demonstration that the dose distribution from 
the scattering foil free electron beam can be accurately calculated using Monte Carlo dose 
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calculations. The accuracy of Monte Carlo calculations for electron dose distributions is well 
established. In this study it has additionally been shown that the dose at extended SSD for small 
fields collimated with the xMLC can be accurately calculated by correctly accounting for the jaws 
and MLC and scatter in the air gap between the MLC and the patient. 
The third contribution of this work is in the development of a two stage optimisation 
procedure to take advantage of the electron component of the mixed modality beam. In 
development of the optimisation routine a number of properties of the mixed modality plan have 
been highlighted. The issue of matching electron fields with effective widths greater than their 
geometric widths has been examined. The benefit of leaving gaps between electron segments was 
demonstrated and it was shown that by introducing gaps and optimising the field a uniform dose 
distribution can be built up in the central part of the electron field. It has been shown that these 
gaps are also useful when matching dissimilar energies and that the optimal way to combine 
multiple energies is by free optimisation rather than pre-determined selection by range. The option 
of overlapping matrices to produce a feathering effect was considered but found to provide only a 
small benefit for a large increase in computational time. Optimising the mixed modality treatment 
plan lead to multiple local minima dependent on the initial proportion of electron dose 
contribution. Using an 85% proportion of electrons relative to the total dose was found to be 
optimal. Optimisation of the mixed modality ‘exIMRT’ plan for geometric phantom demonstrated 
a potential improvement in OAR dose with the technique 
The fourth contribution of this work is in demonstrating the clinical application of the 
exIMRT technique to clinical situations. For the four cases chosen the exIMRT technique has been 
shown to be able to reduce dose to organs at risk with the average improvement in mean dose 
between 45.6% and 76.3% using exIMRT.  The absolute dose to these OAR is already low and 
the optimised clinical plan NTCP calculations, in most cases, produced a negligible value. It was 
however possible to identify a significant reduction in the relative risk of pneumonitis for the breast 
case, i.e. 0.36 with exIMRT. In all cases no appreciable change in target EUD was seen with 
exIMRT. A reduction in the low dose wash with exIMRT was converted to a relMIP value of 
between 0.20 and 0.67. This suggests that some reduction in the probability of secondary cancer 
induction is possible with exIMRT. 
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In summary this work has shown that an isocentric combined X-ray and electron therapy 
treatment is possible with no modifications to equipment and can potentially be used to improve 
radiotherapy dose distributions. In particular, exIMRT appears promising as a method to reduce 
the low dose wash with a corresponding reduction in secondary cancer risk for treatment sites 
close to the surface including breast, sarcoma and superficial brain treatments. 
 
7.2. Further research perspectives 
Although the results of this study are encouraging there are a number of questions that remain to 
be answered before exIMRT is put into clinical practice. These further research perspectives are 
described in the following sections.  
 
7.2.1. Robustness 
Throughout this study the concept of the planning target volume (PTV) has been used. The PTV 
is defined to take into consideration the net effect of all possible geometrical variation from the 
clinical target volume (CTV). The PTV includes a margin to account for set up uncertainties 
including patient positioning and patient movement during treatment. The effect of patient 
movement in particular may be different for exIMRT when compared to IMRT. Movement of the 
patient along the axis of the electron beam direction will result in less of a change in dose 
distribution than if the patient were moved within a uniformly distributed IMRT X-ray dose 
distribution. This effect could be beneficial in that perhaps PTV margins can be reduced at the 
distal edge of the PTV. However, the effect could also be problematic if it results in a mismatch 
with the X-ray field component. It is suggested that a study is required to artificially introduce 
geometric shifts into exIMRT plans to investigate their robustness to patient movement. 
In addition to patient movement the robustness to air density should be studied. Henzen et 
al. (Henzen et al. 2014) suggest that changes in the order of 3% are possible due to the variation 
in scatter conditions with air density changes due to fluctuations in atmospheric pressure.  Some 
of these variations would be accounted for by the output monitoring of the linac ionisation 
chamber. It is suggested therefore that robustness to air density for exIMRT is studied and should 
include measurement as well as modelling. 
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7.2.2. Planning studies 
As part of this work clinical examples have been used to demonstrate the potential benefits of the 
exIMRT technique. Now for each treatment site of interest a full planning study is required to 
prove whether the exIMRT technique is statistically an improvement over standard techniques. 
Selecting multiple patients each with different characteristics would provide a more complete test 
of the technique 
 
7.2.3. Clinical implementation and validation 
Clinical implemented of the exIMRT requires further work in a number of areas. First a clinical 
implementation of the exIMRT treatment planning system would be required. This clinical 
exIMRT treatment planning system would include segmentation of the X-ray component and MU 
calculation and sequencing of the electron component. The system would also have to be 
integrated with the treatment machine record and verify system in order to deliver the exIMRT 
plan. Once a deliverable plan was achievable additional work is required to verify the accuracy of 
the treatment plan. Verification of the delivered dose distribution could be achieved either with 
radiochromic film measurements or with gel dosimetry.  Calculation of dose to the skin from 
exIMRT should be verified with thermoluminescent dosimeters (TLD) placed on the surface of a 
phantom.  
Additional work would then be required in order to integrate routine calibration of the 
scattering foil electron beam into clinical practice. It is likely that this would require each scattering 
foil free energy to be considered as a separate energy which would undergo calibration according 
to the electron codes of practice (Thwaites et al., 2003). Routine use of exIMRT would also require 
some form of pre-treatment quality control check of the calculated dosimetry. This check would 
be complicated by the fact that it is not possible to extract information from the exit beam of the 
electron component as is done with the X-ray component. Radiochromic film or gel dosimetry 
would be an option but would be difficult to implement efficiently in practice. Possible alternatives 
include measurement of the intensity maps for individual beams at shallow depths, measurement 
using a multi-layered ionisation chamber, independent calculation of dose distributions or some 
combination of these methods.  Note that this issue is also applicable to proton therapy such that 
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This Appendix presents a description of the heuristic optimisation algorithms and parameters used 
in Chapter 5. A description of the function used for benchmarking the algorithm is presented in 
Table A1. This work was conducted in collaboration with undergraduate students Paul Johnson 
and Thomas Roussi.  
 
A.1. Genetic Algorithm 
The Genetic algorithm is a heuristic search method that is inspired by the natural process of 
evolution. Genetic algorithms (GA) have been used extensively for the optimisation of problems 
where gradient based solutions can become trapped into local minima. The general method of a 
genetic algorithm is to randomly create an initial population of solutions in a search space then 
enable these solutions to mutate and combine with each other to create an overall solution that 
meets the required criteria. Each solution in this population has a set of properties that control its 
overall ability. Each property in the solution is referred to as a gene that can be mutated or 
altered. If just one of these genes is changed it has the ability to change the overall solution. Each 
gene is assessed by a fitness factor and the most successful genes selected to progress (Mitchell, 
1996). The basic algorithm for the GA used in this work consists of the following: 
Step 1. Generate: The initial population of random solutions is created with each gene 
being part of the search space. 
Step 2. Evaluate: The fitness function is used to rate the initial population and evaluates 
their ability to solve the problem 
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Step 3. Select: The most effective solutions of the problem are selected from the fitness 
function 
Step 4. Combine: The selected solutions are then have their properties combined by 
the process of crossover to create ‘children’ that contain propertied of each of 
the ‘parents’. 
Step 5. Mutate: A proportion of children are allowed to randomly mutate. 
Step 6. Evaluate: These solutions are then evaluated by the fitness function 
Step 7. Destroy: The old less effective solutions are destroyed and replaced by newer 
solutions 
Step 8. Finish or repeat: If the fitness function produces a result the meets the needed 
criteria then the program is stopped. If the system has not reached this criteria 
then the system resets back to step 3 
The parameters used for the GA algorithm are given Table A2. 
 
A.2. Particle Swarm Optimisation (PSO) 
Particle Swarm Optimisation is a method based on the swarming intelligence that can occur in 
flocks of birds or shoals of fish. The population of this swarm consists of particles. Each particle 
assesses its current fitness value within the search space it is inside and communicates its own 
with neighbours in the swarm. The movement of each particle is controlled by a movement vector 
that is controlled by the history of fitness factors of it and its neighbours and also random 
permutations (Poli, 2008) 
The basic algorithm of the particle swarm used in this work consists of the following: 
Step 1. Initialize : Create a swarm of Particles uniformly distributed around the search 
space 
Step 2. Evaluation: Particles asses their fitness and asses the best know position 
compared to their initial condition 
Step 3. Update: The swarm updates the best know position 
Step 4. Movement: Each particle calculates their vector movement (mixture of 
random movement and best known position) 
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Step 5. End or Repeat: Repeat to step 2 if the system requirements are not met. If they 
are met the algorithm finishes. 
The parameters used for the PSO algorithm are given Table A2. 
 
A.1. Firefly Algorithm 
The Firefly Algorithm is a nature inspired algorithm, inspired by the behaviour of fireflies (Yang, 
2008). In reality, fireflies emit light to attract fireflies of the other sex and to find a loving partner. 
The Firefly Algorithm is inspired by this behaviour but with some modifications: 
 
1) All fireflies are unisexual, so that any individual firefly will be attracted to all other 
fireflies; 
2) Attractiveness is proportional to their brightness, and for any two fireflies, the less bright 
one will be attracted by (and thus move towards) the brighter one; however, the intensity 
(apparent brightness) decrease as their mutual distance increases; 
3) If there are no fireflies brighter than a given firefly, it will move randomly; 
 
With these known factors is in now possible to describe the algorithm for the Firefly 
algorithm. Which follows as: 
Step 1. Initialize: Create a swarm of fireflies uniformly distributed around the search 
space with randomly created initial velocities. 
Step 2. Evaluation: Asses the fitness of the Fireflies through a fitness function and 
then produce the equivalent brightness for each firefly. Including the idea of 
distance change. 
Step 3. Movement: Each firefly moves in the direction of search space that has the 
brightest firefly compared to them. 
Step 4. Repeat and End: This cycle repeats to Step 2 until the criteria for the fitness 
value is best and so the best solution is chosen. 
A summary of the parameters used for the Firefly algorithm are given Table A2. 
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Table A1 Functions used for tuning and evaluation of the optimisation algorithms 
Function Equation 1D or 2D representation 
of function 
   
Second order PID 
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Table A2 Optimisation algorithm parameters used for IMRT problem 
Algorithm Parameter Description 
GA PopulationSize: 1000 Size of the population 
 CrossoverFraction: 0.8 The fraction of the population at the next generation created by the 
crossover function 
 MigrationFraction:0.2 Fraction of individuals in each subpopulation that migrates to a different 
subpopulation 
 MigrationInterval:20 Number of generations that take place between migrations of individuals 
between subpopulations 
PSO MaxGen: 400 Maximum number of generations of each particle 
 D:200 Swarm size 
 1.0 Inertia weight 
 C1,C2: 2.0 Learning factor 
PPO MaxGen: 300 Maximum number of generations of each particle 
 D:50 Swarm Size 
 R: 3 Search Range 
 α:0.1 Alpha Velocity 
 Imax: 10 Inertia Max 
 Imin: 0 Inertia Min 
 C1:2 Learning factor 
 C2:8 Learning factor 
 Fa:1 Fear range: maximum amplitude 
 Fb:1 Fear range: drop off characteristic 
 FL:0.7 Fear level 
 Ev:5 Exploratory move: vector size 
 Es:0.01 Exploratory move: step size 
 Ed:1 Exploratory move: number dimensions 
Firefly MaxGen : 200 Maximum number of generations of each particle 
 n:400 Number of fireflies. 
 𝛽 :1 Adjusts the importance of the move term over the precedent location. 
 𝛾 :0.1 Absorption coefficient: The higher it is, the less the fireflies will be attracted 
by each other. 
 𝛼 :0.8 Adjusts the importance of the random term (0-1).  
 𝛿 :0.99 Randomness reduction 







This Appendix presents the dose objectives used for the treatment plan evaluation in Chapter 6 
along with the dose-volume data achieved for the clinical plan (Monaco), the X-ray only plan 
(xIMRT) and the combined electron and X-ray plan (exIMRT).  






Volume to PTV (Gy)  Dose (Gy) 
98% ≥54Gy 54.0 56.0 55.9 
95% ≥57Gy 57.2 57.9 57.3 
50% =60Gy 60 60 60 
5% ≤63 61.7 61.3 62.4 
2% ≤66 62.4 61.8 63.4 
    
Structure   Dose to 1cc (Gy) 
Spinal cord PRV ≤50Gy 50.0 25.2 33.0 
  Dose to 100cc 
Small Bowel a.l.a.p 6.9 4.3 2.2 
Large Bowel a.l.a.p 7.1 6.3 1.2 
  Mean Dose (Gy) 
Right Kidney a.l.a.p 8.5 6.3 2.4 
Left Kidney a.l.a.p 8.5 7.3 2.6 
Spleen a.l.a.p 12.5 10.5 2.6 
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Table B2 Dose-volume data: Case 2 Brain 
 Dose Objective 6MV VMAT 
(Monaco) 
xIMRT exIMRT 
Dose to PTV (Gy)  Dose (Gy) 
99% ≥54Gy 57 57.1 54.2 
95% ≥57Gy 57.8 58.2 57.1 
50% =60Gy 60 60 60 
5% ≤63 61.6 61.0 62.7 
2% ≤66 62.0 61.5 63.4 
    
Structure    
Brain stem PRV D1cc≤60Gy (54Gy optimal) 56.4 55.3 32.6 
 V59Gy<10cc 0 0 0 
Chiasm PRV Dmax<60Gy (54Gy optimal) 59.3 58.7 47.7 
Optic Nerve Left Dmax<60Gy (54Gy optimal) 23.1 23.2 9.1 
Optic Nerve Right Dmax<60Gy (54Gy optimal) 57.5 40.1 45.4 
Orbit Left Dmax<50 11.1 9.3 2.5 
Orbit Right Dmax<50 34.9 6.7 19.5 
Lens Left Dmax<6 3.9 5.7 1.1 
Lens Right Dmax<6 8.1 1.5 5.3 
 
 
Table B3 Dose-volume data: Case 3 Breast 
Volume Dose Objective   6MV 
ssIMRT 
(Monaco) 
 xIMRT exIMRT 
 Volume Dose     
PTVWB -PTVPB >90%   32.4Gy  98.3 96.8 94.3 
 median dose = 34 - 37Gy  37.0 36.1 35.6 
 < 5% > 40Gy  0.9 0.8 1.8 
PTVPB -PTVTB > 90% 36.0Gy  97.0 97.5 99.4 
 median dose = 40 - 44Gy  40.8 39.7 43.2 
 < 3%  > 53Gy  0.4 0.1 0.2 
PTVTB > 95%  50.4Gy  96.9 97.4 95.1 
 median dose = 52.5 - 53.5 Gy  53.0 53.6 53.5 
 < 3%  > 56.7 Gy  0.1 0.0 0.6 
 Global max < 58.3 Gy  57.4 57.9 58.2 
 Dose (Gy) %Max allowable 
volume (Optimal) 
  
Ipsilateral Lung 18 15 (10)  9.3 7.2 6.9 
 9 -  18.2 13.0 10 
 2 -  51.1 45.0 25.7 
 Mean 6  5.8 5.0 3.5 
Contralateral Lung 2.5 15 (5)  11.2 9.7 0.1 
 Mean (1)  1.0 0.9 0.1 
Heart 13 10 (2)  0.7 0.4 0.3 
 2 -  15.5 12.0 10.4 
 Mean (3)  1.9 1.1 0.7 
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Table B4 Dose-volume data: Case 4 Head and Neck re-treatment 




Dose to PTV (Gy)  Dose (Gy) 
99% ≥54Gy 55.4 53.5 54.0 
95% ≥57Gy 57.7 57.0 57.2 
50% =60Gy 60 60 60 
5% ≤63 61.5 61.5 63.5 
2% ≤66 61.9 62.5 64.5 
    
Structure    
Cord PRV D1cc≤5Gy Optimal 5.9 3.3 5.1 
 Dmax <10Gy 7.5 15.1 8.6 
Mandible D1cc a.l.a.p. 56.8 54.8 57.4 
 Dmean a.l.a.p. 19.7 17.8 15.6 








This Appendix presents a description of the radiobiology models and parameters used for the 
treatment plan evaluation in Chapter 6. 
 
C1.   NTCP 
Two normal tissue complication (NTCP) models have been used for the calculations in Chapter 6. 
The Lyman-Kutcher-Burman (LKB) model and the relative seriality model. Both models are 
described in detail in TG-166 (Allen Li et al., 2012). They are formulated as described below with 
parameters used for these models presented in Table C1. 
 
LKB NTCP model 


















where EUD is the dose that, if given uniformly to the entire volume, will lead to the same NTCP 
as the actual non-uniform dose distribution, TD50 is the uniform dose given to the entire organ that 
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results in 50% complication risk, m is a measure of the slope of the sigmoid curve, n is the volume 
effect parameter, and vi is the fractional organ volume receiving a dose Di.  
 
Relative Seriality Model 











where vi is the volume irradiated to a homogeneous dose Di , V the total volume, TD50 is the 
uniform dose that causes 50% probability of complication, γ is the slope of the curve, and s is the 
relative seriality. 
Table C1Parameters for NTCP calculations 
Organ Complication Model TD50 a m Reference 
Kidney Renal dysfunction LKB 28 0.7 0.1 Emami-Burman (1991) 
Liver Radiation induced liver 
disease 
LKB 40 0.32 0.15 Emami-Burman (1991) 
Brain Necrosis LKB 60 0.25 0.15 Emami-Burman (1991) 
Breast Fibrosis LKB 
(BEUD3) 
132 0.012 0.35 Mukesh et al. (2013) 
Lung Grade ≥ 1 pneumonitis LKB 16.4 0.86 0.36 Rancati et al., (2007) 
Lungs as a 
paired Organ 
Grade ≥ 2 pneumonitis LKB  30.8 0.99 0.37 Seppenwoolde et al. (2003) 
Heart Cardiac mortality Relative 
seriality 
52.3 γ=1.28 s=0.87 Gagliardi (2007) 
Mandible Osteoradionecrosis LKB 72 0.07 0.1 Emami-Burman (1991) 
 
C2.    Malignant Induction probability (MIP) 
Malignant induction probability has been calculated according to Timlin et al. (Timlin et al., 2011, 
Timlin et al., 2015). The calculation has been formulated as described below with parameters used 
for this model presented in Table C2. 
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where di, is the dose per fraction in voxel i, N is the number of voxels and α, β, γ, and δ are the 
radiobiological parameters.  The number of fractions, n, the probability that a transformed cell 
becomes an overt malignancy, ϵ, and the number of cells pre-treatment in voxel i, C0i , all cancel 
in the calculation of relative MIP. 
Table C2 Parameters for relMIP calculations 
  α, β γ δ 
Case 1&3  0.09 0.03 10-6α 10-6 β 
Case 2  0.06 0.03 10-6α 10-6 β 
 
